
<html lang="en"     class="pb-page"  data-request-id="686fc878-34ce-42bb-8f67-de5584fa092a"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2017.60.issue-15;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/acs.jmedchem.7b00648;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Synthesis and Evaluation of Diphenyl Conjugated Imidazole Derivatives as Potential Glutaminyl Cyclase Inhibitors for Treatment of Alzheimer’s Disease" /></meta><meta name="dc.Creator" content="Manman  Li" /></meta><meta name="dc.Creator" content="Yao  Dong" /></meta><meta name="dc.Creator" content="Xi  Yu" /></meta><meta name="dc.Creator" content="Yue  Li" /></meta><meta name="dc.Creator" content="Yongdong  Zou" /></meta><meta name="dc.Creator" content="Yizhi  Zheng" /></meta><meta name="dc.Creator" content="Zhendan  He" /></meta><meta name="dc.Creator" content="Zhigang  Liu" /></meta><meta name="dc.Creator" content="Junmin  Quan" /></meta><meta name="dc.Creator" content="Xianzhang  Bu" /></meta><meta name="dc.Creator" content="Haiqiang  Wu" /></meta><meta name="dc.Description" content="High expression of glutaminyl cyclase (QC) contributes to the initiation of Alzheimer’s disease (AD) by catalyzing the generation of neurotoxic pyroglutamate (pE)-modified β-amyloid (Aβ) peptides. ..." /></meta><meta name="Description" content="High expression of glutaminyl cyclase (QC) contributes to the initiation of Alzheimer’s disease (AD) by catalyzing the generation of neurotoxic pyroglutamate (pE)-modified β-amyloid (Aβ) peptides. ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 25, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b00648" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00648" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b00648" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00648" /></link>
        
    
    

<title>Synthesis and Evaluation of Diphenyl Conjugated Imidazole Derivatives as Potential Glutaminyl Cyclase Inhibitors for Treatment of Alzheimer’s Disease | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b00648" /></meta><meta property="og:title" content="Synthesis and Evaluation of Diphenyl Conjugated Imidazole Derivatives as Potential Glutaminyl Cyclase Inhibitors for Treatment of Alzheimer’s Disease" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00648/20170804/images/large/jm-2017-00648m_0015.jpeg" /></meta><meta property="og:description" content="High expression of glutaminyl cyclase (QC) contributes to the initiation of Alzheimer’s disease (AD) by catalyzing the generation of neurotoxic pyroglutamate (pE)-modified β-amyloid (Aβ) peptides. Preventing the generation of pE-Aβs by QC inhibition has been suggested as a novel approach to a disease-modifying therapy for AD. In this work, a series of diphenyl conjugated imidazole derivatives (DPCIs) was rationally designed and synthesized. Analogues with this scaffold exhibited potent inhibitory activity against human QC (hQC) and good in vitro blood–brain barrier (BBB) permeability. Further assessments corroborated that the selected hQC inhibitor 28 inhibits the activity of hQC, dramatically reduces the generation of pE-Aβs in cultured cells and in vivo, and improves the behavior of AD mice." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b00648"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b00648">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b00648&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b00648&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b00648&amp;href=/doi/10.1021/acs.jmedchem.7b00648" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 15</span><span class="cit-fg-pageRange">, 6664-6677</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/15" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b00597" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b00662" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Synthesis and Evaluation of Diphenyl Conjugated Imidazole Derivatives as Potential Glutaminyl Cyclase Inhibitors for Treatment of Alzheimer’s Disease</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Manman++Li">Manman Li</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span><span class="author-xref-symbol "><sup>∇</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yao++Dong">Yao Dong</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span><span class="author-xref-symbol "><sup>∇</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xi++Yu">Xi Yu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yue++Li">Yue Li</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yongdong++Zou">Yongdong Zou</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yizhi++Zheng">Yizhi Zheng</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhendan++He">Zhendan He</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhigang++Liu">Zhigang Liu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Junmin++Quan">Junmin Quan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xianzhang++Bu">Xianzhang Bu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Haiqiang++Wu">Haiqiang Wu</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0003-3979-7304" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">§</span> <span class="aff-text">Department of Pharmacy, School of Medicine, Shenzhen University, Shenzhen 518060, China</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">#</span> <span class="aff-text">College of Life Sciences and Oceanography, Shenzhen University, Shenzhen 518060, China</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">⊥</span> <span class="aff-text">School of Medicine, Shenzhen University, Shenzhen 518060, China</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">†</span> <span class="aff-text">Key Laboratory of Structural Biology, School of Chemical Biology & Biotechnology, Peking University, Shenzhen Graduate School, Shenzhen 518055, China</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">‡</span> <span class="aff-text">School of Pharmaceutical Science, Sun Yat-sen University, Guangzhou, 510006, China</span></div><div class="aff-info" id="aff6"><span class="aff-symbol">∥</span> <span class="aff-text">Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, California 90095, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: +86 755 8617 2799. E-mail: <a href="/cdn-cgi/l/email-protection#5a2d2f322b1a29202f743f3e2f743934"><span class="__cf_email__" data-cfemail="86f1f3eef7c6f5fcf3a8e3e2f3a8e5e8">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00648&amp;href=/doi/10.1021%2Facs.jmedchem.7b00648" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 15</span><span class="cit-pageRange">, 6664–6677</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 12, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>1 May 2017</li><li><span class="item_label"><b>Published</b> online</span>25 July 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 10 August 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b00648" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00648</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6664%26pageCount%3D14%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DManman%2BLi%252C%2BYao%2BDong%252C%2BXi%2BYu%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D15%26contentID%3Dacs.jmedchem.7b00648%26title%3DSynthesis%2Band%2BEvaluation%2Bof%2BDiphenyl%2BConjugated%2BImidazole%2BDerivatives%2Bas%2BPotential%2BGlutaminyl%2BCyclase%2BInhibitors%2Bfor%2BTreatment%2Bof%2BAlzheimer%25E2%2580%2599s%2BDisease%26numPages%3D14%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6677%26publicationDate%3DAugust%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b00648"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1846</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">24</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b00648" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Synthesis and Evaluation of Diphenyl Conjugated Imidazole Derivatives as Potential Glutaminyl Cyclase Inhibitors for Treatment of Alzheimer’s Disease&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Manman&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Yao&quot;,&quot;last_name&quot;:&quot;Dong&quot;},{&quot;first_name&quot;:&quot;Xi&quot;,&quot;last_name&quot;:&quot;Yu&quot;},{&quot;first_name&quot;:&quot;Yue&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Yongdong&quot;,&quot;last_name&quot;:&quot;Zou&quot;},{&quot;first_name&quot;:&quot;Yizhi&quot;,&quot;last_name&quot;:&quot;Zheng&quot;},{&quot;first_name&quot;:&quot;Zhendan&quot;,&quot;last_name&quot;:&quot;He&quot;},{&quot;first_name&quot;:&quot;Zhigang&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Junmin&quot;,&quot;last_name&quot;:&quot;Quan&quot;},{&quot;first_name&quot;:&quot;Xianzhang&quot;,&quot;last_name&quot;:&quot;Bu&quot;},{&quot;first_name&quot;:&quot;Haiqiang&quot;,&quot;last_name&quot;:&quot;Wu&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;25&quot;,&quot;issue&quot;:&quot;15&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;6664-6677&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b00648&quot;},&quot;abstract&quot;:&quot;High expression of glutaminyl cyclase (QC) contributes to the initiation of Alzheimer’s disease (AD) by catalyzing the generation of neurotoxic pyroglutamate (pE)-modified β-amyloid (Aβ) peptides. Preventing the generation of pE-Aβs by QC inhibition has been suggested as a novel approach to a disease-modifying therapy for AD. In this work, a series of diphenyl conjugated imidazole derivatives (DPCIs) was rationally designed and synthesized. Analogues with this scaffold exhibited potent inhibitory activity against human QC (hQC) and good in vitro blood–brain barrier (BBB) permeability. Further assessments corroborated that the selected hQC inhibitor 28 inhibits the activity of hQC, dramatically reduces the generation of pE-Aβs in cultured cells and in vivo, and improves the behavior of AD mice.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00648&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00648" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00648&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00648" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00648&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00648" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00648&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00648&amp;href=/doi/10.1021/acs.jmedchem.7b00648" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b00648" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b00648" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (8 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b00648%26sid%3Dliteratum%253Aachs%26pmid%3D28700245%26genre%3Darticle%26aulast%3DLi%26date%3D2017%26atitle%3DSynthesis%2Band%2BEvaluation%2Bof%2BDiphenyl%2BConjugated%2BImidazole%2BDerivatives%2Bas%2BPotential%2BGlutaminyl%2BCyclase%2BInhibitors%2Bfor%2BTreatment%2Bof%2BAlzheimer%25E2%2580%2599s%2BDisease%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D15%26spage%3D6664%26epage%3D6677%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292253" title="Imidazoles">Imidazoles</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/15" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/jmcmar.2017.60.issue-15/20170810/jmcmar.2017.60.issue-15.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00648/20170804/images/medium/jm-2017-00648m_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00648/20170804/images/large/jm-2017-00648m_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00648&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">High expression of glutaminyl cyclase (QC) contributes to the initiation of Alzheimer’s disease (AD) by catalyzing the generation of neurotoxic pyroglutamate (pE)-modified β-amyloid (Aβ) peptides. Preventing the generation of pE-Aβs by QC inhibition has been suggested as a novel approach to a disease-modifying therapy for AD. In this work, a series of diphenyl conjugated imidazole derivatives (DPCIs) was rationally designed and synthesized. Analogues with this scaffold exhibited potent inhibitory activity against human QC (hQC) and good <i>in vitro</i> blood–brain barrier (BBB) permeability. Further assessments corroborated that the selected hQC inhibitor <b>28</b> inhibits the activity of hQC, dramatically reduces the generation of pE-Aβs in cultured cells and <i>in vivo</i>, and improves the behavior of AD mice.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30433" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30433" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Alzheimer’s disease manifests as a progressive dementia that currently affects over 40 million people worldwide.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The devastating impact of AD on public health, the global economy, and society in general is widely recognized.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> The hallmarks of AD are the presence of extracellular amyloid plaques composed of Aβ peptides (mainly Aβ<sub>42</sub> and Aβ<sub>40</sub>) surrounded by activated glia and by intracellular neurofibrillary tangles composed of hyperphosphorylated tau protein, which makes Aβs and tau protein the prime drug targets for the development of anti-AD agents.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a></div><div class="NLM_p">The pathogenesis of AD has been extensively investigated, and the Aβ pathology, in which the Aβ peptides produced from proteolytic cleavage of the amyloid precursor protein (APP) by β- and γ-secretase, are believed to trigger AD pathogenesis via their aggregating forms, is well documented.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4, 5)</a> In this regard, targeting Aβ pathology was considered a promising approach for prevention of AD and possibly other dementias. Unfortunately, though the behavior of AD can be improved in AD model mice by inhibiting the production or aggregation or increasing clearance of Aβ peptides, many key elements of the disease neurobiology remain controversial, and there is no reliable cure or disease-modifying therapy available for use before AD progresses to major memory loss and functional decline.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> The consistent failure of drug candidates targeting late-stage Aβ pathology in clinical trials has led to a major shift toward exploring new causes involved in the very early phases of AD.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a></div><div class="NLM_p">During the past decades a variety of N-truncated Aβs starting with amino residue Ala-2, pyroglutamylated Glu-3, phe-4, arg-5, pyroglutamylated Glu-11, and so on, have been identified in AD brains.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Aβs undergo N-terminal truncation and cyclization of N-terminal glutamate (E) to pyroglutamate (pE), generating pE-Aβ<sub>3–40/42</sub> and pE-Aβ<sub>11–40/42</sub>. These pE-Aβs, especially pE-Aβ<sub>3–42</sub>, account for more than 50% of the total Aβ plaques in the AD brains.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a> These modified Aβs have proteolytic resistance and increased hydrophobicity, and they aggregate more rapidly than normal Aβs, seed further Aβ aggregation, and are more neurotoxic.<a onclick="showRef(event, 'ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13">(11-13)</a> Importantly, pE-Aβs may be key initiators of AD pathogenesis in the early stages of AD.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a> Reducing the generation of pE-Aβs should promote more efficient Aβ proteolysis and prevent aggregation by clearance of a major nucleation factor and thus help prevent the initiation of the disease process.</div><div class="NLM_p">The pyroglutamylation of N-truncated, N-terminal Glu-Aβs is catalyzed by glutaminyl cyclase (QC, also known as QPCT, EC 2.5.2.3),<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a> which is widely distributed in mammalian brain with robust expression in the hippocampus and cortex.<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15, 16)</a> Consistently increased expression of QC is correlated with the generation of pE-Aβ<sub>3–42</sub> and other Aβs in AD brains. Moreover, higher levels of QC mRNA are found in AD brains compared to age-matched normal brains, and a positive correlation between QC expression and the severity of AD has been confirmed.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> It is revealed that QC inhibition attenuated the generation of pE-Aβ<sub>3–4</sub> in an AD model mouse brain, diminished the formation of Aβ plaques, and significantly improved the AD-like pathology.<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18, 19)</a> Thus, QC inhibitors may offer a new option for the development of novel anti-AD agents.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> In view of this, a few QC inhibitors have been reported.<a onclick="showRef(event, 'ref21 ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref21 ref22 ref23 ref24">(21-24)</a> Typically, these inhibitors contain an aromatic motif tethered to an imidazole moiety, where the aromatic ring matches the hydrophobic space at the entrance of the active site, and the imidazole moiety is used to bind the catalytic zinc ion at the bottom of the pocket. For instance, the representative analogue <b>1</b> (PBD150, <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>A, upper), which was developed by Buchholz et al.,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> was found to be efficient in reducing the generation of pE-Aβ in a transgenic <i>Drosophila</i> model and also reduced AD pathology in several transgenic mouse models. Despite this proof of principle, however, these QC inhibitors have poor BBB permeability.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Therefore, the discovery of QC inhibitors with high activity and appropriate BBB penetrability is urgently needed to bring these novel anti-AD drugs to the clinic. Here, we describe the design and discovery of a series of DPCIs as potential QC inhibitors. These DPCIs retained the general properties required for reported inhibitory mechanisms but with enhanced inflexibility and BBB penetration, through conformational restriction and polarity tuning based on rational design. Our optimal DPCI shows higher QC inhibitory potency and improved <i>in vitro</i> BBB penetrability than <b>1</b>, and its beneficial effects on the pE-Aβ production and AD pathogenesis were validated in cell culture and in B6C3-Tg (APPswe/PSEN1dE9) double-transgenic mice.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00648/20170804/images/medium/jm-2017-00648m_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00648/20170804/images/large/jm-2017-00648m_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Proposed skeleton of DPCIs and the docked model with hQC. (A) Structure of <b>1</b> (top) and prototypical DPCI (<b>2</b>, bottom); (B, C) Overlay pose of <b>1</b> (green) and <b>2</b> (brown) in the catalytically active region of hQC (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PBB">3PBB</a>). Protein surface is illustrated in panel B. Compound <b>2</b> was predicted to interact with hQC in a manner similar to <b>1</b>; the important residues are shown using stick format in panel C.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00648/20170804/images/large/jm-2017-00648m_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00648&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67582" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67582" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Design and Synthesis of DPCIs</h3><div class="NLM_p">To search for efficient QC inhibitors, the interaction of reported analogue <b>1</b> with the human QC (hQC) was first determined based on the crystal structure of hQC in complex with <b>1</b> (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PBB">3PBB</a>).<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Of interest is the π–π stacking between the aromatic motif of <b>1</b> and Phe325 at the hydrophobic entrance of the active site, the orthogonally directed thiocarbamide starting linker, and the imidazole ring at the other terminus that runs deep into the narrow active site and binds with the catalytic zinc ion at the bottom of the pocket (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>B,C). Therefore, it was predicted that flexibility of the thiocarbamide starting linker may limit the binding of <b>1</b> with QC; moreover, the presence of the thiocarbamide motif makes the linker hydrophilic, which would be expected to contribute to poor BBB penetrability. After these considerations, we replaced the thiocarbamide motif by an additional phenyl ring to generate a diphenyl moiety and introduced an imidazole functionalized linker at the <i>ortho</i>-position of the new phenyl ring to generate the new DPCI analogues. These modifications are anticipated to result in a more rigid conformation that will match the binding features by restricting the orthogonal conformation between the aromatic motif with the imidazole attached linker (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>B,C) and increase the hydrophobicity to favor BBB penetration. The basic structure of DPCIs is shown in <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>A (bottom).</div><div class="NLM_p">According to this concept, a series of DPCIs (<b>2</b>–<b>41</b>, <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) with various substitutions and different linker lengths were designed and synthesized (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). Briefly, bromoaniline derivatives were coupled with phenylboronic acid derivatives to give the diphenyl intermediates <b>i</b> by Suzuki–Miyaura reactions under the catalysis of Pd(DPPF)<sub>2</sub>Cl<sub>2</sub> and K<sub>2</sub>CO<sub>3</sub> in 1,4-dioxane. Then the intermediates <b>i</b> reacted with 1,3-dibromopropane or 1,2-dibromoethane providing the intermediate <b>ii</b> in the presence of K<sub>2</sub>CO<sub>3</sub> in acetonitrile. Finally, the nucleophile substitution reaction between <b>ii</b> and imidazole derivatives afforded the desired products in the presence of K<sub>2</sub>CO<sub>3</sub> in acetonitrile.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00648/20170804/images/medium/jm-2017-00648m_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00648/20170804/images/large/jm-2017-00648m_0006.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00648/20170804/images/large/jm-2017-00648m_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00648&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Pd(DPPF)<sub>2</sub>Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, reflux, 3 h, 100 °C, Ar; (b) acetonitrile, K<sub>2</sub>CO<sub>3</sub>, reflux, overnight; (c) acetonitrile, K<sub>2</sub>CO<sub>3</sub>, reflux, overnight.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Screening of DPCIs as hQC Inhibitors</h3><div class="NLM_p">The hQC–glutamic acid dehydrogenase linked assay was used to evaluate the inhibitory potency of the resulting compounds. The percentages of inhibition at 100 μM (% at 100 μM) toward hQC were recorded. As expected, compound <b>2</b> significantly inhibited the activity of hQC (85.34%, <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). By modifying substitutions on ring A, we observed that the methyl substitution at R<sub>3</sub> (<b>3</b>) or R<sub>4</sub> (<b>5</b>) or isopropyl substitution at R<sub>5</sub> (<b>6</b>) sharply decreased the inhibitory activity, while replacing the methyl at R<sub>3</sub> (<b>4</b>) with smaller F recovered the activity to an even higher level, indicating hindrance occurred by methyl substitution at the R<sub>3</sub>, R<sub>4</sub>, and R<sub>5</sub> positions. In contrast, the methyl substitution at R<sub>6</sub> (<b>7</b>) moderately increased the inhibitory potency (96.14%), and F substitution at R<sub>6</sub> did not affect the activity (compare <b>10</b> with <b>8</b>). These observations are consistent with the predicted mode (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>B), wherein A ring presents at the entrance of the deep pocket; therefore the methyl substitution at inner positions R<sub>3</sub>, R<sub>4</sub>, or R<sub>5</sub> may limit the interaction of the compounds with hQC, while the R<sub>6</sub> points to the outside and allows substitutions with appropriate volume. In addition, replacing the 3′,4′-dimethoxy on the B ring with 3′- or 4′-F substitution apparently did not affect the binding (compare the inhibitory activities of <b>2</b> with <b>8</b> and <b>11</b> and <b>7</b> with <b>9</b>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Inhibitory Activities of Imidazole Unsubstituted Analogues on hQC</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00648/20170804/images/medium/jm-2017-00648m_0007.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center">R<sub>3</sub></th><th class="colsep0 rowsep0" align="center">R<sub>4</sub></th><th class="colsep0 rowsep0" align="center">R<sub>5</sub></th><th class="colsep0 rowsep0" align="center">R<sub>6</sub></th><th class="colsep0 rowsep0" align="center" char=".">% inhibition at 100 μM</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">85.34 ± 2.04</td><td class="colsep0 rowsep0" align="char" char=".">2.08</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">51.74 ± 7.69</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">94.67 ± 1.78</td><td class="colsep0 rowsep0" align="char" char=".">1.38</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="."><a class="ref internalNav" href="#t1fn2" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH(CH<sub>3</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">51.23 ± 3.8</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">96.14 ± 0.89</td><td class="colsep0 rowsep0" align="char" char=".">0.64</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">85.11 ± 7.03</td><td class="colsep0 rowsep0" align="char" char=".">3.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">92.83 ± 2.25</td><td class="colsep0 rowsep0" align="char" char=".">0.83</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char=".">85.50 ± 1.46</td><td class="colsep0 rowsep0" align="char" char=".">1.56</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">78.21 ± 4.67</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn2"><div class="footnote" id="t1fn2"><sup>a</sup><p class="last">No obvious activity.</p></div></div></div><div class="NLM_p">The second batch of evaluation was focused on the analogues <b>12</b>–<b>20</b> (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>) with a 2′-methyl substituted imidazole ring (C ring), and similar substitution patterns in rings A and B. These analogues generally showed low to moderate activities, and the 2′-methyl substitution at the C ring dramatically decreased the activity comparing the inhibitory potency of <b>12</b>, <b>13</b>, <b>14</b>, <b>15</b>, <b>16</b>, <b>17</b>, and <b>19</b> to that of <b>3</b>, <b>5</b>, <b>6</b>, <b>8</b>, <b>9</b>, <b>10</b>, and <b>11</b>, respectively. According to the proposed binding model, the zinc atom located at the bottle of the active site of hQC could be chelated by the 3′-N atom in the imidazole moiety. Therefore, it could be concluded that the decrease of their activities may be attributed to the blockage of the chelation by 2′-methyl substitution of the C ring.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Inhibitory Activities of Analogues with 2′-Methyl Substituted Imidazole Ring on hQC</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00648/20170804/images/medium/jm-2017-00648m_0009.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center">R<sub>3</sub></th><th class="colsep0 rowsep0" align="center">R<sub>4</sub></th><th class="colsep0 rowsep0" align="center">R<sub>5</sub></th><th class="colsep0 rowsep0" align="center">R<sub>6</sub></th><th class="colsep0 rowsep0" align="center" char=".">% inhibition at 100 μM</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="."><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">8.61 ± 3.57</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH(CH<sub>3</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">11.83 ± 1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">37.04 ± 4.38</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">48.05 ± 3.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char=".">45.95 ± 24.76</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">41.97 ± 9.76</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">20.41 ± 4.36</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH(CH<sub>3</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">72.48 ± 9.18</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">No obvious activity.</p></div></div></div><div class="NLM_p">Interestingly, unlike the 2′-methyl substitution, 4′-methyl substitution at the C ring moderately or slightly increased the activity as compared with the inhibition rate of <b>21</b>, <b>23</b>, <b>27</b>, <b>28</b>, <b>30</b>, <b>31</b> and <b>32</b> vs <b>2</b>, <b>4</b>, <b>7</b>, <b>8</b>, <b>9</b>, <b>10</b> and <b>11,</b> respectively (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). More strikingly, compound <b>5</b>, which contains a methyl substitution in the R<sub>4</sub> position, was the least potent, nevertheless an additional introduction of methyl in the 4′-position of imidazole motif led to compound <b>24</b> with sharply increased inhibitory potency (94.48%). We reasoned that the 4′-methyl substitution at the imidazole ring may shift the binding site of <b>24</b> in hQC by the hydrophobic force between 4′-methyl and other residues in the native pocket. This would contribute to the chelation of the 3′-N atom in the imidazole motif with the zinc atom and favor the direct interaction between the molecule and enzyme. In the presence of an R<sub>3</sub> methyl (<b>3</b>) or R<sub>5</sub> isopropyl (<b>6</b>), however, the 4′-methyl substitution in imidazole cannot achieve the optimal binding position as indicated by the dramatically decreased activity of <b>22</b> and <b>26</b>, respectively.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Inhibitory Activities of Analogues with 4′-Methyl Substituted Imidazole Ring on hQC</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00648/20170804/images/medium/jm-2017-00648m_0011.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center">R<sub>3</sub></th><th class="colsep0 rowsep0" align="center">R<sub>4</sub></th><th class="colsep0 rowsep0" align="center">R<sub>5</sub></th><th class="colsep0 rowsep0" align="center">R<sub>6</sub></th><th class="colsep0 rowsep0" align="center" char=".">% inhibition at 100 μM</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">93.61 ± 3.8</td><td class="colsep0 rowsep0" align="char" char=".">0.89</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="."><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">95.19 ± 2.63</td><td class="colsep0 rowsep0" align="char" char=".">0.50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">94.48 ± 2.55</td><td class="colsep0 rowsep0" align="char" char=".">2.57</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">95.91 ± 1.63</td><td class="colsep0 rowsep0" align="char" char=".">0.94</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH(CH<sub>3</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="."><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">96.24 ± 1.54</td><td class="colsep0 rowsep0" align="char" char=".">0.70</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">92.57 ± 3.3</td><td class="colsep0 rowsep0" align="char" char=".">1.23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">92.41 ± 2.01</td><td class="colsep0 rowsep0" align="char" char=".">1.62</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">94.65 ± 2.00</td><td class="colsep0 rowsep0" align="char" char=".">0.79</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char=".">95.70 ± 2.62</td><td class="colsep0 rowsep0" align="char" char=".">0.88</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">87.28 ± 7.71</td><td class="colsep0 rowsep0" align="char" char=".">15.50</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">No obvious activity.</p></div></div></div><div class="NLM_p">While designing the molecules, we noticed that a propyl linker is sufficient to deliver the imidazole motif to the zinc ion located at the bottom of the active site. To explore the effect of linker length on the inhibitory potency, analogues with a shorter ethyl linker instead of the propyl linker and similar substitution partners on rings A and C were further designed, synthesized, and evaluated. All these compounds (<b>33</b>–<b>41</b>) showed poor potency on hQC inhibition as listed in <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>, and the reduction of the linker length dramatically decreased the activity (compare <b>33</b>, <b>35</b>, <b>36</b>, <b>37</b>, <b>38</b>, <b>39</b>, <b>40</b>, and <b>41</b> with <b>2</b>, <b>21</b>, <b>8</b>, <b>15</b>, <b>28</b>, <b>11</b>, <b>19</b>, and <b>32</b>, respectively). This observation indicated that the distance between the imidazole and biphenyl motif is critical to achieve favorable chelation of imidazole with the zinc ion on the bottom and the formation of π–π stacking of the aromatic motif with Phe325 at the entrance of the hQC active site.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Inhibitory Activities of Analogues with Short Linker on hQC</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00648/20170804/images/medium/jm-2017-00648m_0013.gif" alt="" id="fx4" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center">R<sub>3</sub></th><th class="colsep0 rowsep0" align="center">R<sub>4</sub></th><th class="colsep0 rowsep0" align="center" char=".">% inhibition at 100 μM</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">34.55 ± 4.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="."><a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">7.99 ± 4.64</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="."><a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="."><a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">8.82 ± 13.96</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">39.6 ± 1.19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">8.86 ± 4.81</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">19.05 ± 4.85</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">No obvious activity.</p></div></div></div><div class="NLM_p">Based on the results mentioned above, the inhibitory IC<sub>50</sub> values toward hQC of the analogues with percentages of inhibition >80% at 100 μM (<b>2</b>, <b>4</b>, <b>7</b>, <b>8</b>, <b>9</b>, <b>10</b>, <b>21</b>, <b>23</b>, <b>24</b>, <b>25</b>, <b>27</b>, <b>28</b>, <b>29</b>, <b>30</b>, <b>31</b>, and <b>32</b>) were determined using <b>1</b> as a positive control. All compounds except <b>32</b> demonstrated a sub- or low micromolar IC<sub>50</sub> (0.50–3.02 μM), which is lower than that of <b>1</b> (3.19 μM; <a class="ref internalNav" href="#tbl1" aria-label="Tables 1">Tables 1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). The structure–activity relationship (SAR) revealed by IC<sub>50</sub> values is in accordance with rules indicated by the screening, wherein the 4′-methyl substitution at the imidazole motif generally increases the potency of hQC inhibition (<b>2</b>, <b>4</b>, <b>8</b>, <b>9</b>, and <b>10</b> vs <b>21</b>, <b>23</b>, <b>28</b>, <b>30</b>, and <b>31</b> respectively) and methyl substitutions closer to the linker are more harmful to the activity (<b>24</b>, <b>25</b>, <b>27</b>, <b>29</b>, and <b>30</b>). Moreover, F substitution (<b>2</b> vs <b>4</b>, <b>21</b> vs <b>23</b>) at R<sub>3</sub>, as well as F (<b>8</b> vs <b>10</b>, <b>28</b> vs <b>31</b>) or methyl (<b>2</b>, <b>8</b>, <b>21</b>, and <b>28</b> vs <b>7</b>, <b>9</b>, <b>27</b>, and <b>30</b>, respectively) substitution at R<sub>6</sub> increases activity to a variable extent.</div><div class="NLM_p">To further understand the observed hQC inhibitory activity, molecular docking analysis of several potent inhibitors (<b>2</b>, <b>23</b>, and <b>28</b>) and the inactive inhibitors (<b>36</b> and <b>37</b>) was performed. The top ranked docked conformations for each compound were analyzed. The docked poses of the potent inhibitors (<b>2</b>, <b>23</b>, and <b>28</b>) resemble that of <b>1</b>. Both the π–π stacking between the terminal aromatic motif of the inhibitors and Phe325 at the hydrophobic entrance of the active site, and the chelation between the imidazole ring and the catalytic zinc ion at the bottom of the pocket were conserved (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>A–D). The binding of these potential DPCIs with hQC in the catalytically active region is predicted to be stronger. These compounds also exhibited increased potency of hQC inhibition compared with the positive control. In contrast, the poses of <b>36</b> and <b>37</b> deviate markedly from that of the potent inhibitors; the π–π stacking between the terminal aromatic motif of the inhibitors and Phe325 of hQC is disrupted due to the shorter linker (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>E,F). This also illuminated the SAR and hQC inhibitory potency of these designed DPCIs.</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00648/20170804/images/medium/jm-2017-00648m_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00648/20170804/images/large/jm-2017-00648m_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Docked conformations of DPCIs with hQC. (A) Binding mode of <b>1</b> with hQC (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PBB">3PBB</a>) in the crystal structure; (B–D) docked poses of potent inhibitors <b>2</b>, <b>23</b>, and <b>28</b>, respectively, with hQC; (E, F) docked poses of inactive inhibitors <b>36</b> and <b>37</b>, respectively, with hQC. The inhibitors are shown in stick mode, and hQC is shown in yellow cartoons. Interactions between the protein residues and inhibitors with the catalytic zinc ion at the bottom of the pocket are shown in dash lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00648/20170804/images/large/jm-2017-00648m_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00648&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Compound <b>28</b> Exhibits Improved Penetrability than <b>1</b> in PAMPA-BBB Mode</h3><div class="NLM_p">One of the main concerns in the development of active chemicals targeting the central nervous system (CNS) is the BBB permeation. In the current work, the new derivatives were expected to have improved BBB permeability attributed to the introduction of the diphenyl moiety. This expectancy was supported by the prediction with ADMET/blood–brain barrier descriptors using professional drug design software Discovery Studio. Two parameters, ADMET_BBB and ADMET_AlogP98, were used to evaluate the selected analogues and <b>1</b>, wherein ADMET_BBB means the base 10 logarithm of (brain concentration)/(blood concentration) as predicted by a robust (least-median-of-squares) regression derived from literature <i>in vivo</i> brain penetration data, and ADMET_AlogP98 is the octanol/water partition coefficient, which is another key molecular characteristic for bioactive chemicals. Here, <b>1</b> showed low scores with both ADMET_BBB and ADMET_AlogP98 (Table S1, see <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>), which were in line with expectations. Among the evaluated DPCI analogues, <b>9</b>, <b>10</b>, <b>28</b>, <b>29</b>, <b>30</b>, <b>31</b>, and <b>32</b> exhibited higher scores than <b>2</b>, <b>4</b>, <b>7</b>, <b>21</b>, <b>23</b>, <b>24</b>, <b>25</b>, and <b>27</b> with 3′,4′-dimethoxy substitutions in B ring, indicating that these analogues exhibited significantly enhanced lipophilicity, which may contribute to improved permeability of these DPCIs.</div><div class="NLM_p">To verify the prediction, we selected <b>28</b> as the representative compound for <i>in vitro</i> BBB penetration examination after a combined consideration of inhibitory activity, predicted ADMET_BBB score, and molecular weight, in which <b>28</b> and <b>30</b> were distinguished from others, but <b>30</b> is unfortunately less soluble in the test buffer. The <i>in vitro</i> BBB penetration was evaluated using a parallel artificial membrane permeation assay (PAMPA-BBB) following the generally reported protocols.<a onclick="showRef(event, 'ref27 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref29">(27-29)</a> The UV/vis absorptions of <b>28</b> and <b>1</b> after permeating through a porcine polar brain lipid (PBL) membrane were recorded from 290 to 310 nm and the effective permeabilities (Pe) were calculated. As described in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>, the Pe values of <b>28</b> in various wavelengths were significant higher than that of <b>1</b>, demonstrating a much stronger permeability of <b>28</b>. This result is consistent with our prediction.</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00648/20170804/images/medium/jm-2017-00648m_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00648/20170804/images/large/jm-2017-00648m_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Permeability of <b>28</b> determined by the PAMPA-BBB assay.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00648/20170804/images/large/jm-2017-00648m_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00648&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Compound <b>28</b> Inhibits QC and Reduces Generation of pE-Aβ<sub>3–42</sub> in Transfected HEK293T Cells</h3><div class="NLM_p">The hQC inhibitory potency of <b>28</b> was investigated in hQC and APP695 (NLQ) transfected human embryonal kidney cells, HEK293T, which overexpress recombinant hQC and Aβ<sub>3–42</sub>. It was found that <b>28</b> had no effect on the expression of hQC in transfected HEK293T cells (data not shown), but the activity of cellular hQC was effectively blocked by addition of <b>28</b> in the culture at a concentration of 10 μM. The percentage inhibition increased along with the culture time, and a maximal percentage inhibition was obtained after 24 h incubation (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A). Noticeably, when the culture time was extended to 48 h, a decreased percentage inhibition was observed, which could be attributed to a change in the expression and activity of recombinant hQC protein in the cell cycle different stages. The transfected HEK293T cells were therefore incubated with different concentrations of <b>28</b> for 24 h (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>B), and a significant dose-dependent inhibition was observed as expected, which is associated with the dose-dependent decreased generation of pE-Aβ<sub>3–42</sub> as determined by ELISA (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>C). These results indicated that <b>28</b> prevents the generation of pE-Aβ<sub>3–42</sub> by the inhibition of hQC in cultured cells.</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00648/20170804/images/medium/jm-2017-00648m_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00648/20170804/images/large/jm-2017-00648m_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Analysis of the inhibitory potency of <b>28</b> in transfected HEK293T cells. (A) Inhibitory effects of <b>28</b> on hQC in PCMV3-QPCT (hQC) and APP695-A673V transfected HEK293T cells, which were treated for 6, 12, 24, and 48 h at the concentration of 10 μM; (B) inhibitory effects of <b>28</b> on hQC in transfected HEK293T cells, which were treated for 24 h at the concentrations of 1, 10, 50, and 100 μM; (C) quantification of the pE-Aβ<sub>3–42</sub> in transfected HEK293T cells, which were treated with <b>28</b> for 24 h at the concentrations of 0, 1, 10, 50, and 100 μM using amyloid-β (N 3pE-42) ELISA kit. All experiments were performed in triplicate. Data are expressed as mean ± SD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00648/20170804/images/large/jm-2017-00648m_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00648&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Compound <b>28</b> Inhibits QC, Reduces Generation of pE-Aβ<sub>3–42</sub>, and Improves the Behavior of B6C3-Tg Mice</h3><div class="NLM_p">Based on the above results of <b>28</b> on the hQC inhibition at both molecular and cellular levels, we would expect it to exhibit beneficial effects on AD pathogenesis by inhibiting the activity of QC and reducing the generation of toxic pE-Aβ<sub>3–42</sub><i>in vivo</i>. Therefore, compound <b>28</b> was applied to 3-month-old female B6C3-Tg mice for 2 months by intraperitoneal injection with two doses, L and H (2 and 10 mg/kg weight respectively). QC activity assay revealed a dose-dependent decrease of QC activity in the hippocampus, cortex, and total brain of the <b>28</b> treated mice, respectively (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>A,B, <i>P</i> < 0.05), which is associated with the dose-dependent decrease of pE-Aβ<sub>3–42</sub> as revealed by ELISA (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>C) and immunohistochemistry (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>E,F). Interestingly, the accumulation of total soluble Aβs in the AD brain increased dose-dependently after the treatment with <b>28</b> (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>D), which is attributed to the low conversion of normal Aβs to pE-Aβs caused by QC inhibition. As pE-Aβs are believed to serve as seed and promote the formation of Aβ plaques, especially in the early stage, the significant dose-dependent reduction of Aβ plaques (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>G,H) may also have resulted from the inhibition of pE-Aβ generation by <b>28</b> treatment.</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00648/20170804/images/medium/jm-2017-00648m_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00648/20170804/images/large/jm-2017-00648m_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effects of <b>28</b> on the AD pathogenesis in the B6C3-Tg (APPswe/PSEN1dE9) double-transgenic mice. (A) Determination of QC activities in hippocampus, cortex, and total brain of AD mice treated with <b>28</b> at concentrations of 0 (C), 2 mg (L), and 10 mg/kg weight (H) by intraperitoneal injection for 2 months by SensoLyte green glutaminyl cyclase activity assay kit; (B) determination of QC activities in hippocampus, cortex, and total brain of AD mice by GD-QC assay; (C) quantification of pE-Aβ<sub>3–42</sub> in hippocampus, cortex, and total brain of AD mice using amyloid-β (N3pE-42) ELISA kit; (D) quantification of total soluble Aβs in the supernatants of hippocampus, cortex, and total brain of AD mice using ELISA analysis; (E) immunohistochemical detection of pE-Aβ<sub>3–42</sub> plaques in hippocampus and cortex area in the brain of AD mice; (F) quantification of the pE-Aβ<sub>3–42</sub> plaque load based on the histochemical staining in panel E; (G) immunohistochemical detection of total Aβ plaques in hippocampous and cortex area in the brain of AD mice; (H) quantification of the Aβ plaque load based on the histochemical staining in panel G; (I) evaluation of the house building capacity of the AD mice by Nesting test. To reduce the within group variance, only female mice were used in the study (<i>n</i> = 4 per group). Data are expressed as mean ± SE; * means <i>p</i> < 0.05 versus control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00648/20170804/images/large/jm-2017-00648m_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00648&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Subsequently, compound <b>28</b> treatment resulted in a significant behavioral improvement in B6C3-Tg mice as measured by a Nest-building test, reported as a useful index of behavioral deficits.<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30, 31)</a> Compared with the mice in the control group, compound <b>28</b>-treated mice exhibited an obvious improvement in nest-building capacity (<a class="ref internalNav" href="#fig5" aria-label="Figures 5">Figures 5</a>I and S1, see <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>). These findings validated that the QC inhibitor <b>28</b> specifically blocks the generation of pE-Aβs, reduces the Aβ plaques in AD brain, and finally improves function in B6C3-Tg mice by inhibiting the activity of QC.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13741" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13741" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">QC is a new target for the development of novel drugs for the prevention and treatment of AD because of the positive correlation between the expression of QC in the brain and the course of AD. Based on rational design, a new series of DPCIs were prepared. These chemicals with enhanced inflexibility and hydrophobicity exhibited powerful hQC inhibitory potency <i>in vitro</i> as expected. Fifteen compounds were more potent than the positive control, and the improved permeability of several was also confirmed by <i>in silico</i> and <i>in vitro</i> assays. In particular, the selected compound <b>28</b> showed remarkable inhibitory activities in a dose- and time-dependent manner in APP transfected HEK293T model cells. Treatment with <b>28</b> significantly decreased the generation of pE-Aβ<sub>3–42</sub> in living cells and inhibited the activity of hQC without interfering with its expression. Inhibitory efficacy was further validated in animal studies by intraperitoneal injections of <b>28</b> in B6C3-Tg AD mice. The inhibitory effect of <b>28</b><i>in vivo</i> improved nest-building behavior, an index of functional deficits in these AD model mice. We believe these compounds represented a new class of hQC inhibitors that can contribute to the development of novel anti-AD agents. Further efforts toward revealing in the depth mechanism and activity of these inhibitors are now the focus of our ongoing investigations.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48810" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48810" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The <sup>1</sup>H NMR (400 MHz) data and <sup>13</sup>C NMR (100 MHz) was recorded on a Bruker Avance III, using CDCl<sub>3</sub> as solvent. The high-resolution positive ion electrospray mass spectra were obtained from a LCMS-IT-TOF (SHIMADZU). Thin-layer chromatography (TLC) was performed on Merck silica gel 60F<sub>254</sub> plates and visualized with UV. Flash column chromatography was performed using silica gel (200–300 mesh, Qingdao Haiyang Chemical Co. Ltd., China). Purities of the final compounds used for biological evaluation were determined as above 95% by HPLC/UV criteria (Agilent 1200). The porcine polar brain lipid (PBL) was purchased from Avanti Polar Lipids, Inc., USA. SensoLyte green glutaminyl cyclase activity assay kit was purchased from AnaSpec, Inc. Amyloid-β (N3pE-42) ELISA kit was purchased from IBL International, Germany. Monoclonal anti-β-amyloid protein (mouse IgG1 isotype) was purchased from Sigma, USA. Monoclonal mouse antibody against Aβ-pE3 was purchased from Synaptic Systems GmbH, Germany. Other materials were purchased from Alfa Aesar Co. All other reagents were of analytical grade.</div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> General Procedure for the Preparation of Compounds <b>2</b>–<b>41</b></h3><div class="NLM_p">(1) To a solution of bromaniline or derivatives (1 equiv) and phenylboronic acid or derivatives (1.2 equiv) in 1,4-dioxane (10 mL), Pd(DPPF)<sub>2</sub>Cl<sub>2</sub> (0.06 equiv) and K<sub>2</sub>CO<sub>3</sub> solution (2 mol/L, 10 mL) were added. Under an atmosphere of Ar, the mixture was warmed to 100 °C. After 3 h, the reaction was quenched with a saturated NaCl solution (1 mL). The reaction mixture was extracted using ethyl acetate (20 mL × 3). The combined organic phase was washed with saturated NaCl solution, dried with anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The residue was purified using flash column chromatography (silica gel, ethyl acetate/hexane, gradient elution) to provide the intermediate <b>i</b>.</div><div class="NLM_p">(2) To intermediate <b>i</b> (1 equiv) in anhydrous acetonitrile (6 mL), 1,3-dibromopropane or 1,2-dibromoethane (7 equiv) and anhydrous K<sub>2</sub>CO<sub>3</sub> (2 equiv) were added; the mixture was warmed and refluxed overnight. When the mixture cooled to room temperature, the acetonitrile was removed under reduced pressure, water (20 mL) was added, and the water phase was extracted using ethyl acetate (20 mL × 3). The combined organic phase was washed with saturated NaCl solution, dried with anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The residue was purified using flash column chromatography (silica gel, ethyl acetate/hexane, gradient elution) to provide the intermediate <b>ii</b>.</div><div class="NLM_p">(3) The nucleophile substitution reaction of <b>ii</b> (1 equiv) and imidazoles (1 equiv) provided the designed inhibitors according to the procedure in step 2.</div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> <i>N</i>-(3-(1<i>H</i>-Imidazol-1-yl)propyl)-3′,4′-dimethoxy-[1,1′-biphenyl]-2-amine (<b>2</b>)</h4><div class="NLM_p last">Yield: 26%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.97–2.06 (m, 2H, CH<sub>2</sub>), 3.08–3.12 (m, 2H, CH<sub>2</sub>), 3.88 (s, 3H, OCH<sub>3</sub>), 3.93 (s, 3H, OCH<sub>3</sub>), 3.97–4.01 (m, 2H, CH<sub>2</sub>), 6.62–6.64 (d, <i>J</i> = 8.113 Hz, 1H, ArH), 6.76–6.81 (m, 1H, ArH), 6.86 (s, 1H, ArH), 6.91 (s, 1H, ArH), 6.95 (m, 2H, ArH), 7.06 (s, 1H, ArH), 7.09–7.12 (m, 1H, ArH), 7.20–7.23 (m, 1H, ArH), 7.26 (s, solv), 7.42 (s, 1H, ArH). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 30.71, 40.83, 44.48, 56.02, 110.51, 111.83, 112.96, 117.48, 118.74, 121.45, 127.96, 129.60, 130.30, 131.86, 137.08, 144.77, 148.54, 149.44. HRMS (EI): calculated for C<sub>20</sub>H<sub>23</sub>N<sub>3</sub>O<sub>2</sub>, 337.1790; found, C<sub>20</sub>H<sub>24</sub>N<sub>3</sub>O<sub>2</sub>, 338.1860 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> <i>N</i>-(3-(1<i>H</i>-Imidazol-1-yl)propyl)-3′,4′-dimethoxy-3-methyl-[1,1′-biphenyl]-2-amine (<b>3</b>)</h4><div class="NLM_p last">Yield: 13%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.79–1.85 (m, 2H, CH<sub>2</sub>), 2.31 (s, 3H, CH<sub>3</sub>), 2.81–2.85 (t, <i>J</i> = 13.663 Hz, 2H, CH<sub>2</sub>), 3.81–3.85 (t, <i>J</i> = 14.033 Hz, 2H, CH<sub>2</sub>), 3.88 (s, 3H, OCH<sub>3</sub>), 3.95 (s, 3H, OCH<sub>3</sub>), 6.76 (s, 1H, ArH), 6.93–6.97 (m, 4H, ArH), 7.03–7.07 (m, 2H, ArH), 7.13–7.15 (d, <i>J</i> = 7.123 Hz, 1H, ArH), 7.28 (s, solv), 7.33 (s, 1H, ArH). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 18.86, 32.10, 44.50, 45.22, 55.97, 111.36, 112.43, 112.59, 118.66, 121.11, 121.46, 128.70, 128.93, 129.38, 130.56, 133.19, 133.61, 144.51, 148.25, 148.96. HRMS (EI): calcd for C<sub>21</sub>H<sub>25</sub>N<sub>3</sub>O<sub>2</sub>, 351.1947; found, C<sub>21</sub>H<sub>26</sub>N<sub>3</sub>O<sub>2</sub>, 352.2025 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> <i>N</i>-(3-(1<i>H</i>-Imidazol-1-yl)propyl)-3-fluoro-3′,4′-dimethoxy-[1,1′-biphenyl]-2-amine (<b>4</b>)</h4><div class="NLM_p last">Yield: 33%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.85–1.91 (m, 2H, CH<sub>2</sub>), 3.04–3.07 (t, <i>J</i> = 13.368 Hz, 2H, CH<sub>2</sub>), 3.87–3.91 (m, 5H, CH<sub>2</sub>, OCH<sub>3</sub>), 3.95 (s, 3H, OCH<sub>3</sub>), 6.79 (s, 1H, ArH), 6.83–6.87 (m, 1H, ArH), 6.92 (s, 1H, ArH), 6.94–6.96 (m, 2H, ArH), 6.98–6.99 (m, 1H, ArH), 7.01–7.04 (m, 2H, ArH), 7.28 (s, solv), 7.33 (s, 1H, ArH). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 32.00, 44.00, 44.24, 56.00, 111.51, 112.24, 115.04, 115.25, 118.64, 119.94, 121.11, 126.17, 128.52, 131.30, 133.27, 133.79, 136.99, 148.65, 149.20. HRMS (EI): calcd for C<sub>20</sub>H<sub>22</sub>FN<sub>3</sub>O<sub>2</sub>, 355.1696; found, C<sub>20</sub>H<sub>23</sub>FN<sub>3</sub>O<sub>2</sub>, 356.1769 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> <i>N</i>-(3-(1<i>H</i>-Imidazol-1-yl)propyl)-3′,4′-dimethoxy-4-methyl-[1,1′-biphenyl]-2-amine (<b>5</b>)</h4><div class="NLM_p last">Yield: 14.6%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 2.01–2.07 (m, 2H, CH<sub>2</sub>), 2.36 (s, 3H, CH<sub>3</sub>), 3.11–3.14 (m, 2H, CH<sub>2</sub>), 3.89 (s, 3H, OCH<sub>3</sub>), 3.95 (s, 3H, OCH<sub>3</sub>), 4.00–4.03 (m, 2H, CH<sub>2</sub>), 6.47 (s, 1H, ArH), 6.63–6.65 (d, <i>J</i> = 7.916 Hz, 1H, ArH), 6.89 (s, 1H, ArH), 6.92 (s, 1H, ArH), 6.95–6.96 (m, 2H, ArH), 7.01–7.03 (d, <i>J</i> = 7.916 Hz, 1H, ArH), 7.08 (s, 1H, ArH), 7.28 (s, solv), 7.46 (s, 1H, ArH). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 21.67, 30.69, 40.72, 44.45, 55.96, 111.25, 111.58, 112.83, 118.19, 118.77, 121.45, 125.20, 129.62, 130.17, 131.76, 137.12, 138.52, 144.60, 148.27, 149.25. HRMS (EI): calcd for C<sub>21</sub>H<sub>25</sub>N<sub>3</sub>O<sub>2</sub>, 351.1947; found, C<sub>21</sub>H<sub>26</sub>N<sub>3</sub>O<sub>2</sub>, 352.2020 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> <i>N</i>-(3-(1<i>H</i>-Imidazol-1-yl)propyl)-5-isopropyl-3′,4′-dimethoxy-[1,1′-biphenyl]-2-amine (<b>6</b>)</h4><div class="NLM_p last">Yield: 15%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.25 (s, 3H, CH<sub>3</sub>), 1.27 (s, 3H, CH<sub>3</sub>), 2.01–2.05 (t, <i>J</i> = 13.620 Hz, 2H, CH<sub>2</sub>), 2.83–2.90 (m, 1H, CH), 3.10–3.13 (t, <i>J</i> = 13.439 Hz, 2H, CH<sub>2</sub>), 3.91 (s, 3H, OCH<sub>3</sub>), 3.96 (s, 3H, OCH<sub>3</sub>), 4.00–4.03 (t, <i>J</i> = 13.894 Hz, 2H, CH<sub>2</sub>), 6.60–6.62 (d, <i>J</i> = 8.350 Hz, 1H, ArH), 6.89 (s, 1H, ArH), 6.95 (s, 1H, ArH), 6.98–7.11 (m, 3H, ArH), 7.11 (s, 1H, ArH), 7.11–7.13 (d, <i>J</i> = 10.66 Hz, 1H, ArH), 7.28 (s, solv), 7.45 (s, 1H, ArH). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 24.23, 30.76, 33.16, 41.03, 44.56, 56.00, 110.61, 111.57, 112.76, 118.84, 121.45, 126.29, 127.86, 128.50, 129.24, 132.09, 137.02, 138.01, 142.76, 148.33, 149.21. HRMS (EI): calcd for C<sub>23</sub>H<sub>29</sub>N<sub>3</sub>O<sub>2</sub>, 379.2260; found, C<sub>23</sub>H<sub>30</sub>N<sub>3</sub>O<sub>2</sub>, 380.2334 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> <i>N</i>-(3-(1<i>H</i>-Imidazol-1-yl)propyl)-3′,4′-dimethoxy-6-methyl-[1,1′-biphenyl]-2-amine (<b>7</b>)</h4><div class="NLM_p last">Yield: 14%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.96–1.99 (t, <i>J</i> = 13.494 Hz, 2H, CH<sub>2</sub>), 2.03 (s, 3H, CH<sub>3</sub>), 3.06–3.09 (t, <i>J</i> = 13.465 Hz, 2H, CH<sub>2</sub>), 3.87 (s, 3H, OCH<sub>3</sub>), 3.93–3.96 (m, 5H, CH<sub>2</sub>, OCH<sub>3</sub>), 6.50–6.52 (d, <i>J</i> = 8.295 Hz, 1H, ArH), 6.69–6.71 (d, <i>J</i> = 7.585 Hz, 1H, ArH), 6.75–6.80 (m, 2H, ArH), 6.85 (s, 1H, ArH), 7.00–7.02 (d, <i>J</i> = 8.014 Hz, 1H, ArH), 7.06 (s, 1H, ArH), 7.14–7.18 (t, <i>J</i> = 15.472 Hz, 1H, ArH), 7.28 (s, solv), 7.40 (s,1H, ArH). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 20.65, 30.56, 40.65, 44.33, 55.99, 107.78, 111.94, 113.08, 118.74, 119.09, 122.07, 127.55, 128.23, 129.62, 130.21, 137.09, 137.15, 145.37, 148.28, 149.66. HRMS (EI): calcd for C<sub>21</sub>H<sub>25</sub>N<sub>3</sub>O<sub>2</sub>, 351.1947; found, C<sub>21</sub>H<sub>26</sub>N<sub>3</sub>O<sub>2</sub>, 352.2024 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> <i>N</i>-(3-(1<i>H</i>-Imidazol-1-yl)propyl)-4′-fluoro-[1,1′-biphenyl]-2-amine (<b>8</b>)</h4><div class="NLM_p last">Yield: 22%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.99–2.06 (m, 2H, CH<sub>2</sub>), 3.09–3.12 (t, <i>J</i> = 13.178 Hz, 2H, CH<sub>2</sub>), 3.71 (s, 1H, NH), 3.98–4.01 (t, <i>J</i> = 13.868 Hz, 2H, CH<sub>2</sub>), 6.63–6.65 (d, <i>J</i> = 8.241 Hz, 1H, ArH), 6.77–6.81 (m, 1H, ArH), 6.86 (s, 1H, ArH), 7.05–7.08 (m, 2H, ArH), 7.12–7.17 (t, <i>J</i> = 17.530 Hz, 2H, ArH), 7.22–7.24 (m, 1H, ArH), 7.26 (s, solv), 7.34–7.38 (m, 2H, ArH), 7.41 (s, 1H, ArH). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 30.61, 40.72, 44.42, 110.53, 115.84, 116.05, 117.58, 118.71, 126.97, 128.97, 129.78, 130.43, 130.97, 135.09, 137.11, 144.59, 160.93, 163.38. HRMS (EI): calcd for C<sub>18</sub>H<sub>18</sub>FN<sub>3</sub>, 295.1485; found, C<sub>18</sub>H<sub>19</sub>FN<sub>3</sub>, 296.1556 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> <i>N</i>-(3-(1<i>H</i>-Imidazol-1-yl)propyl)-4′-fluoro-6-methyl-[1,1′-biphenyl]-2-amine (<b>9</b>)</h4><div class="NLM_p last">Yield: 13%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.96–2.00 (m, 5H, CH<sub>2</sub>, CH<sub>3</sub>), 3.06–3.09 (t, <i>J</i> = 13.147 Hz, 2H, CH<sub>2</sub>), 3.93–3.97 (t, <i>J</i> = 13.878 Hz, 2H, CH<sub>2</sub>), 6.50–6.52 (d, <i>J</i> = 7.950 Hz, 1H, ArH), 6.69–6.71 (d, <i>J</i> = 7.666 Hz, 1H, ArH), 6.85 (s, 1H, ArH), 7.06 (s, 1H, ArH), 7.15–7.21 (m, 5H, ArH), 7.28 (s, solv), 7.41 (s, 1H, ArH). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 20.70, 30.48, 40.58, 44.34, 107.85, 116.31, 116.52, 118.74, 119.23, 126.60, 128.48, 129.62, 131.77, 131.84, 133.67, 137.01, 145.12, 160.96, 163.41. HRMS (EI): calcd for C<sub>19</sub>H<sub>20</sub>FN<sub>3</sub>, 309.1641; found, C<sub>19</sub>H<sub>21</sub>FN<sub>3</sub>, 310.1714 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> <i>N</i>-(3-(1<i>H</i>-Imidazol-1-yl)propyl)-4′,6-difluoro-[1,1′-biphenyl]-2-amine (<b>10</b>)</h4><div class="NLM_p last">Yield: 15%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.98–2.04 (m, 2H, CH<sub>2</sub>), 3.08–3.11 (t, <i>J</i> = 13.455 Hz, 2H, CH<sub>2</sub>), 3.60 (s, 1H, NH), 3.97–4.00 (t, <i>J</i> = 13.491 Hz, 2H, CH<sub>2</sub>), 6.39–6.41 (d, <i>J</i> = 8.197 Hz, 1H, ArH), 6.51–6.55 (t, <i>J</i> = 17.335 Hz, 1H, ArH), 6.86 (s, 1H, ArH), 7.07 (s, 1H, ArH), 7.15–7.20 (m, 3H, ArH), 7.27 (s, solv), 7.29–7.32 (m, 2H, ArH), 7.50 (s, 1H, ArH). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 30.46, 40.79, 44.48, 104.44, 104.63, 105.89, 116.16, 116.33, 118.75, 127.87, 129.36, 129.63, 129.71, 132.18, 132.24, 146.63, 161.54, 163.51. HRMS (EI): calcd for C<sub>18</sub>H<sub>17</sub>F<sub>2</sub>N<sub>3</sub>, 313.1391; found, C<sub>18</sub>H<sub>18</sub>F<sub>2</sub>N<sub>3</sub>, 314.1464 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> <i>N</i>-(3-(1<i>H</i>-Imidazol-1-yl)propyl)-3′-fluoro-[1,1′-biphenyl]-2-amine (<b>11</b>)</h4><div class="NLM_p last">Yield: 17%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 2.01–2.05 (m, 2H, CH<sub>2</sub>), 3.09–3.11 (t, <i>J</i> = 13.490 Hz, 2H, CH<sub>2</sub>), 3.73 (s, 1H, NH), 3.98–4.00 (t, <i>J</i> = 14.156 Hz, 2H, CH<sub>2</sub>), 6.63–6.64 (d, <i>J</i> = 8.150 Hz, 1H, ArH), 6.77–6.80 (t, <i>J</i> = 15.640 Hz, 1H, ArH), 6.86 (s, 1H, ArH), 7.04–7.08 (m, 3H, ArH), 7.10–7.12 (d, <i>J</i> = 8.440 Hz, 1H, ArH), 7.17–7.18 (d, <i>J</i> = 7.599 Hz, 1H, ArH), 7.22–7.25 (t, <i>J</i> = 17.061 Hz, 1H, ArH), 7.27 (s, solv), 7.29–7.43 (m, 2H, ArH). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 30.53, 40.64, 44.52, 110.62, 114.24, 114.45, 116.20, 116.41, 117.60, 124.99, 126.64, 129.24, 130.27, 130.51, 141.55, 144.36, 161.86, 164.32. HRMS (EI): calcd for C<sub>18</sub>H<sub>18</sub>FN<sub>3</sub>, 295.1485; found, C<sub>18</sub>H<sub>19</sub>FN<sub>3</sub>, 296.1559 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 3′,4′-Dimethoxy-3-methyl-<i>N</i>-(3-(2-methyl-1<i>H</i>-imidazol-1-yl)propyl)-[1,1′-biphenyl]-2-amine (<b>12</b>)</h4><div class="NLM_p last">Yield: 14%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.92–1.96 (m, 2H, CH<sub>2</sub>), 2.03 (s, 3H, CH<sub>3</sub>), 2.21 (s, 3H, CH<sub>3</sub>), 3.05–3.09 (m, 2H, CH<sub>2</sub>), 3.84–3.89 (m, 5H, CH<sub>2</sub>, OCH<sub>3</sub>), 3.96 (s, 3H, OCH<sub>3</sub>), 6.50–6.55 (m, 2H, ArH), 6.68–6.70 (d, <i>J</i> = 7.306 Hz, 1H, ArH), 6.74–6.75 (d, <i>J</i> = 1.965 Hz, 1H, ArH), 6.77–6.79 (m, 1H, ArH), 6.99–7.02 (m, 1H, ArH), 7.14–7.18 (t, <i>J</i> = 15.688 Hz, 1H,), 7.28 (s, solv), 7.31 (s, 1H, ArH). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 12.80, 18.89, 31.66, 43.63, 45.31, 55.96, 111.27, 112.35, 118.82, 121.08, 121.38, 126.88, 128.75, 128.77, 130.54, 133.21, 133.41, 144.22, 144.55, 148.19, 148.90. HRMS (EI): calcd for C<sub>22</sub>H<sub>27</sub>N<sub>3</sub>O<sub>2</sub>, 365.2103; found, C<sub>22</sub>H<sub>28</sub>N<sub>3</sub>O<sub>2</sub>, 366.2177 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 3′,4′-Dimethoxy-4-methyl-<i>N</i>-(3-(2-methyl-1<i>H</i>-imidazol-1-yl)propyl)-[1,1′-biphenyl]-2-amine (<b>13</b>)</h4><div class="NLM_p last">Yield: 17%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.77–1.80 (m, 2H, CH<sub>2</sub>), 2.20 (s, 3H, CH<sub>3</sub>), 2.31 (s, 3H, CH<sub>3</sub>), 2.81–2.84 (m, 2H, CH<sub>2</sub>), 3.73–3.76 (m, 2H, CH<sub>2</sub>), 3.88 (s, 3H, OCH<sub>3</sub>), 3.95 (s, 3H, OCH<sub>3</sub>), 6.46 (s, 1H, ArH), 6.91–6.96 (m, 4H, ArH), 7.05–7.06 (d, <i>J</i> = 7.487 Hz, 1H, ArH), 7.12–7.14 (d, <i>J</i> = 7.113 Hz, 1H, ArH), 7.21 (s, 1H, ArH), 7.28(s, solv). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 13.57, 18.88, 32.06, 44.40, 45.25, 55.95, 111.34, 112.42, 112.43, 115.12, 121.12, 121.39, 128.69, 128.76, 128.89, 130.55, 133.22, 133.53, 144.55, 148.24, 148.95. HRMS <i>m</i>/<i>z</i>: calcd for C<sub>22</sub>H<sub>27</sub>N<sub>3</sub>O<sub>2</sub>, 365.2103; found, C<sub>22</sub>H<sub>28</sub>N<sub>3</sub>O<sub>2</sub>, 366.2177 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 5-Isopropyl-3′,4′-dimethoxy-<i>N</i>-(3-(2-methyl-1<i>H</i>-imidazol-1-yl)propyl)-[1,1′-biphenyl]-2-amine (<b>14</b>)</h4><div class="NLM_p last">Yield: 20%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.25 (s, 3H, CH<sub>3</sub>), 1.27 (s, 3H, CH<sub>3</sub>), 1.96–2.03 (m, 2H, CH<sub>2</sub>), 2.22 (s, 3H, CH<sub>3</sub>), 2.83–2.90 (m, 1H, CH), 3.09–3.12 (t, <i>J</i> = 13.434 Hz, 2H, CH<sub>2</sub>), 3.88–3.93 (m, 5H, CH<sub>2</sub>, OCH<sub>3</sub>), 3.96 (s, 3H, OCH<sub>3</sub>), 6.58–6.63 (m, 2H, ArH), 6.96 (s, 1H, ArH), 6.98 (s, 2H, ArH), 7.00–7.01 (d, <i>J</i> = 2.226 Hz, 1H, ArH), 7.11–7.14 (m, 1H, ArH), 7.28 (s, solv), 7.31 (s, 1H, ArH). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 12.64, 23.22, 29.72, 32.15, 40.04, 43.30, 54.98, 109.60, 110.55, 111.75, 114.22, 120.45, 125.27, 126.80, 127.46, 131.11, 135.20, 136.91, 137.63, 141.81, 147.31, 148.20. HRMS (EI): calcd for C<sub>24</sub>H<sub>31</sub>N<sub>3</sub>O<sub>2</sub>, 393.2416; found, C<sub>24</sub>H<sub>32</sub>N<sub>3</sub>O<sub>2</sub>, 394.2486 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 4′-Fluoro-<i>N</i>-(3-(2-methyl-1<i>H</i>-imidazol-1-yl)propyl)-[1,1′-biphenyl]-2-amine (<b>15</b>)</h4><div class="NLM_p last">Yield: 32%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.94–2.00 (m, 2H, CH<sub>2</sub>), 2.31 (s, 3H, CH<sub>3</sub>), 3.11 (s, 2H, CH<sub>2</sub>), 3.69 (s, 1H, NH), 3.87–3.90 (t, <i>J</i> = 13.833 Hz, 2H, CH<sub>2</sub>), 6.62–6.64 (d, <i>J</i> = 7.880 Hz, 1H, ArH), 6.75–6.76 (d, <i>J</i> = 1.360 Hz, 1H, ArH), 6.78–6.81 (t, <i>J</i> = 15.721 Hz, 1H, ArH), 6.90 (s, 1H, ArH), 7.06–7.08 (m, 1H, ArH), 7.12–7.16 (t, <i>J</i> = 17.136 Hz, 2H, ArH), 7.22–7.24 (m, 1H, ArH), 7.26 (s, solv), 7.34–7.38 (m, 2H, ArH). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 12.92, 30.29, 40.68, 43.42, 110.50, 115.82, 116.03, 117.59, 118.89, 125.97, 127.44, 128.97, 130.40, 130.97, 131.05, 135.11, 144.60, 160.93, 163.38. HRMS (EI): calcd for C<sub>19</sub>H<sub>20</sub>FN<sub>3</sub>, 309.1641; found, C<sub>19</sub>H<sub>21</sub>FN<sub>3</sub>, 310.1715 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 4′-Fluoro-6-methyl-<i>N</i>-(3-(2-methyl-1<i>H</i>-imidazol-1-yl)propyl)-[1,1′-biphenyl]-2-amine (<b>16</b>)</h4><div class="NLM_p last">Yield: 13%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.89–1.96 (m, 2H, CH<sub>2</sub>), 1.99 (s, 3H, CH<sub>3</sub>), 2.30 (s, 3H, CH<sub>3</sub>), 3.06–3.10 (t, <i>J</i> = 13.097 Hz, 2H, CH<sub>2</sub>), 3.82–3.86 (t, <i>J</i> = 13.692 Hz, 2H, CH<sub>2</sub>), 6.50–6.52 (d, <i>J</i> = 8.169 Hz, 1H, ArH), 6.69–6.71 (d, <i>J</i> = 7.495 Hz, 1H, ArH), 6.73–6.74 (d, <i>J</i> = 1.361 Hz, 1H, ArH), 6.91 (s, 1H, ArH), 7.15–7.21 (m, 5H, ArH), 7.28 (s, solv). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 12.87, 20.70, 30.21, 40.54, 43.32, 107.80, 116.30, 116.51, 118.90, 119.24, 126.59, 127.28, 128.49, 131.77, 131.85, 133.65, 136.98, 145.15, 160.95, 166.28. HRMS (EI): calcd for C<sub>20</sub>H<sub>22</sub>FN<sub>3</sub>, 323.1798; found, C<sub>20</sub>H<sub>23</sub>FN<sub>3</sub>, 324.1873 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 4′,6-Difluoro-<i>N</i>-(3-(2-methyl-1<i>H</i>-imidazol-1-yl)propyl)-[1,1′-biphenyl]-2-amine (<b>17</b>)</h4><div class="NLM_p last">Yield: 20%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.94–2.00 (m, 2H, CH<sub>2</sub>), 2.37 (s, 3H, CH<sub>3</sub>), 3.12 (s, 2H, CH<sub>2</sub>), 3.61 (s, 1H, NH), 3.87–3.90 (t, <i>J</i> = 14.039 Hz, 2H, CH<sub>2</sub>), 6.40–6.42 (d, <i>J</i> = 8.199 Hz, 1H, ArH), 6.52–6.57 (t, <i>J</i> = 17.440 Hz, 1H, ArH), 6.77 (s, 1H, ArH), 6.95 (s, 1H, ArH), 7.17–7.22 (m, 3H, ArH), 7.28 (s, solv), 7.30–7.33 (m, 2H, ArH). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 12.66, 30.07, 40.70, 43.53, 104.52, 104.70, 105.86, 116.17, 116.34, 118.94, 127.84, 129.66, 129.75, 132.17, 132.24, 146.59, 159.47, 161.54, 163.51. HRMS (EI): calcd for C<sub>19</sub>H<sub>19</sub>F<sub>2</sub>N<sub>3</sub>, 327.1547; found, C<sub>19</sub>H<sub>20</sub>F<sub>2</sub>N<sub>3</sub>, 328.1624 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 4′-Fluoro-4-methyl-<i>N</i>-(3-(2-methyl-1<i>H</i>-imidazol-1-yl)propyl)-[1,1′-biphenyl]-2-amine (<b>18</b>)</h4><div class="NLM_p last">Yield: 15%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 2.01–2.04 (m, 2H, CH<sub>2</sub>), 2.19 (s, 3H, CH<sub>3</sub>), 2.35 (s, 3H, CH<sub>3</sub>), 3.11–3.13 (t, <i>J</i> = 13.519 Hz, 2H, CH<sub>2</sub>), 3.95–3.98 (t, <i>J</i> = 13.846 Hz, 2H, CH<sub>2</sub>), 6.45 (s, 1H, ArH), 6.62–6.64 (d, <i>J</i> = 7.860 Hz, 2H, ArH), 6.96–6.97 (d, <i>J</i> = 7.482 Hz, 1H, ArH), 7.12–7.15 (t, <i>J</i> = 17.449 Hz, 3H, ArH), 7.27 (s, solv), 7.33–7.35 (m, 2H, ArH). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 12.87, 20.70, 30.21, 40.54, 43.32, 107.80, 116.30, 116.51, 118.90, 119.24, 125.59, 127.28, 128.49, 131.77, 131.85, 133.65, 133.68, 136.98, 145.15, 160.95. HRMS (EI): calcd for C<sub>20</sub>H<sub>22</sub>FN<sub>3</sub>, 323.1798; found, C<sub>20</sub>H<sub>23</sub>FN<sub>3</sub>, 324.1872 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 3′-Fluoro-<i>N</i>-(3-(2-methyl-1<i>H</i>-imidazol-1-yl)propyl)-[1,1′-biphenyl]-2-amine (<b>19</b>)</h4><div class="NLM_p last">Yield: 19%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.98–2.02 (m, 2H, CH<sub>2</sub>), 2.20 (s, 3H, CH<sub>3</sub>), 3.08–3.11 (t, <i>J</i> = 13.664 Hz, 2H, CH<sub>2</sub>), 3.90–3.93 (t, <i>J</i> = 13.674 Hz, 2H, CH<sub>2</sub>), 6.57 (s, 1H, ArH), 6.64–6.65 (d, <i>J</i> = 2.014 Hz, 1H, ArH), 6.76–6.81 (m, 1H, ArH), 7.05–7.09 (m, 2H, ArH), 7.11–7.13 (d, <i>J</i> = 5.998 Hz, 1H, ArH), 7.17–7.19 (d, <i>J</i> = 6.014 Hz, 1H, ArH), 7.23–7.25 (d, <i>J</i> = 5.875 Hz, 1H, ArH), 7.26 (s, solv), 7.31 (s, 1H, ArH), 7.39–7.44 (m, 1H, ArH). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 12.75, 30.21, 40.58, 43.51, 110.60, 114.25, 114.46, 116.21, 116.42, 117.67, 118.95, 125.00, 126.87, 129.25, 130.26, 130.51, 144.34, 161.85, 164.31. HRMS (EI): calcd for C<sub>19</sub>H<sub>20</sub>FN<sub>3</sub>, 309.1641; found, C<sub>19</sub>H<sub>21</sub>FN<sub>3</sub>, 310.1709 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 3′-Fluoro-5-isopropyl-<i>N</i>-(3-(2-methyl-1<i>H</i>-imidazol-1-yl)propyl)-[1,1′-biphenyl]-2-amine (<b>20</b>)</h4><div class="NLM_p last">Yield: 19%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.22 (s, 3H, CH<sub>3</sub>), 1.24 (s, 3H, CH<sub>3</sub>), 1.93–2.01 (m, 2H, CH<sub>2</sub>), 2.35 (s, 3H, CH<sub>3</sub>), 2.80–2.89 (m, 1H, CH), 3.08–3.13 (t, <i>J</i> = 13.007 Hz, 2H, CH<sub>2</sub>), 3.88–3.93 (t, <i>J</i> = 13.996 Hz, 2H, CH<sub>2</sub>), 6.58–6.61 (d, <i>J</i> = 8.203 Hz, 1H, ArH), 6.78 (s, 1H, ArH), 6.93 (s, 1H,), 6.96–6.97 (d, <i>J</i> = 2.190 Hz, 1H, ArH), 7.03–7.21 (m, 4H, ArH), 7.26 (s, solv), 7.38–7.45 (m, 1H, ArH). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 12.61, 24.14, 30.35, 33.13, 40.95, 43.59, 108.51, 110.89, 114.11, 116.25, 116.41, 118.94, 125.01, 125.95, 128.39, 130.45, 138.34, 142.37, 162.11, 164.07. HRMS (EI): calcd for C<sub>22</sub>H<sub>26</sub>FN<sub>3</sub>, 351.2111; found, C<sub>22</sub>H<sub>27</sub>FN<sub>3</sub>, 352.2184 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 3′,4′-Dimethoxy-<i>N</i>-(3-(4-methyl-1<i>H</i>-imidazol-1-yl)propyl)-[1,1′-biphenyl]-2-amine (<b>21</b>)</h4><div class="NLM_p last">Yield: 19%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.94–2.03 (m, 2H, CH<sub>2</sub>), 2.20 (s, 3H, CH<sub>3</sub>), 3.07–3.12 (m, 2H, CH<sub>2</sub>), 3.83–3.91 (m, 5H, CH<sub>2</sub>, OCH<sub>3</sub>), 3.93 (s, 3H, OCH<sub>3</sub>), 6.56 (s, 1H, ArH), 6.62–6.65 (d, <i>J</i> = 7.996 Hz, 1H, ArH), 6.76–6.81 (m, 1H, ArH), 6.91 (s, 1H, ArH), 6.95 (s, 2H, ArH), 7.09–7.12 (dd, <i>J</i> = 9.012 Hz, 1H, ArH), 7.20–7.22 (m, 1H, ArH), 7.26 (s, solv), 7.31 (s, 1H, ArH). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 12.84, 30.32, 40.69, 43.44, 55.98, 110.41, 111.57, 112.72, 117.45, 118.92, 121.39, 127.20, 127.88, 128.64, 130.27, 130.56, 131.72, 144.74, 148.39, 149.29. HRMS (EI): calcd for C<sub>21</sub>H<sub>25</sub>N<sub>3</sub>O<sub>2</sub>, 351.1947; found, C<sub>21</sub>H<sub>26</sub>N<sub>3</sub>O<sub>2</sub>, 352.2023 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 3′,4′-Dimethoxy-3-methyl-<i>N</i>-(3-(4-methyl-1<i>H</i>-imidazol-1-yl)propyl)-[1,1′-biphenyl]-2-amine (<b>22</b>)</h4><div class="NLM_p last">Yield: 14%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.76–1.80 (m, 2H, CH<sub>2</sub>), 2.20 (s, 3H, CH<sub>3</sub>), 2.31 (s, 3H, CH<sub>3</sub>), 2.81–2.84 (t, <i>J</i> = 14.081 Hz, 2H, CH<sub>2</sub>), 3.73–3.76 (t, <i>J</i> = 13.765 Hz, 2H, CH<sub>2</sub>), 3.88 (s, 3H, OCH<sub>3</sub>), 3.95 (s, 3H, OCH<sub>3</sub>), 6.46 (s, 1H, ArH), 6.93–6.95 (m, 4H, ArH), 7.05–7.06 (d, <i>J</i> = 7.373 Hz, 1H, ArH), 7.12–7.14 (d, <i>J</i> = 7.145 Hz, 1H, ArH), 7.21 (s, 1H, ArH), 7.28 (s, solv). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 13.57, 18.88, 32.06, 44.40, 45.25, 55.97, 111.34, 112.43, 115.12, 121.12, 121.39, 128.69, 128.75, 128.89, 130.53, 130.55, 133.22, 133.53, 144.55, 148.24, 148.95. HRMS (EI): calcd for C<sub>22</sub>H<sub>27</sub>N<sub>3</sub>O<sub>2</sub>, 365.2103; found, C<sub>22</sub>H<sub>28</sub>N<sub>3</sub>O<sub>2</sub>, 366.2179 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 3-Fluoro-3′,4′-dimethoxy-<i>N</i>-(3-(4-methyl-1<i>H</i>-imidazol-1-yl)propyl)-[1,1′-biphenyl]-2-amine (<b>23</b>)</h4><div class="NLM_p last">Yield: 22%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.80–1.88 (m, 2H, CH<sub>2</sub>), 2.20 (s, 3H, CH<sub>3</sub>), 3.03–3.06 (t, <i>J</i> = 13.102 Hz, 2H, CH<sub>2</sub>), 3.79–3.82 (t, <i>J</i> = 14.252 Hz, 2H, CH<sub>2</sub>), 3.89 (s, 3H, OCH<sub>3</sub>), 3.95 (s, 3H, OCH<sub>3</sub>), 6.48 (s, 1H, ArH), 6.82–6.87 (m, 1H, ArH), 6.92–6.96 (m, 4H, ArH), 6.98–7.04 (m, 1H, ArH), 7.20 (s, 1H, ArH), 7.28 (s, solv). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 13.63, 31.92, 44.01, 44.11, 55.97, 111.48, 112.25, 115.08, 115.24, 119.81, 119.89, 121.12, 126.15, 131.35, 133.19, 133.75, 136.07, 138.48, 148.64, 149.20. HRMS (EI): calcd for C<sub>21</sub>H<sub>24</sub>FN<sub>3</sub>O<sub>2</sub>, 369.1853; found, C<sub>21</sub>H<sub>25</sub>FN<sub>3</sub>O<sub>2</sub>, 370.1922 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 3′,4′-Dimethoxy-4-methyl-<i>N</i>-(3-(4-methyl-1<i>H</i>-imidazol-1-yl)propyl)-[1,1′-biphenyl]-2-amine (<b>24</b>)</h4><div class="NLM_p last">Yield: 15%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.92–1.96 (m, 2H, CH<sub>2</sub>), 2.03 (s, 3H, CH<sub>3</sub>), 2.21 (s, 3H, CH<sub>3</sub>), 3.05–3.09 (t, <i>J</i> = 13.564 Hz, 2H, CH<sub>2</sub>), 3.84–3.89 (m, 5H, CH<sub>2</sub>, OCH<sub>3</sub>), 3.96 (s, 3H, OCH<sub>3</sub>), 6.50–6.55 (m, 2H, ArH), 6.68–6.70 (d, <i>J</i> = 7.402 Hz, 1H, ArH), 6.74–6.75 (d, <i>J</i> = 1.866 Hz, 1H, ArH), 6.77–6.79 (m, 1H, ArH), 6.99–7.02 (dd, <i>J</i> = 10.143 Hz, 1H, ArH), 7.14–7.18 (t, <i>J</i> = 15.855 Hz, 1H, ArH), 7.28 (s, solv), 7.31 (s, 1H, ArH). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 13.56, 20.64, 30.47, 40.62, 44.23, 55.97, 107.76, 111.91, 113.07, 115.24, 119.00, 122.06, 127.49, 128.20, 130.20, 136.12, 137.10, 138.45, 145.38, 148.25, 149.62. HRMS (EI) <i>m</i>/<i>z</i>: calcd for C<sub>22</sub>H<sub>27</sub>N<sub>3</sub>O<sub>2</sub>, 365.2103; found, C<sub>22</sub>H<sub>28</sub>N<sub>3</sub>O<sub>2</sub>, 366.2179 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 3′,4′-Dimethoxy-5-methyl-<i>N</i>-(3-(4-methyl-1<i>H</i>-imidazol-1-yl)propyl)-[1,1′-biphenyl]-2-amine (<b>25</b>)</h4><div class="NLM_p last">Yield: 23%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.95–2.02 (m, 2H, CH<sub>2</sub>), 2.21 (s, 3H, CH<sub>3</sub>), 2.29 (s, 3H, CH<sub>3</sub>), 3.07–3.11 (t, <i>J</i> = 13.342 Hz, 2H, CH<sub>2</sub>), 3.55–3.59 (t, <i>J</i> = 12.350 Hz, 2H, CH<sub>2</sub>), 3.90 (s, 3H, OCH<sub>3</sub>), 3.94 (s, 3H, OCH<sub>3</sub>), 6.57–6.59 (d, <i>J</i> = 7.916 Hz, 2H, ArH), 6.92–6.96 (m, 4H, ArH), 7.04–7.06 (d, <i>J</i> = 8.041 Hz, 1H, ArH), 7.28(s, solv), 7.32(s, 1H, ArH). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 13.52, 20.31, 31.08, 34.88, 41.08, 55.97, 110.85, 111.54, 112.71, 115.30, 121.35, 125.63, 125.69, 127.97, 128.01, 128.96, 131.01, 131.90, 142.49, 148.32, 149.24. HRMS (EI): calcd for C<sub>22</sub>H<sub>27</sub>N<sub>3</sub>O<sub>2</sub>, 365.2103; found, C<sub>22</sub>H<sub>28</sub>N<sub>3</sub>O<sub>2</sub>, 366.2170 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 5-Isopropyl-3′,4′-dimethoxy-<i>N</i>-(3-(4-methyl-1<i>H</i>-imidazol-1-yl)propyl)-[1,1′-biphenyl]-2-amine (<b>26</b>)</h4><div class="NLM_p last">Yield: 17%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.25 (s, 3H, CH<sub>3</sub>), 1.27 (s, 3H, CH<sub>3</sub>), 1.96–2.03 (m, 2H, CH<sub>2</sub>), 2.22 (s, 3H, CH<sub>3</sub>), 2.83–2.90 (m, 1H, CH), 3.09–3.12 (t, <i>J</i> = 13.614 Hz, 2H, CH<sub>2</sub>), 3.88–3.93 (m, 5H, CH<sub>2</sub>, OCH<sub>3</sub>), 3.96 (s, 3H, OCH<sub>3</sub>), 6.58–6.63 (m, 2H, ArH), 6.96 (s, 1H, ArH), 6.98 (m, 2H, ArH), 7.00–7.01 (d, <i>J</i> = 2.339 Hz, 1H, ArH), 7.11–7.14 (m, 1H, ArH), 7.28 (s, solv), 7.31 (s, 1H, ArH). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 12.64, 23.22, 29.72, 32.15, 40.04, 43.30, 54.98, 109.60, 110.55, 111.75, 114.22, 120.45, 125.27, 126.80, 127.46, 131.11, 135.20, 136.91, 137.63, 141.81, 147.31, 148.20. HRMS (EI): calcd for C<sub>24</sub>H<sub>31</sub>N<sub>3</sub>O<sub>2</sub>, 393.2416; found, C<sub>24</sub>H<sub>32</sub>N<sub>3</sub>O<sub>2</sub>, 394.2485 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 3′,4′-Dimethoxy-6-methyl-<i>N</i>-(3-(4-methyl-1<i>H</i>-imidazol-1-yl)propyl)-[1,1′-biphenyl]-2-amine (<b>27</b>)</h4><div class="NLM_p last">Yield: 15%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.91–1.98 (m, 2H, CH<sub>2</sub>), 2.03 (s, 3H, CH<sub>3</sub>), 2.21 (s, 3H, CH<sub>3</sub>), 3.06–3.09 (t, <i>J</i> = 13.551 Hz, 2H, CH<sub>2</sub>), 3.84–3.88 (m, 5H, CH<sub>2</sub>, CH<sub>3</sub>), 3.96 (s, 3H, OCH<sub>3</sub>), 6.50–6.55 (m, 2H, ArH), 6.68–6.70 (d, <i>J</i> = 7.335 Hz, 1H, ArH), 6.74–6.79 (m, 2H, ArH), 7.00–7.02 (d, <i>J</i> = 8.067 Hz, 1H, ArH), 7.14–7.18 (t, <i>J</i> = 15.845 Hz, 1H, ArH), 7.28 (s, solv), 7.31 (s, 1H, ArH). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 13.56, 20.64, 30.47, 40.62, 44.23, 55.90, 107.76, 111.91, 113.07, 115.24, 119.00, 122.06, 127.49, 128.20, 130.20, 135.12, 137.10, 138.45, 145.38, 148.25, 149.62. HRMS (EI): calcd for C<sub>22</sub>H<sub>27</sub>N<sub>3</sub>O<sub>2</sub>, 365.2103; found, C<sub>22</sub>H<sub>28</sub>N<sub>3</sub>O<sub>2</sub>, 366.2176 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 4′-Fluoro-<i>N</i>-(3-(4-methyl-1<i>H</i>-imidazol-1-yl)propyl)-[1,1′-biphenyl]-2-amine (<b>28</b>)</h4><div class="NLM_p last">Yield: 26%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.98–2.02 (m, 2H, CH<sub>2</sub>), 2.20 (s, 3H, CH<sub>3</sub>), 3.08–3.11 (t, <i>J</i> = 13.381 Hz, 2H, CH<sub>2</sub>), 3.90–3.93 (t, <i>J</i> = 14.287 Hz, 2H, CH<sub>2</sub>), 6.57 (s, 1H, ArH), 6.63–6.65 (d, <i>J</i> = 8.270 Hz, 1H, ArH), 6.77–6.80 (t, <i>J</i> = 15.947 Hz, 2H, ArH), 7.05–7.07 (d, <i>J</i> = 8.703 Hz, 1H, ArH), 7.13–7.16 (t, <i>J</i> = 166.900 Hz, 2H, ArH), 7.22–7.25 (m, 1H, ArH), 7.26 (s, solv), 7.34–7.37 (m, 2H, ArH). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 13.54, 30.48, 40.72, 44.40, 110.54, 115.33, 115.77, 115.98, 117.45, 126.88, 128.91, 130.35, 130.93, 131.01, 136.13, 138.31, 144.61, 160.86, 163.31. HRMS (EI): calcd for C<sub>19</sub>H<sub>20</sub>FN<sub>3</sub>, 309.1641; found, C<sub>19</sub>H<sub>21</sub>FN<sub>3</sub>, 310.1716 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 4′-Fluoro-4-methyl-<i>N</i>-(3-(4-methyl-1<i>H</i>-imidazol-1-yl)propyl)-[1,1′-biphenyl]-2-amine (<b>29</b>)</h4><div class="NLM_p last">Yield: 15%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.98–2.04 (m, 2H, CH<sub>2</sub>), 2.18 (s, 3H, CH<sub>3</sub>), 2.34 (s, 3H, CH<sub>3</sub>), 3.10–3.13 (t, <i>J</i> = 13.678 Hz, 2H, CH<sub>2</sub>), 3.94–3.97 (t, <i>J</i> = 13.640 Hz, 2H, CH<sub>2</sub>), 6.46 (s, 1H, ArH), 6.61–6.63 (d, <i>J</i> = 7.442 Hz, 2H, ArH), 6.95–6.97 (d, <i>J</i> = 7.555 Hz, 1H, ArH), 7.11–7.15 (t, <i>J</i> = 17.322 Hz, 3H, ArH), 7.26 (s, solv), 7.31–7.35 (m, 2H, ArH). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 12.80, 21.64, 30.43, 40.80, 45.24, 111.42, 115.79, 115.96, 118.49, 118.57, 124.44, 130.31, 131.00, 131.07, 135.14, 137.47, 138.85, 144.39, 161.09, 163.06. HRMS (EI): calcd for C<sub>20</sub>H<sub>22</sub>FN<sub>3</sub>, 323.1798; found, C<sub>20</sub>H<sub>23</sub>FN<sub>3</sub>, 324.1870 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 4′-Fluoro-6-methyl-<i>N</i>-(3-(4-methyl-1<i>H</i>-imidazol-1-yl)propyl)-[1,1′-biphenyl]-2-amine (<b>30</b>)</h4><div class="NLM_p last">Yield: 15%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.95–2.02 (m, 2H, CH<sub>2</sub>), 2.19 (s, 3H, CH<sub>3</sub>), 2.27 (s, 3H, CH<sub>3</sub>), 3.07–3.10 (t, <i>J</i> = 13.755 Hz, 2H, CH<sub>2</sub>), 3.90–3.94 (t, <i>J</i> = 13.556 Hz, 2H, CH<sub>2</sub>), 6.56–6.58 (d, <i>J</i> = 7.982 Hz, 2H, ArH), 6.90 (s, 1H, ArH), 7.04–7.16 (m, 4H, ArH), 7.26 (s, solv), 7.33–7.37 (m, 2H, ArH). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 12.87, 20.70, 30.21, 40.54, 43.32, 107.80, 116.30, 116.51, 118.90, 119.24, 126.59, 127.28, 128.49, 131.77, 131.85, 133.65, 136.98, 145.15, 160.95, 166.28. HRMS (EI): calcd for C<sub>20</sub>H<sub>22</sub>FN<sub>3</sub>, 323.1798; found, C<sub>20</sub>H<sub>23</sub>FN<sub>3</sub>, 324.1865 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 4′,6-Difluoro-<i>N</i>-(3-(4-methyl-1<i>H</i>-imidazol-1-yl)propyl)-[1,1′-biphenyl]-2-amine (<b>31</b>)</h4><div class="NLM_p last">Yield: 20%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.94–2.00 (m, 2H, CH<sub>2</sub>), 2.20 (s, 3H, CH<sub>3</sub>), 3.08–3.11 (t, <i>J</i> = 14.105 Hz, 2H, CH<sub>2</sub>), 3.60 (s, 1H, NH), 3.88–3.91 (t, <i>J</i> = 13.410 Hz, 2H, CH<sub>2</sub>), 6.40–6.41 (d, <i>J</i> = 8.202 Hz, 1H, ArH), 6.51–6.56 (m, 2H, ArH), 6.79 (s, 1H, ArH), 7.16–7.20 (m, 3H, ArH), 7.27 (s, solv), 7.29–7.32 (m, 2H, ArH). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 12.66, 30.07, 40.70, 43.53, 104.52, 104.70, 105.86, 116.17, 116.34, 118.94, 127.84, 129.66, 129.75, 132.17, 132.24, 146.59, 159.47, 161.54, 163.51. HRMS (EI): calcd for C<sub>19</sub>H<sub>19</sub>F<sub>2</sub>N<sub>3</sub>, 327.1547; found, C<sub>19</sub>H<sub>20</sub>F<sub>2</sub>N<sub>3</sub>, 328.1622 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 3′-Fluoro-<i>N</i>-(3-(4-methyl-1<i>H</i>-imidazol-1-yl)propyl)-[1,1′-biphenyl]-2-amine (<b>32</b>)</h4><div class="NLM_p last">Yield: 22%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.93–2.02 (m, 2H, CH<sub>2</sub>), 2.31 (s, 3H, CH<sub>3</sub>), 3.10–3.14 (t, <i>J</i> = 12.914 Hz, 2H, CH<sub>2</sub>), 3.80 (s, 1H, NH), 3.87–3.92 (t, <i>J</i> = 14.199 Hz, 2H, CH<sub>2</sub>), 6.63–6.66 (d, <i>J</i> = 7.987 Hz, 1H, ArH), 6.77–6.78 (t, <i>J</i> = 3.616 Hz, 1H, ArH), 6.80–6.82 (d, <i>J</i> = 7.992 Hz, 1H, ArH), 6.90 (s, 1H, ArH), 7.04–7.10 (m, 2H, ArH), 7.13–7.19 (m, 2H, ArH), 7.22–7.25 (m, 1H, ArH), 7.26 (s, solv), 7.38–7.45 (m, 1H, ArH). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 13.56, 30.47, 40.73, 44.35, 110.55, 115.31, 115.75, 115.96, 117.44, 126.68, 128.91, 130.35, 130.94, 136.11, 136.58, 138.36, 144.64, 160.84, 163.29. HRMS (EI): calcd for C<sub>19</sub>H<sub>20</sub>FN<sub>3</sub>, 309.1641; found, C<sub>19</sub>H<sub>21</sub>FN<sub>3</sub>, 310.1714 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> <i>N</i>-(2-(1<i>H</i>-Imidazol-1-yl)ethyl)-3′,4′-dimethoxy-[1,1′-biphenyl]-2-amine (<b>33</b>)</h4><div class="NLM_p last">Yield: 17%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 3.5 (m, 2H, CH<sub>2</sub>), 3.84 (s, 3H, OCH<sub>3</sub>), 3.91 (s, 3H, OCH<sub>3</sub>), 4.05 (s, 1H, NH), 4.11–4.14 (m, 2H, CH<sub>2</sub>), 6.66–6.68 (d, <i>J</i> = 7.953 Hz, 1H, ArH), 6.79–6.81 (m, 3H, ArH), 6.84 (s, 1H, ArH), 6.89–6.91 (d, <i>J</i> = 8.444 Hz, 1H, ArH), 7.02 (s, 1H, ArH), 7.10–7.12 (d, <i>J</i> = 7.953 Hz, 1H, ArH), 7.23–7.25 (d, <i>J</i> = 8.12 Hz, 1H, ArH), 7.26 (s, solv), 7.40 (s, 1H, ArH). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 44.55, 45.69, 55.98, 109.91, 111.58, 112.37, 117.78, 118.89, 121.23, 128.63, 129.68, 130.60, 131.26, 137.23, 143.71, 148.35, 149.23. HRMS (EI): calcd for C<sub>19</sub>H<sub>21</sub>N<sub>3</sub>O<sub>2</sub>, 323.1634; found, C<sub>19</sub>H<sub>22</sub>N<sub>3</sub>O<sub>2</sub>, 324.1705 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 3′,4′-Dimethoxy-<i>N</i>-(2-(2-methyl-1<i>H</i>-imidazol-1-yl)ethyl)-[1,1′-biphenyl]-2-amine (<b>34</b>)</h4><div class="NLM_p last">Yield: 14%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 2.28 (s, 3H, CH<sub>3</sub>), 3.45–3.48 (m, 2H, CH<sub>2</sub>), 3.83 (s, 3H, OCH<sub>3</sub>), 3.91 (s, 3H, OCH<sub>3</sub>), 4.01–4.04 (m, 2H, CH<sub>2</sub>), 6.65–6.67 (d, <i>J</i> = 8.218 Hz, 1H, ArH), 6.74 (s, 1H, ArH), 6.76–6.79 (m, 2H, ArH), 6.81–6.83 (d, <i>J</i> = 1.424 Hz, 1H, ArH), 6.88–6.92 (m, 2H, ArH), 7.10–7.12 (dd, <i>J</i> = 6.504 Hz, 1H, ArH), 7.23–7.25 (m, 1H, ArH), 7.27 (s, solv). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 12.62, 43.95, 53.50, 55.98, 109.83, 111.65, 112.39, 117.83, 119.19, 121.29, 126.65, 128.16, 128.64, 129.90, 130.62, 131.22, 143.74, 148.38, 149.24. HRMS (EI): calcd for C<sub>20</sub>H<sub>23</sub>N<sub>3</sub>O<sub>2</sub>, 337.1790; found, C<sub>20</sub>H<sub>24</sub>N<sub>3</sub>O<sub>2</sub>, 338.1867 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 3′,4′-Dimethoxy-<i>N</i>-(2-(4-methyl-1<i>H</i>-imidazol-1-yl)ethyl)-[1,1′-biphenyl]-2-amine (<b>35</b>)</h4><div class="NLM_p last">Yield: 14%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 2.28 (s, 3H, CH<sub>3</sub>), 3.45–3.48 (m, 2H, CH<sub>2</sub>), 3.83 (s, 3H, OCH<sub>3</sub>), 3.91 (s, 3H, OCH<sub>3</sub>), 4.01–4.04 (m, 2H, CH<sub>2</sub>), 6.65–6.67 (d, <i>J</i> = 8.128 Hz, 1H, ArH), 6.74 (s, 1H, ArH), 6.79 (s, 1H, ArH), 6.81–6.82 (d, <i>J</i> = 6.750 Hz, 1H, ArH), 6.88 (s, 1H, ArH), 6.90 (s, 1H, ArH), 6.92 (s, 1H, ArH), 7.10–7.12 (dd, <i>J</i> = 9.043 Hz, 1H, ArH), 7.25 (s, 1H, ArH), 7.27 (s, solv). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 12.57, 43.96, 44.76, 55.97, 109.83, 111.62, 112.37, 117.84, 119.22, 121.26, 126.28, 128.16, 128.63, 128.83, 130.61, 131.20, 143.71, 148.36, 149.22. HRMS (EI): calcd for C<sub>20</sub>H<sub>23</sub>N<sub>3</sub>O<sub>2</sub>, 337.1790; found, C<sub>20</sub>H<sub>24</sub>N<sub>3</sub>O<sub>2</sub>, 338.1862 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> <i>N</i>-(2-(1<i>H</i>-Imidazol-1-yl)ethyl)-4′-fluoro-[1,1′-biphenyl]-2-amine (<b>36</b>)</h4><div class="NLM_p last">Yield: 16%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 3.49 (m, 2H, CH<sub>2</sub>), 3.93 (s, 1H, NH), 4.03–4.06 (t, <i>J</i> = 12.127 Hz, 2H, CH<sub>2</sub>), 6.69–6.71 (d, <i>J</i> = 8.284 Hz, 1H, ArH), 6.74 (s, 1H, ArH), 6.82–6.86 (t, <i>J</i> = 14.763 Hz, 1H, ArH), 6.90 (s, 1H, ArH), 7.02–7.07 (m, 3H, ArH), 7.10–7.12 (d, <i>J</i> = 7.815 Hz, 1H, ArH), 7.27–7.29 (t, <i>J</i> = 13.907 Hz, 2H, ArH), 7.36–7.42 (m, 1H, ArH). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 44.42, 45.69, 110.17, 115.88, 116.10, 117.98, 118.84, 127.31, 128.95, 129.70, 130.67, 130.86, 130.94, 137.21, 143.57, 160.92, 163.38. HRMS (EI): calcd for C<sub>17</sub>H<sub>16</sub>FN<sub>3</sub>, 281.1328; found, C<sub>17</sub>H<sub>17</sub>FN<sub>3</sub>, 282.1404 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 4′-Fluoro-<i>N</i>-(2-(2-methyl-1<i>H</i>-imidazol-1-yl)ethyl)-[1,1′-biphenyl]-2-amine (<b>37</b>)</h4><div class="NLM_p last">Yield: 20%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 2.25 (s, 3H, CH<sub>3</sub>), 3.43–3.48 (m, 2H, CH<sub>2</sub>), 3.84 (s, 1H, NH), 4.00–4.04 (t, <i>J</i> = 11.422 Hz, 2H, CH<sub>2</sub>), 6.66–6.70 (m, 2H, ArH), 6.78–6.84 (m, 1H, ArH), 6.87 (d, <i>J</i> = 1.324 Hz, 1H, ArH), 7.05–7.06 (m, 1H, ArH), 7.08–7.09 (m, 1H, ArH), 7.12 (s, 1H, ArH), 7.18 (s, 1H, ArH), 7.20–7.21 (d, <i>J</i> = 2.336 Hz, 1H, ArH), 7.22–7.24 (t, <i>J</i> = 4.583 Hz, 1H, ArH), 7.26 (s, solv). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 12.79, 43.88, 44.60, 110.09, 115.87, 116.08, 117.96, 118.98, 127.13, 127.30, 128.95, 130.68, 130.86, 130.94, 134.60, 143.63, 160.92, 163.37. HRMS (EI): calcd for C<sub>18</sub>H<sub>18</sub>FN<sub>3</sub>, 295.1485; found, C<sub>18</sub>H<sub>19</sub>FN<sub>3</sub>, 296.1557 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 4′-Fluoro-<i>N</i>-(2-(4-methyl-1<i>H</i>-imidazol-1-yl)ethyl)-[1,1′-biphenyl]-2-amine (<b>38</b>)</h4><div class="NLM_p last">Yield: 26%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 2.17 (s, 3H, CH<sub>3</sub>), 3.45–3.48 (t, <i>J</i> = 11.899 Hz, 2H, CH<sub>2</sub>), 3.84 (s, 1H, NH), 4.03–4.05 (t, <i>J</i> = 10.748 Hz, 2H, CH<sub>2</sub>), 6.50 (s, 1H, ArH), 6.65–6.69 (t, <i>J</i> = 15.111 Hz, 1H, ArH), 6.80–6.83 (t, <i>J</i> = 14.753 Hz, 1H, ArH), 7.06–7.12 (m, 5H, ArH), 7.21–7.24 (m, 2H, ArH), 7.26 (s, solv). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 12.79, 43.88, 44.60, 110.09, 115.87, 116.08, 117.96, 118.98, 127.13, 127.30, 128.95, 130.68, 130.86, 130.94, 134.60, 143.63, 160.92, 163.37. HRMS (EI): calcd for C<sub>18</sub>H<sub>18</sub>FN<sub>3</sub>, 295.1485; found, C<sub>18</sub>H<sub>19</sub>FN<sub>3</sub>, 296.1554 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> <i>N</i>-(2-(1<i>H</i>-Imidazol-1-yl)ethyl)-3′-fluoro-[1,1′-biphenyl]-2-amine (<b>39</b>)</h4><div class="NLM_p last">Yield: 19%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 3.49 (m, 2H, CH<sub>2</sub>), 3.93 (s, 1H, NH), 4.03–4.06 (t, <i>J</i> = 11.939 Hz, 2H, CH<sub>2</sub>), 6.69–6.71 (d, <i>J</i> = 7.586 Hz, 1H, ArH), 6.74 (s, 1H, ArH), 6.82–6.86 (t, <i>J</i> = 14.977 Hz, 1H, ArH), 6.90 (s, 1H, ArH), 7.02–7.07 (m, 3H, ArH), 7.10–7.12 (d, <i>J</i> = 8.241 Hz, 1H, ArH), 7.27–7.31 (t, <i>J</i> = 15.197 Hz, 2H, ArH), 7.36–7.42 (m, 1H, ArH). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 44.48, 45.76, 110.29, 114.31, 114.51, 116.15, 116.35, 118.01, 118.85, 124.81, 129.21, 129.69, 130.48, 137.13, 143.39, 161.84, 164.30. HRMS (EI): calcd for C<sub>17</sub>H<sub>16</sub>FN<sub>3</sub>, 281.1328; found, C<sub>17</sub>H<sub>17</sub>FN<sub>3</sub>, 282.1403 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 3′-Fluoro-<i>N</i>-(2-(2-methyl-1<i>H</i>-imidazol-1-yl)ethyl)-[1,1′-biphenyl]-2-amine (<b>40</b>)</h4><div class="NLM_p last">Yield: 33%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 2.29 (s, 3H, CH<sub>3</sub>), 3.49 (m, 2H, CH<sub>2</sub>), 3.93 (s, 1H, NH), 4.03–4.06 (t, <i>J</i> = 11.922 Hz, 2H, CH<sub>2</sub>), 6.69–6.71 (d, <i>J</i> = 8.184 Hz, 1H, ArH), 6.74 (s, 1H, ArH), 6.82–6.86 (t, <i>J</i> = 13.919 Hz, 1H, ArH), 6.90 (s, 1H, ArH), 7.07–7.12 (m, 3H, ArH), 7.27–7.31 (t, <i>J</i> = 14.475 Hz, 2H, ArH), 7.36–7.42 (m, 1H, ArH). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 12.74, 43.91, 44.70, 110.24, 114.30, 114.51, 116.16, 116.37, 118.02, 118.98, 124.81, 127.21, 129.22, 130.49, 130.65, 143.49, 161.85, 164.31. HRMS (EI): calcd for C<sub>18</sub>H<sub>18</sub>FN<sub>3</sub>, 295.1485; found, C<sub>18</sub>H<sub>19</sub>FN<sub>3</sub>, 296.1556 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 3′-Fluoro-<i>N</i>-(2-(4-methyl-1<i>H</i>-imidazol-1-yl)ethyl)-[1,1′-biphenyl]-2-amine (<b>41</b>)</h4><div class="NLM_p last">Yield: 22%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 2.20 (s, 3H, CH<sub>3</sub>), 3.08–3.11 (t, <i>J</i> = 13.145 Hz, 2H, CH<sub>2</sub>), 3.90–3.93 (t, <i>J</i> = 12.877 Hz, 2H, CH<sub>2</sub>), 6.57 (s, 1H, ArH), 6.64–6.65 (d, <i>J</i> = 8.145 Hz, 1H, ArH), 6.76–6.81 (m, 1H, ArH), 7.05–7.09 (m, 2H, ArH), 7.11–7.13 (d, <i>J</i> = 7.869 Hz, 1H, ArH), 7.17–7.19 (d, <i>J</i> = 8.091 Hz, 1H, ArH), 7.23–7.25 (d, <i>J</i> = 7.695 Hz, 1H, ArH), 7.26 (s, solv), 7.31 (s, 1H, ArH), 7.39–7.44 (m, 1H, ArH). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 12.79, 43.88, 44.60, 110.09, 115.87, 116.08, 117.96, 118.98, 127.13, 127.30, 128.95, 130.68, 130.86, 130.94, 134.60, 143.63, 160.92, 163.37. HRMS (EI): calcd for C<sub>18</sub>H<sub>18</sub>FN<sub>3</sub>, 295.1485; found, C<sub>18</sub>H<sub>19</sub>FN<sub>3</sub>, 296.1556 [M + H]<sup>+</sup>.</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> Design and <i>in Silico</i> Analysis</h3><div class="NLM_p">A molecular operating environment (MOE, 2011.10, Chemical Computing Group, Canada) was used. The protein preparation steps involved 3D protonation, energy minimization, and active site identification. The docking template structure of hQC was derived from the crystal structure of hQC bound to the inhibitor <b>1</b> (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PBB">3PBB</a>), in which <b>1</b> was extracted from the crystal structure of the complex and all crystal waters were removed. The protein was energy minimized and 3D protonated using the structure preparation module of MOE. Ligand files for the molecular docking studies were prepared in MOE and were followed by energy optimization at a standard MMFF94 force field level, with a 0.0001 kcal/mol energy gradient convergence criterion. The optimized geometries were saved in a molecular database file for further studies.</div><div class="NLM_p">The optimized ligands were flexibly docked with the rigid hQC using the MOE-Dock program. Thirty independent docking runs were performed using the MOE docking simulation program. The docked poses were analyzed, and the best scored pose for each compound was chosen for further analysis. The illustrated structures were made with PyMOL (Delano Scientific LLC, USA).</div><div class="NLM_p last">The ADMET_BBB and ADMET_AlogP98 of selected compounds were predicted by Discovery Studio (Accelrys Co., Ltd., USA).</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> Inhibitory Activities <i>in Vitro</i></h3><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> Preparation of hQC</h4><div class="NLM_p last">Cloning, expression, and large scale preparation of hQC were performed according to previous reports.<a onclick="showRef(event, 'ref32 ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref32 ref33 ref34">(32-34)</a> The gene for hQC was inserted via the <i>Bam</i>HI and <i>Xho</i>I restriction sites into <i>Escherichia coli</i> expression vector pET32a with additional introduction of an N-terminal His6-tag (primer pair Cs/Cas). Primers were as follows: 5–3 ACCT<i>GGATCC</i>GCTTCTGCTTGGCCGG, <i>Bam</i>HI; 5–3 TATC<i>CTCGAG</i>TTACAGGTGCAGGTATTC, <i>Xho</i>I (Takara, China). <i>Escherichia coli</i> strain DH5α was used for all cloning procedures. The cDNA was verified by sequencing (Samgon, China). Plasmid DNA was amplified, purified, and linearized. hQC was heterologously expressed in <i>E. coli</i> BL21(DE3) using Fernbach flasks at room temperature overnight, and expression was induced by addition of 0.2 mM IPTG (isopropyl β-<span class="smallcaps smallerCapital">d</span>-1-thiogalactopyranoside). Cells were disrupted with 1 mg/mL lysozyme and a freeze–thaw cycle. The purification of hQC protein followed two chromatographic steps: Ni<sup>2+</sup>-IMAC (immobilized metal affinity chromatography) and molecular sieve chromatography. QC-containing fractions were pooled, and purity was analyzed by SDS-PAGE (15%, sodium dodecyl sulfate polyacrylamide gel electrophoresis) and Coomassie blue staining. The purified hQC enzyme was stored at −80 °C without glycerol.</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> hQC and Inhibitory Activities Studies</h4><div class="NLM_p">The hQC activity was assayed as described elsewhere.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Briefly, for spectrophotometric assessment, the assay reactions (200 μL) consisted of varying concentrations (0–4 mM) of freshly prepared H-gln-gln-H, 30 units/mL glutamic acid dehydrogenase, 0.5 mM NADH/H<sup>+</sup>, and 15 mM α-ketoglutaric acid in 0.05 M Tris-HCl, pH 8.0. Reactions were started by the addition of hQC. Activity was monitored by recording the decrease in absorbance at 340 nm for 15 min.</div><div class="NLM_p last">For the inhibitor testing, the assay reaction composition was the same as described above, except for the addition of different concentrations of the synthesized DPCIs and <b>1</b>. The percentage of inhibition at 100 mM was calculated according to the formula % inhibition = (<i>V</i><sub>C</sub> – <i>V</i><sub>S</sub>)/<i>V</i><sub>C</sub>, where <i>V</i><sub>C</sub> is the reaction velocity of control and <i>V</i><sub>S</sub> is the reaction velocity of samples. All experiments were performed in triplicate. The IC<sub>50</sub> values were determined graphically from log concentration vs % inhibition curves.</div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> BBB Permeation Assay</h3><div class="NLM_p last">PAMPA-BBB assay <i>in vitro</i> was carried out according to previous reports.<a onclick="showRef(event, 'ref27 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref29">(27-29)</a> Simply, test compounds were dissolved in DMSO (2 mg/mL), and the stock solutions were diluted in PBS at pH 8.0 to make secondary stock solutions (100 μg/mL, 5% DMSO). The Millipore MultiScreen assay system (Millipore, Bedford, MA) was used for the artificial membrane support and as the receiver plate. After the required pretreatment, the filter membrane (hydrophobic PVDF) on the 96-well filtration plate was coated with 6 μL of PBL solution in dodecane (20 mg/mL) in each well. The donor well was filled with 250 μL of the secondary stock solution. Then the donor plate was securely placed on the top of an acceptor plate which was prefilled with equal volumes of blank receiving solution to form a “sandwich”. After 4 h at 25 °C, the absorbance of solutions in the acceptor wells was determined by a multiwavelength UV plate reader at 290–310 nm. Pe was calculated according to the formula: Pe = −<i>V</i><sub>d</sub><i>V</i><sub>a</sub>/[(<i>V</i><sub>d</sub> + <i>V</i><sub>a</sub>)<i>St</i>] ln(1 – <i>A</i><sub>a</sub>/<i>A</i><sub>e</sub>), where <i>V</i><sub>d</sub> and <i>V</i><sub>a</sub> are the mean volumes of the donor and acceptor solutions, <i>S</i> is the surface area of the artificial membrane, <i>t</i> is the incubation time, and <i>A</i><sub>a</sub> and <i>A</i><sub>e</sub> are the UV absorbance of the acceptor well and the theoretical equilibrium absorbance, respectively. Each test compound was analyzed in three wells and at least in three runs, and the results are given as the mean of the whole data set ± standard deviation.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> Inhibitory Activities in Cells</h3><div id="sec4_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> Vector, Cell Culture, and Transfection</h4><div class="NLM_p last">The APP695-A673V and the PCMV3-QPCT (human glutaminyl cyclase) plasmids were constructed. Human embryonal kidney cells HEK293T were purchased from the Shanghai Cell Bank (Shanghai, China) and cultured in a humidified atmosphere of 5% CO<sub>2</sub> at 37 °C. According to the manufacturer’s manual, HEK293T cells were transfected with the APP695-A673 V and PCMV3-QPCT plasmids using Lipofectamin2000 (Invitrogen, USA). Transiently transfected cells were grown with serum-free Opti-MEM for 6 h and afterward incubated overnight under normal DMEM conditions. Then, transfected HEK293T cells were cultured either in the presence of <b>28</b> at a concentration of 10 μM for 0, 6, 12, 24, and 48 h or in concentrations of 0, 1, 10, 50, and 100 μM for 24 h. After the culture period, cells and culture media were immediately collected for assay.</div></div><div id="sec4_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> QC Activities Assay</h4><div class="NLM_p last">Cells were lysed using tissue grinding tube on ice. The hQC activities in the supernatants were determined using the same method mentioned in <a class="ref internalNav" href="#sec4_3_2" aria-label="hQC and Inhibitory Activities Studies">hQC and Inhibitory Activities Studies</a>.</div></div><div id="sec4_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> pE-Aβ<sub>3–42</sub> Concentration Assay</h4><div class="NLM_p last">pE-Aβ<sub>3–42</sub> concentrations in the cell lysate supernatants and culture media were determined using amyloid-β (N3pE-42) ELISA kit. Briefly, 100 μL of the sample or 100 μL of standard were added to 96-well microtiter-plates coated with anti-human Aβ<sub>38–42</sub> rabbit IgG (affinity purified), followed by incubation overnight at 4 °C. The next day, plates were washed and incubated with horseradish peroxidase-conjugated antibodies for detecting pE-Aβ<sub>3–42</sub>. After a final washing step, bound enzyme activity was measured using a TMB peroxidase substrate in a colorimetric reaction. The absorbance at 450 nm was determined using a Sunrise plate reader (Tecan, Switzerland).</div></div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> The Anti-AD Effects <i>in Vivo</i></h3><div id="sec4_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> Animals</h4><div class="NLM_p last">All animal experiments were approved by the Animal Ethic Committee at Shenzhen University and were carried out in accordance with the approved guidelines. The B6C3-Tg (APPswe/PSEN1dE9) double-transgenic mice (12 weeks, female) were selected, purchased from Guangdong Medical Laboratory Animal Center (GDMLAC) (Foshan, China), and housed under a 12-h day/12-h night cycle with free access to water and food pellets. Animals were treated with contrast solution (control, C), or 2 mg (low dose, L) or 10 mg of compound <b>28</b> per kg weight (high dose, H) by intraperitoneal injection for 8 weeks.</div></div><div id="sec4_6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> Behavioral Testing</h4><div class="NLM_p last">Nesting behavior was used to measure changes in social behavior. Here, the nest-building task was administered with slight modifications as previously reported.<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30, 31)</a> At the end of the treatment period, mice were individually housed. Eight pieces of cotton paper were introduced inside the home cage to allow nesting behavior, and 24 h later, the quality of the nest was determined.</div></div><div id="sec4_6_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> QC Activities, pE-Aβ<sub>3–42</sub>, and soluble Aβs Concentration Assay</h4><div class="NLM_p last">One day after the behavioral testing, mice were sacrificed by CO<sub>2</sub> inhalation; the brains were removed, flushed with cold saline, and placed on filter paper. Separated hippocampus, cortex, and one half-brain were homogenized in PBS (pH 7.6) containing a protease inhibitor cocktail using tissue grinding tube on ice. After centrifugation, these supernatants were used for the following assay or stored at −80 °C. QC activities were determined using SensoLyte green glutaminyl cyclase activity assay kit and the spectrophotometric method mentioned in <a class="ref internalNav" href="#sec4_3_2" aria-label="hQC and Inhibitory Activities Studies">hQC and Inhibitory Activities Studies</a>. pE-Aβ<sub>3–42</sub> and total soluble Aβ concentrations in these supernatants were determined by amyloid-β (N 3pE-42) ELISA kit and ELISA assay using monoclonal anti-β-amyloid protein (mouse IgG1 isotype) as the first antibody, respectively.</div></div><div id="sec4_6_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> pE-Aβ<sub>3–42</sub> and Total Aβ Plaque Assay</h4><div class="NLM_p last">Mice were anaesthetized with pentobarbital and sequentially perfused transcardially with PBS (pH 7.4) and 4% paraformaldehyde in PBS. The brains were removed and placed in the same 4% paraformaldehyde solution for 24 h at 4 °C, followed by sequential immersion in 10%, 20%, and 30% sucrose at 4 °C, at the end of which they had sunk to the bottom of the container. When embedded in OCT, frozen 8 μm sections were prepared with a freezing microtome at −20 to −30 °C and used for the immunohistochemical analysis. Briefly, after antigen-retrieval (5 min), sections were stained with monoclonal mouse antibody against Aβ-pE3 and monoclonal anti-β-amyloid protein (mouse IgG1 isotype) as first antibody for the detection of pE-Aβ<sub>3–42</sub> and total Aβ plaques, respectively, overnight at 4 °C. Primary antibodies were visualized with secondary horseradish peroxidase-conjugated antibodies and the diaminobenzidine reaction in the presence of H<sub>2</sub>O<sub>2</sub>. Brain sections were washed extensively, mounted on slides and covered with a coverslip. Plaques were observed and photographed under white light or fluorescent microscopy (CX51, Olympus Corporation, Japan). The photographs were further analyzed by Image-Pro Plus 6.0 and Graphpad Prism 5.</div></div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> Statistical Analysis</h3><div class="NLM_p last">The results were expressed as the mean ± SD or mean of means ± SE. The data of the studies <i>in vivo</i> were also evaluated by one-way analysis of variance (ANOVA) followed by a post hoc test or <i>t</i>-test; <i>p</i> < 0.05 was considered to be significant.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i70"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00648">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00874" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00874" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b00648" class="ext-link">10.1021/acs.jmedchem.7b00648</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Evaluation of the house building capacity of the AD mice by Nesting test and the predicted ADMET_BBB and ADMET_AlogP98 of selected analogues (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00648/suppl_file/jm7b00648_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00648/suppl_file/jm7b00648_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00648/suppl_file/jm7b00648_si_001.pdf">jm7b00648_si_001.pdf (201.77 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00648/suppl_file/jm7b00648_si_002.csv">jm7b00648_si_002.csv (2.87 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b00648" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55263" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55263" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Haiqiang Wu</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmacy,
School of Medicine, Shenzhen University, Shenzhen 518060, China</span>; 
    <span class="hlFld-Affiliation affiliation">College of Life Sciences and Oceanography, Shenzhen University, Shenzhen 518060, China</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Neurology, David Geffen School of Medicine, University of California, Los
Angeles, California 90095, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3979-7304" title="Orcid link">http://orcid.org/0000-0003-3979-7304</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#ddaaa8b5ac9daea7a8f3b8b9a8f3beb3"><span class="__cf_email__" data-cfemail="a7d0d2cfd6e7d4ddd289c2c3d289c4c9">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Manman Li</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmacy,
School of Medicine, Shenzhen University, Shenzhen 518060, China</span>; 
    <span class="hlFld-Affiliation affiliation">College of Life Sciences and Oceanography, Shenzhen University, Shenzhen 518060, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yao Dong</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmacy,
School of Medicine, Shenzhen University, Shenzhen 518060, China</span>; 
    <span class="hlFld-Affiliation affiliation">College of Life Sciences and Oceanography, Shenzhen University, Shenzhen 518060, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xi Yu</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmacy,
School of Medicine, Shenzhen University, Shenzhen 518060, China</span>; 
    <span class="hlFld-Affiliation affiliation">College of Life Sciences and Oceanography, Shenzhen University, Shenzhen 518060, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yue Li</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmacy,
School of Medicine, Shenzhen University, Shenzhen 518060, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yongdong Zou</span> - <span class="hlFld-Affiliation affiliation">College of Life Sciences and Oceanography, Shenzhen University, Shenzhen 518060, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yizhi Zheng</span> - <span class="hlFld-Affiliation affiliation">College of Life Sciences and Oceanography, Shenzhen University, Shenzhen 518060, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhendan He</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmacy,
School of Medicine, Shenzhen University, Shenzhen 518060, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhigang Liu</span> - <span class="hlFld-Affiliation affiliation">School of Medicine, Shenzhen University, Shenzhen 518060, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Junmin Quan</span> - <span class="hlFld-Affiliation affiliation">Key Laboratory of Structural Biology, School
of Chemical Biology & Biotechnology, Peking University, Shenzhen Graduate School, Shenzhen 518055, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xianzhang Bu</span> - <span class="hlFld-Affiliation affiliation">School of Pharmaceutical Science, Sun Yat-sen University, Guangzhou, 510006, China</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>Manman Li and Yao Dong contributed equally to this work.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e6218-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i72">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28752" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28752" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by the grants from National Natural Science Foundation of China (No. 81573288) and the Science and Technology Planning Project of Guangdong Province (No. 2013B021100022).</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i73" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i73"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i74" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i74"> Abbreviations Used</h2><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">QC</td><td class="NLM_def"><p class="first last">glutaminyl cyclase</p></td></tr><tr><td class="NLM_term">hQC</td><td class="NLM_def"><p class="first last">human glutaminyl cyclase</p></td></tr><tr><td class="NLM_term">DPCI</td><td class="NLM_def"><p class="first last">diphenyl conjugated imidazole derivatives</p></td></tr><tr><td class="NLM_term">BBB</td><td class="NLM_def"><p class="first last">blood–brain barrier</p></td></tr><tr><td class="NLM_term">PDB</td><td class="NLM_def"><p class="first last">Protein Data Bank</p></td></tr><tr><td class="NLM_term">Aβ</td><td class="NLM_def"><p class="first last">β-amyloid</p></td></tr><tr><td class="NLM_term">pE-Aβ</td><td class="NLM_def"><p class="first last">pyroglutamate-modified β-amyloid</p></td></tr><tr><td class="NLM_term">APP</td><td class="NLM_def"><p class="first last">amyloid precursor protein</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">PBL</td><td class="NLM_def"><p class="first last">polar brain lipid</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">PAMPA-BBB</td><td class="NLM_def"><p class="first last">parallel artificial membrane permeation assay</p></td></tr><tr><td class="NLM_term">ADMET</td><td class="NLM_def"><p class="first last">adsorption, distribution, metabolism, excretion, and toxicity</p></td></tr><tr><td class="NLM_term">TLC</td><td class="NLM_def"><p class="first last">thin-layer chromatography</p></td></tr><tr><td class="NLM_term">MOE</td><td class="NLM_def"><p class="first last">molecular operating environment</p></td></tr><tr><td class="NLM_term">IPTG</td><td class="NLM_def"><p class="first last">isopropyl β-<span class="smallcaps smallerCapital">d</span>-1-thiogalactopyranoside</p></td></tr><tr><td class="NLM_term">IMAC</td><td class="NLM_def"><p class="first last">immobilized metal affinity chromatography</p></td></tr><tr><td class="NLM_term">SDS-PAGE</td><td class="NLM_def"><p class="first last">sodium dodecyl sulfate polyacrylamide gel electrophoresis</p></td></tr><tr><td class="NLM_term">TMB</td><td class="NLM_def"><p class="first last">3,3′,5,5′-tetramethylbenzidine</p></td></tr><tr><td class="NLM_term">HRP</td><td class="NLM_def"><p class="first last">horseradish peroxidase</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i75">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56115" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56115" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 35 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Dobson, C. M.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease: addressing a twenty-first century plague</span> <span class="citation_source-journal">Rend. Fis. Accad. Lincei</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">251</span><span class="NLM_x">–</span> <span class="NLM_lpage">262</span><span class="refDoi"> DOI: 10.1007/s12210-015-0453-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=10.1007%2Fs12210-015-0453-y" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2015&pages=251-262&author=C.+M.+Dobson&title=Alzheimer%E2%80%99s+disease%3A+addressing+a+twenty-first+century+plague&doi=10.1007%2Fs12210-015-0453-y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1007%2Fs12210-015-0453-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12210-015-0453-y%26sid%3Dliteratum%253Aachs%26aulast%3DDobson%26aufirst%3DC.%2BM.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520addressing%2520a%2520twenty-first%2520century%2520plague%26jtitle%3DRend.%2520Fis.%2520Accad.%2520Lincei%26date%3D2015%26volume%3D26%26spage%3D251%26epage%3D262%26doi%3D10.1007%2Fs12210-015-0453-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Snyder, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendrix, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bain, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrillo, M. C.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease research in the context of the national plan to address Alzheimer’s disease</span> <span class="citation_source-journal">Mol. Aspects Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">43–44</span><span class="NLM_x">, </span> <span class="NLM_fpage">16</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span><span class="refDoi"> DOI: 10.1016/j.mam.2015.06.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=10.1016%2Fj.mam.2015.06.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=26096321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=1%3ACAS%3A280%3ADC%252BC2MblsFGnsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43%E2%80%9344&publication_year=2015&pages=16-24&author=H.+M.+Snyderauthor=J.+Hendrixauthor=L.+J.+Bainauthor=M.+C.+Carrillo&title=Alzheimer%E2%80%99s+disease+research+in+the+context+of+the+national+plan+to+address+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.mam.2015.06.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease research in the context of the national plan to address Alzheimer's disease</span></div><div class="casAuthors">Snyder Heather M; Hendrix James; Carrillo Maria C; Bain Lisa J</div><div class="citationInfo"><span class="NLM_cas:title">Molecular aspects of medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">43-44</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">16-24</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">In 2012, the first National Plan to Address Alzheimer's Disease in the United States (U.S.) was released, a component of the National Alzheimer's Project Act legislation.  Since that time, there have been incremental increases in U.S. federal funding for Alzheimer's disease and related dementia research, particularly in the areas of biomarker discovery, genetic link and related biological underpinnings, and prevention studies for Alzheimer's.  A central theme in each of these areas has been the emphasis of cross-sector collaboration and private-public partnerships between government, non-profit organizations and for-profit organizations.  This paper will highlight multiple private-public partnerships supporting the advancement of Alzheimer's research in the context of the National Plan to Address Alzheimer's.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQzU-y67cBwVq_dlEzl_fBafW6udTcc2eZ8MfikQq3Wy7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MblsFGnsA%253D%253D&md5=872d588c0d16ffe40f650cf876fffd72</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.mam.2015.06.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mam.2015.06.005%26sid%3Dliteratum%253Aachs%26aulast%3DSnyder%26aufirst%3DH.%2BM.%26aulast%3DHendrix%26aufirst%3DJ.%26aulast%3DBain%26aufirst%3DL.%2BJ.%26aulast%3DCarrillo%26aufirst%3DM.%2BC.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%2520research%2520in%2520the%2520context%2520of%2520the%2520national%2520plan%2520to%2520address%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DMol.%2520Aspects%2520Med.%26date%3D2015%26volume%3D43%25E2%2580%259344%26spage%3D16%26epage%3D24%26doi%3D10.1016%2Fj.mam.2015.06.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Eisele, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monteiro, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fearns, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Encalada, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiseman, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, J. W.</span><span> </span><span class="NLM_article-title">Targeting protein aggregation for the treatment of degenerative diseases</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">759</span><span class="NLM_x">–</span> <span class="NLM_lpage">780</span><span class="refDoi"> DOI: 10.1038/nrd4593</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=10.1038%2Fnrd4593" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=26338154" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVCrt7rI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=759-780&author=Y.+S.+Eiseleauthor=C.+Monteiroauthor=C.+Fearnsauthor=S.+E.+Encaladaauthor=R.+L.+Wisemanauthor=E.+T.+Powersauthor=J.+W.+Kelly&title=Targeting+protein+aggregation+for+the+treatment+of+degenerative+diseases&doi=10.1038%2Fnrd4593"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting protein aggregation for the treatment of degenerative diseases</span></div><div class="casAuthors">Eisele, Yvonne S.; Monteiro, Cecilia; Fearns, Colleen; Encalada, Sandra E.; Wiseman, R. Luke; Powers, Evan T.; Kelly, Jeffery W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">759-780</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The aggregation of specific proteins is hypothesized to underlie several degenerative diseases, which are collectively known as amyloid disorders.  However, the mechanistic connection between the process of protein aggregation and tissue degeneration is not yet fully understood.  Here, we review current and emerging strategies to ameliorate aggregation-assocd. degenerative disorders, with a focus on disease-modifying strategies that prevent the formation of and/or eliminate protein aggregates.  Persuasive pharmacol. and genetic evidence now supports protein aggregation as the cause of postmitotic tissue dysfunction or loss.  However, a more detailed understanding of the factors that trigger and sustain aggregate formation and of the structure-activity relationships underlying proteotoxicity is needed to develop future disease-modifying therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom0hmQxYx0MrVg90H21EOLACvtfcHk0ljwbrJHNlPTSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVCrt7rI&md5=26a6a0e986547aea92da63242fe02292</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnrd4593&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4593%26sid%3Dliteratum%253Aachs%26aulast%3DEisele%26aufirst%3DY.%2BS.%26aulast%3DMonteiro%26aufirst%3DC.%26aulast%3DFearns%26aufirst%3DC.%26aulast%3DEncalada%26aufirst%3DS.%2BE.%26aulast%3DWiseman%26aufirst%3DR.%2BL.%26aulast%3DPowers%26aufirst%3DE.%2BT.%26aulast%3DKelly%26aufirst%3DJ.%2BW.%26atitle%3DTargeting%2520protein%2520aggregation%2520for%2520the%2520treatment%2520of%2520degenerative%2520diseases%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2015%26volume%3D14%26spage%3D759%26epage%3D780%26doi%3D10.1038%2Fnrd4593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Hamley, I. W.</span><span> </span><span class="NLM_article-title">The amyloid beta peptide: a chemist’s perspective. Role in Alzheimer’s and fibrillization</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">5147</span><span class="NLM_x">–</span> <span class="NLM_lpage">5192</span><span class="refDoi"> DOI: 10.1021/cr3000994</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr3000994" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVKgtLzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2012&pages=5147-5192&author=I.+W.+Hamley&title=The+amyloid+beta+peptide%3A+a+chemist%E2%80%99s+perspective.+Role+in+Alzheimer%E2%80%99s+and+fibrillization&doi=10.1021%2Fcr3000994"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The Amyloid Beta Peptide: A Chemist's Perspective Role in Alzheimer's and Fibrillization</span></div><div class="casAuthors">Hamley, I. W.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5147-5192</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review, discussing the role of fibrillization of the amyloid β (Aβ)-peptide in Alzheimer's disease (AD).  The perspective is that of a phys. chemist, and one aim is to introduce relevant key findings on physicochem. properties.  However, in addn., key aspects of the biol. and biochem. assocd. with the role of Aβ in AD are also summarized (more detailed reviews of these aspects can be found elsewhere), as are developments in potential therapies and biomarkers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4Zs86qZNALbVg90H21EOLACvtfcHk0lhlGSySa7aOwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVKgtLzM&md5=647d2b3f9e9243b3a373f6aadd2d1376</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Fcr3000994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr3000994%26sid%3Dliteratum%253Aachs%26aulast%3DHamley%26aufirst%3DI.%2BW.%26atitle%3DThe%2520amyloid%2520beta%2520peptide%253A%2520a%2520chemist%25E2%2580%2599s%2520perspective.%2520Role%2520in%2520Alzheimer%25E2%2580%2599s%2520and%2520fibrillization%26jtitle%3DChem.%2520Rev.%26date%3D2012%26volume%3D112%26spage%3D5147%26epage%3D5192%26doi%3D10.1021%2Fcr3000994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">LaFerla, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oddo, S.</span><span> </span><span class="NLM_article-title">Intracellular amyloid-beta in Alzheimer’s disease</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">499</span><span class="NLM_x">–</span> <span class="NLM_lpage">509</span><span class="refDoi"> DOI: 10.1038/nrn2168</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=10.1038%2Fnrn2168" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=17551515" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmslWjsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=499-509&author=F.+M.+LaFerlaauthor=K.+N.+Greenauthor=S.+Oddo&title=Intracellular+amyloid-beta+in+Alzheimer%E2%80%99s+disease&doi=10.1038%2Fnrn2168"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Intracellular amyloid-β in Alzheimer's disease</span></div><div class="casAuthors">LaFerla, Frank M.; Green, Kim N.; Oddo, Salvatore</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">499-509</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The primal role that the amyloid-β (Aβ) peptide has in the development of Alzheimer's disease is now almost universally accepted.  It is also well recognized that Aβ exists in multiple assembly states, which have different physiol. or pathophysiol. effects.  Although the classical view is that Aβ is deposited extracellularly, emerging evidence from transgenic mice and human patients indicates that this peptide can also accumulate intraneuronally, which may contribute to disease progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_7YmF12y-hbVg90H21EOLACvtfcHk0lhlGSySa7aOwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmslWjsr8%253D&md5=35993dacf1599863e6e1a8ac508c4dc0</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrn2168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn2168%26sid%3Dliteratum%253Aachs%26aulast%3DLaFerla%26aufirst%3DF.%2BM.%26aulast%3DGreen%26aufirst%3DK.%2BN.%26aulast%3DOddo%26aufirst%3DS.%26atitle%3DIntracellular%2520amyloid-beta%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2007%26volume%3D8%26spage%3D499%26epage%3D509%26doi%3D10.1038%2Fnrn2168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Demetrius, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Driver, J. A.</span><span> </span><span class="NLM_article-title">Preventing Alzheimer’s disease by means of natural selection</span> <span class="citation_source-journal">J. R. Soc., Interface</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">20140919</span><span class="refDoi"> DOI: 10.1098/rsif.2014.0919</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=10.1098%2Frsif.2014.0919" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=25551134" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=1%3ACAS%3A280%3ADC%252BC2MvivFCisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=20140919&author=L.+A.+Demetriusauthor=J.+A.+Driver&title=Preventing+Alzheimer%E2%80%99s+disease+by+means+of+natural+selection&doi=10.1098%2Frsif.2014.0919"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Preventing Alzheimer's disease by means of natural selection</span></div><div class="casAuthors">Demetrius Lloyd A; Driver Jane A</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Royal Society, Interface</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">102</span>),
    <span class="NLM_cas:pages">20140919</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The amyloid cascade model for the origin of sporadic forms of Alzheimer's disease (AD) posits that the imbalance in the production and clearance of beta-amyloid is a necessary condition for the disease.  A competing theory called the entropic selection hypothesis asserts that the primary cause of sporadic AD is age-induced mitochondrial dysregulation and the following cascade of events: (i) metabolic reprogramming--the upregulation of oxidative phosphorylation in compensation for insufficient energy production in neurons, (ii) natural selection--competition between intact and reprogrammed neurons for energy substrates and (iii) propagation--the spread of the disease due to the selective advantage of neurons with upregulated metabolism.  Experimental studies to evaluate the predictions of the amyloid cascade model are being continually retuned to accommodate conflicts of the predictions with empirical data.  Clinical trials of treatments for AD based on anti-amyloid therapy have been unsuccessful.  We contend that these anomalies and failures stem from a fundamental deficit of the amyloid hypothesis: the model derives from a nuclear-genomic perspective of sporadic AD and discounts the bioenergetic processes that characterize the progression of most age-related disorders.  In this article, we review the anomalies of the amyloid model and the theoretical and empirical support for the entropic selection theory.  We also discuss the new therapeutic strategies based on natural selection which the model proposes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRiZ6E5KZeY3JVVjGoY74BafW6udTcc2eZUPxOikFx6MLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MvivFCisA%253D%253D&md5=dad1b98deb282cfddcf0c8a1f1325495</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1098%2Frsif.2014.0919&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1098%252Frsif.2014.0919%26sid%3Dliteratum%253Aachs%26aulast%3DDemetrius%26aufirst%3DL.%2BA.%26aulast%3DDriver%26aufirst%3DJ.%2BA.%26atitle%3DPreventing%2520Alzheimer%25E2%2580%2599s%2520disease%2520by%2520means%2520of%2520natural%2520selection%26jtitle%3DJ.%2520R.%2520Soc.%252C%2520Interface%26date%3D2015%26volume%3D12%26spage%3D20140919%26doi%3D10.1098%2Frsif.2014.0919" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Bayer, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wirths, O.</span><span> </span><span class="NLM_article-title">Focusing the amyloid cascade hypothesis on N-truncated Abeta peptides as drug targets against Alzheimer’s disease</span> <span class="citation_source-journal">Acta Neuropathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">787</span><span class="NLM_x">–</span> <span class="NLM_lpage">801</span><span class="refDoi"> DOI: 10.1007/s00401-014-1287-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=10.1007%2Fs00401-014-1287-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=24803226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnvVSrsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2014&pages=787-801&author=T.+A.+Bayerauthor=O.+Wirths&title=Focusing+the+amyloid+cascade+hypothesis+on+N-truncated+Abeta+peptides+as+drug+targets+against+Alzheimer%E2%80%99s+disease&doi=10.1007%2Fs00401-014-1287-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Focusing the amyloid cascade hypothesis on N-truncated Abeta peptides as drug targets against Alzheimer's disease</span></div><div class="casAuthors">Bayer, Thomas A.; Wirths, Oliver</div><div class="citationInfo"><span class="NLM_cas:title">Acta Neuropathologica</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">787-801</span>CODEN:
                <span class="NLM_cas:coden">ANPTAL</span>;
        ISSN:<span class="NLM_cas:issn">0001-6322</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Although N-truncated Aβ variants are known to be the main constituent of amyloid plaques in the brains of patients with Alzheimer's disease, their potential as targets for pharmacol. intervention has only recently been investigated.  In the last few years, the Alzheimer field has experienced a paradigm shift with the ever increasing understanding that targeting amyloid plaques has not led to a successful immunotherapy.  On the other hand, there can be no doubt that the amyloid cascade hypothesis is central to the etiol. of Alzheimer's disease, raising the question as to why it is apparently failing to translate into the clinic.  In this review, we aim to refocus the amyloid hypothesis integrating N-truncated Aβ peptides based on mounting evidence that they may represent better targets than full-length Aβ.  In addn. to Aβ peptides starting with an Asp at position 1, a variety of different N-truncated Aβ peptides have been identified starting with amino residue Ala-2, pyroglutamylated Glu-3, Phe-4, Arg-5, His-6, Asp-7, Ser-8, Gly-9, Tyr-10 and pyroglutamylated Glu-11.  Certain forms of N-truncated species are better correlates for early pathol. changes found pre-symptomatically more often than others.  There is also evidence that, together with full-length Aβ, they might be physiol. detectable and are naturally secreted by neurons.  Others are known to form sol. aggregates, which have neurotoxic properties in transgenic mouse models.  It has been clearly demonstrated by several groups that some N-truncated Aβs dominate full-length Aβ in the brains of Alzheimer's patients.  We try to address which of the N-truncated variants may be promising therapeutic targets and which enzymes might be involved in the generation of these peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpONpP9jWQ-X7Vg90H21EOLACvtfcHk0lhzGNJwRuu0QQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnvVSrsLs%253D&md5=5374727ba0b50e40ed87a122da1c65bd</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1007%2Fs00401-014-1287-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00401-014-1287-x%26sid%3Dliteratum%253Aachs%26aulast%3DBayer%26aufirst%3DT.%2BA.%26aulast%3DWirths%26aufirst%3DO.%26atitle%3DFocusing%2520the%2520amyloid%2520cascade%2520hypothesis%2520on%2520N-truncated%2520Abeta%2520peptides%2520as%2520drug%2520targets%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DActa%2520Neuropathol.%26date%3D2014%26volume%3D127%26spage%3D787%26epage%3D801%26doi%3D10.1007%2Fs00401-014-1287-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Mehta, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Short, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilmer, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolazzo, J. A.</span><span> </span><span class="NLM_article-title">Drug access to the central nervous system in Alzheimer’s disease: preclinical and clinical insights</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">819</span><span class="NLM_x">–</span> <span class="NLM_lpage">839</span><span class="refDoi"> DOI: 10.1007/s11095-014-1522-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=10.1007%2Fs11095-014-1522-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2015&pages=819-839&author=D.+C.+Mehtaauthor=J.+L.+Shortauthor=S.+N.+Hilmerauthor=J.+A.+Nicolazzo&title=Drug+access+to+the+central+nervous+system+in+Alzheimer%E2%80%99s+disease%3A+preclinical+and+clinical+insights&doi=10.1007%2Fs11095-014-1522-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1007%2Fs11095-014-1522-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11095-014-1522-0%26sid%3Dliteratum%253Aachs%26aulast%3DMehta%26aufirst%3DD.%2BC.%26aulast%3DShort%26aufirst%3DJ.%2BL.%26aulast%3DHilmer%26aufirst%3DS.%2BN.%26aulast%3DNicolazzo%26aufirst%3DJ.%2BA.%26atitle%3DDrug%2520access%2520to%2520the%2520central%2520nervous%2520system%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520preclinical%2520and%2520clinical%2520insights%26jtitle%3DPharm.%2520Res.%26date%3D2015%26volume%3D32%26spage%3D819%26epage%3D839%26doi%3D10.1007%2Fs11095-014-1522-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Saido, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwatsubo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mann, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawashima, S.</span><span> </span><span class="NLM_article-title">Dominant and differential deposition of distinct beta-amyloid peptide species, A beta N3(pE), in senile plaques</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">457</span><span class="NLM_x">–</span> <span class="NLM_lpage">466</span><span class="refDoi"> DOI: 10.1016/0896-6273(95)90301-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=10.1016%2F0896-6273%2895%2990301-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=7857653" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=1%3ACAS%3A528%3ADyaK2MXjvFejsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1995&pages=457-466&author=T.+C.+Saidoauthor=T.+Iwatsuboauthor=D.+M.+Mannauthor=H.+Shimadaauthor=Y.+Iharaauthor=S.+Kawashima&title=Dominant+and+differential+deposition+of+distinct+beta-amyloid+peptide+species%2C+A+beta+N3%28pE%29%2C+in+senile+plaques&doi=10.1016%2F0896-6273%2895%2990301-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Dominant and differential deposition of distinct β-amyloid peptide species, AβN3(pE), in senile plaques</span></div><div class="casAuthors">Saido, Takaomi C.; Iwatsubo, Takeshi; Mann, David M. A.; Shimada, Hiroyuki; Ihara, Yasuo; Kawashima, Selichi</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">457-66</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">We analyzed an amino-terminal modification of β-amyloid (Aβ) peptide in brain, using anti-Aβ antibodies that distinguish distinct mol. species.  Examn. of cortical sections from 28 aged individuals with a wide range in senile plaque d. revealed that a mol. species distinct from the std. Aβ is deposited in the brain in a dominant and differential manner.  This modified Aβ peptide (AβN3(pE)) starts at the 3rd amino-terminal residue of the std. αβ, glutamate, converted to pyroglutamate through intramol. dehydration.  Because plaques composed of αβN3(pE) are present in equiv. or greater densities than those composed of std. Aβ bearing the first amino-terminal residue (AβN1) and because deposition of the former species appears to precede deposition of the latter, as confirmed with specimens from Down's syndrome patients, the processes involved in AβNe(pE) prodn. and retention may play an early and crit. role in senile plaque formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEs7XnR_KCcbVg90H21EOLACvtfcHk0lhzGNJwRuu0QQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjvFejsLk%253D&md5=8405ddfabcebe721ccd5b1dc1e222069</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2F0896-6273%2895%2990301-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0896-6273%252895%252990301-1%26sid%3Dliteratum%253Aachs%26aulast%3DSaido%26aufirst%3DT.%2BC.%26aulast%3DIwatsubo%26aufirst%3DT.%26aulast%3DMann%26aufirst%3DD.%2BM.%26aulast%3DShimada%26aufirst%3DH.%26aulast%3DIhara%26aufirst%3DY.%26aulast%3DKawashima%26aufirst%3DS.%26atitle%3DDominant%2520and%2520differential%2520deposition%2520of%2520distinct%2520beta-amyloid%2520peptide%2520species%252C%2520A%2520beta%2520N3%2528pE%2529%252C%2520in%2520senile%2520plaques%26jtitle%3DNeuron%26date%3D1995%26volume%3D14%26spage%3D457%26epage%3D466%26doi%3D10.1016%2F0896-6273%2895%2990301-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Wirths, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillmann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pradier, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartig, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayer, T. A.</span><span> </span><span class="NLM_article-title">Oligomeric pyroglutamate amyloid-beta is present in microglia and a subfraction of vessels in patients with Alzheimer’s disease: implications for immunotherapy</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">741</span><span class="NLM_x">–</span> <span class="NLM_lpage">749</span><span class="refDoi"> DOI: 10.3233/JAD-121945</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=10.3233%2FJAD-121945" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=23481684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=1%3ACAS%3A280%3ADC%252BC3svltlWhsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2013&pages=741-749&author=O.+Wirthsauthor=A.+Hillmannauthor=L.+Pradierauthor=W.+Hartigauthor=T.+A.+Bayer&title=Oligomeric+pyroglutamate+amyloid-beta+is+present+in+microglia+and+a+subfraction+of+vessels+in+patients+with+Alzheimer%E2%80%99s+disease%3A+implications+for+immunotherapy&doi=10.3233%2FJAD-121945"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Oligomeric pyroglutamate amyloid-β is present in microglia and a subfraction of vessels in patients with Alzheimer's disease: implications for immunotherapy</span></div><div class="casAuthors">Wirths Oliver; Hillmann Antje; Pradier Laurent; Hartig Wolfgang; Bayer Thomas A</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's disease : JAD</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">741-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">N-terminally truncated pyroglutamate amyloid-β (Aβ) starting at position 3 (AβpE3) represents a major fraction of Aβ peptides in Alzheimer's disease (AD).  Recently, we have identified low molecular weight AβpE3 oligomers, which can be detected by 9D5, a novel mouse monoclonal antibody.  In the present study, we analyzed the immunohistochemical staining profile in the brain of patients with AD and in the APP/PS1KI mouse model, as well as in aged rhesus monkeys. 9D5-positive microglia and blood vessels were found in many AD cases, in the transgenic mouse model, and in an aged macaque.  The presence of 9D5-immunoreactivity in microglia indicates that low molecular weight AβpE3 oligomers may be phagocytosed, since in the APP/PS1KI model, Aβ is exclusively produced in neurons due to neuronal expression of transgenic AβPP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSSrGT8hETg2JZoeNcnHOQ9fW6udTcc2eY_riWDc8EX0Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3svltlWhsg%253D%253D&md5=944c79a17a2570d10b12d39fdf73c264</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.3233%2FJAD-121945&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-121945%26sid%3Dliteratum%253Aachs%26aulast%3DWirths%26aufirst%3DO.%26aulast%3DHillmann%26aufirst%3DA.%26aulast%3DPradier%26aufirst%3DL.%26aulast%3DHartig%26aufirst%3DW.%26aulast%3DBayer%26aufirst%3DT.%2BA.%26atitle%3DOligomeric%2520pyroglutamate%2520amyloid-beta%2520is%2520present%2520in%2520microglia%2520and%2520a%2520subfraction%2520of%2520vessels%2520in%2520patients%2520with%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520implications%2520for%2520immunotherapy%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2013%26volume%3D35%26spage%3D741%26epage%3D749%26doi%3D10.3233%2FJAD-121945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Gunn, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masters, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherny, R. A.</span><span> </span><span class="NLM_article-title">Pyroglutamate-Abeta: role in the natural history of Alzheimer’s disease</span> <span class="citation_source-journal">Int. J. Biochem. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1915</span><span class="NLM_x">–</span> <span class="NLM_lpage">1918</span><span class="refDoi"> DOI: 10.1016/j.biocel.2010.08.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=10.1016%2Fj.biocel.2010.08.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=20833262" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtl2itLrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2010&pages=1915-1918&author=A.+P.+Gunnauthor=C.+L.+Mastersauthor=R.+A.+Cherny&title=Pyroglutamate-Abeta%3A+role+in+the+natural+history+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.biocel.2010.08.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Pyroglutamate-Aβ: Role in the natural history of Alzheimer's disease</span></div><div class="casAuthors">Gunn, Adam P.; Masters, Colin L.; Cherny, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biochemistry & Cell Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1915-1918</span>CODEN:
                <span class="NLM_cas:coden">IJBBFU</span>;
        ISSN:<span class="NLM_cas:issn">1357-2725</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The accumulation of amyloid-beta (Aβ) peptides is believed to be a central contributor to the neurodegeneration typically seen in Alzheimer's disease (AD) brain.  Aβ extd. from AD brains invariably possesses extensive truncations, yielding peptides of differing N- and C-terminal compn.  While Aβ is often abundant in the brains of cognitively normal elderly people, the brains of AD patients are highly enriched for N-terminally truncated Aβ bearing the pyroglutamate modification.  Pyroglutamate-Aβ (pE-Aβ) has a higher propensity for oligomerization and aggregation than full-length Aβ, potentially seeding the accumulation of neurotoxic Aβ oligomers and amyloid deposits.  In addn., pE-Aβ has increased resistance to clearance by peptidases, causing these peptides to persist in biol. fluids and tissues.  The extensive deposition of pE-Aβ in human AD brain is under-represented in many transgenic mouse models of AD, reflecting major differences in the prodn. and processing of Aβ peptides in these models compared to the human disease state.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorztlGScimnrVg90H21EOLACvtfcHk0lgY3j_yY_0qVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtl2itLrO&md5=1139e1d56c89eed8e3ac3b08bd3b89ed</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.biocel.2010.08.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biocel.2010.08.015%26sid%3Dliteratum%253Aachs%26aulast%3DGunn%26aufirst%3DA.%2BP.%26aulast%3DMasters%26aufirst%3DC.%2BL.%26aulast%3DCherny%26aufirst%3DR.%2BA.%26atitle%3DPyroglutamate-Abeta%253A%2520role%2520in%2520the%2520natural%2520history%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DInt.%2520J.%2520Biochem.%2520Cell%2520Biol.%26date%3D2010%26volume%3D42%26spage%3D1915%26epage%3D1918%26doi%3D10.1016%2Fj.biocel.2010.08.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Schlenzig, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manhart, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cinar, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleinschmidt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hause, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willbold, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funke, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schilling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demuth, H. U.</span><span> </span><span class="NLM_article-title">Pyroglutamate formation influences solubility and amyloidogenicity of amyloid peptides</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7072</span><span class="NLM_x">–</span> <span class="NLM_lpage">7078</span><span class="refDoi"> DOI: 10.1021/bi900818a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi900818a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnvFWkurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=7072-7078&author=D.+Schlenzigauthor=S.+Manhartauthor=Y.+Cinarauthor=M.+Kleinschmidtauthor=G.+Hauseauthor=D.+Willboldauthor=S.+A.+Funkeauthor=S.+Schillingauthor=H.+U.+Demuth&title=Pyroglutamate+formation+influences+solubility+and+amyloidogenicity+of+amyloid+peptides&doi=10.1021%2Fbi900818a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Pyroglutamate Formation Influences Solubility and Amyloidogenicity of Amyloid Peptides</span></div><div class="casAuthors">Schlenzig, Dagmar; Manhart, Susanne; Cinar, Yeliz; Kleinschmidt, Martin; Hause, Gerd; Willbold, Dieter; Funke, Susanne Aileen; Schilling, Stephan; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">7072-7078</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">N-Terminally truncated and pyroglutamate (pGlu) modified amyloid β (Aβ) peptides are major constituents of amyloid deposits in sporadic and inherited Alzheimer's disease (AD).  Formation of pGlu at the N-terminus confers resistance against cleavage by most aminopeptidases, increases toxicity of the peptides, and may seed Aβ aggregate formation.  Similarly, the deposited amyloid peptides ABri and ADan, which cause a very similar histopathol. in familial British dementia (FBD) and familial Danish dementia (FDD), are N-terminally blocked by pGlu.  Triggered by the coincidence of pGlu-modified amyloid peptides and similar pathol. in AD, FBD, and FDD, we investigated the impact of N-terminal pGlu on biochem. and biophys. properties of Aβ, ABri, and ADan.  N-Terminal pGlu increases the hydrophobicity and changes the pH-dependent soly. profile, rendering the pGlu-modified peptides less sol. in the basic pH range.  The pGlu residue increases the aggregation propensity of all amyloid peptides as evidenced by ThT fluorescence assays and dynamic light scattering.  The far-UV CD spectroscopic anal. points toward an enhanced β-sheet structure of the pGlu-Aβ.  Importantly, changes in fibril morphol. are clearly caused by the N-terminal pGlu, resulting in the formation of short fibers, which are frequently arranged in bundles.  The effect of pGlu on the morphol. is virtually indistinguishable between ABri, ADan, and Aβ.  The data provide evidence for a comparable influence of the pGlu modification on the aggregation process of structurally different amyloid peptides, thus likely contributing to the molecularly distinct neurodegenerative diseases AD, FBD, and FDD.  The main driving force for the aggregation is apparently an increase in the hydrophobicity and thus an accelerated seed formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo01m64gYKSRLVg90H21EOLACvtfcHk0lgY3j_yY_0qVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnvFWkurk%253D&md5=f32a500d5c6e5f44fa2809256c8a90ca</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fbi900818a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi900818a%26sid%3Dliteratum%253Aachs%26aulast%3DSchlenzig%26aufirst%3DD.%26aulast%3DManhart%26aufirst%3DS.%26aulast%3DCinar%26aufirst%3DY.%26aulast%3DKleinschmidt%26aufirst%3DM.%26aulast%3DHause%26aufirst%3DG.%26aulast%3DWillbold%26aufirst%3DD.%26aulast%3DFunke%26aufirst%3DS.%2BA.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DPyroglutamate%2520formation%2520influences%2520solubility%2520and%2520amyloidogenicity%2520of%2520amyloid%2520peptides%26jtitle%3DBiochemistry%26date%3D2009%26volume%3D48%26spage%3D7072%26epage%3D7078%26doi%3D10.1021%2Fbi900818a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Nussbaum, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schilling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cynis, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silva, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swanson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wangsanut, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tayler, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiltgen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatami, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ronicke, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reymann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutter-Paier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexandru, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagla, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graubner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glabe, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demuth, H. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bloom, G. S.</span><span> </span><span class="NLM_article-title">Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-beta</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">485</span><span class="NLM_x">, </span> <span class="NLM_fpage">651</span><span class="NLM_x">–</span> <span class="NLM_lpage">655</span><span class="refDoi"> DOI: 10.1038/nature11060</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=10.1038%2Fnature11060" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=22660329" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=1%3ACAS%3A528%3ADC%252BC38XnvVymsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=485&publication_year=2012&pages=651-655&author=J.+M.+Nussbaumauthor=S.+Schillingauthor=H.+Cynisauthor=A.+Silvaauthor=E.+Swansonauthor=T.+Wangsanutauthor=K.+Taylerauthor=B.+Wiltgenauthor=A.+Hatamiauthor=R.+Ronickeauthor=K.+Reymannauthor=B.+Hutter-Paierauthor=A.+Alexandruauthor=W.+Jaglaauthor=S.+Graubnerauthor=C.+G.+Glabeauthor=H.+U.+Demuthauthor=G.+S.+Bloom&title=Prion-like+behaviour+and+tau-dependent+cytotoxicity+of+pyroglutamylated+amyloid-beta&doi=10.1038%2Fnature11060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Prion-like behavior and tau-dependent cytotoxicity of pyroglutamylated amyloid-β</span></div><div class="casAuthors">Nussbaum, Justin M.; Schilling, Stephan; Cynis, Holger; Silva, Antonia; Swanson, Eric; Wangsanut, Tanaporn; Tayler, Kaycie; Wiltgen, Brian; Hatami, Asa; Roenicke, Raik; Reymann, Klaus; Hutter-Paier, Birgit; Alexandru, Anca; Jagla, Wolfgang; Graubner, Sigrid; Glabe, Charles G.; Demuth, Hans-Ulrich; Bloom, George S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">485</span>
        (<span class="NLM_cas:issue">7400</span>),
    <span class="NLM_cas:pages">651-655</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Extracellular plaques of amyloid-β and intraneuronal neurofibrillary tangles made from tau are the histopathol. signatures of Alzheimer's disease.  Plaques comprise amyloid-β fibrils that assemble from monomeric and oligomeric intermediates, and are prognostic indicators of Alzheimer's disease.  Despite the importance of plaques to Alzheimer's disease, oligomers are considered to be the principal toxic forms of amyloid-β.  Interestingly, many adverse responses to amyloid-β, such as cytotoxicity, microtubule loss, impaired memory and learning, and neuritic degeneration, are greatly amplified by tau expression.  Amino-terminally truncated, pyroglutamylated (pE) forms of amyloid-β are strongly assocd. with Alzheimer's disease, are more toxic than amyloid-β, residues 1-42 (Aβ1-42) and Aβ1-40, and have been proposed as initiators of Alzheimer's disease pathogenesis.  Here we report a mechanism by which pE-Aβ may trigger Alzheimer's disease.  Aβ3(pE)-42 co-oligomerizes with excess Aβ1-42 to form metastable low-n oligomers (LNOs) that are structurally distinct and far more cytotoxic to cultured neurons than comparable LNOs made from Aβ1-42 alone.  Tau is required for cytotoxicity, and LNOs comprising 5% Aβ3(pE)-42 plus 95% Aβ1-42 (5% pE-Aβ) seed new cytotoxic LNOs through multiple serial dilns. into Aβ1-42 monomers in the absence of addnl. Aβ3(pE)-42.  LNOs isolated from human Alzheimer's disease brain contained Aβ3(pE)-42, and enhanced Aβ3(pE)-42 formation in mice triggered neuron loss and gliosis at 3 mo, but not in a tau-null background.  We conclude that Aβ3(pE)-42 confers tau-dependent neuronal death and causes template-induced misfolding of Aβ1-42 into structurally distinct LNOs that propagate by a prion-like mechanism.  Our results raise the possibility that Aβ3(pE)-42 acts similarly at a primary step in Alzheimer's disease pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotg6vra9ty9rVg90H21EOLACvtfcHk0lgY3j_yY_0qVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnvVymsbc%253D&md5=67ba093a16fe5db1bea9f3873bd92ee5</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnature11060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11060%26sid%3Dliteratum%253Aachs%26aulast%3DNussbaum%26aufirst%3DJ.%2BM.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DCynis%26aufirst%3DH.%26aulast%3DSilva%26aufirst%3DA.%26aulast%3DSwanson%26aufirst%3DE.%26aulast%3DWangsanut%26aufirst%3DT.%26aulast%3DTayler%26aufirst%3DK.%26aulast%3DWiltgen%26aufirst%3DB.%26aulast%3DHatami%26aufirst%3DA.%26aulast%3DRonicke%26aufirst%3DR.%26aulast%3DReymann%26aufirst%3DK.%26aulast%3DHutter-Paier%26aufirst%3DB.%26aulast%3DAlexandru%26aufirst%3DA.%26aulast%3DJagla%26aufirst%3DW.%26aulast%3DGraubner%26aufirst%3DS.%26aulast%3DGlabe%26aufirst%3DC.%2BG.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DBloom%26aufirst%3DG.%2BS.%26atitle%3DPrion-like%2520behaviour%2520and%2520tau-dependent%2520cytotoxicity%2520of%2520pyroglutamylated%2520amyloid-beta%26jtitle%3DNature%26date%3D2012%26volume%3D485%26spage%3D651%26epage%3D655%26doi%3D10.1038%2Fnature11060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Schilling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manhart, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demuth, H. U.</span><span> </span><span class="NLM_article-title">Glutaminyl cyclases unfold glutamyl cyclase activity under mild acid conditions</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">563</span><span class="NLM_x">, </span> <span class="NLM_fpage">191</span><span class="NLM_x">–</span> <span class="NLM_lpage">196</span><span class="refDoi"> DOI: 10.1016/S0014-5793(04)00300-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=10.1016%2FS0014-5793%2804%2900300-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=15063747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=1%3ACAS%3A528%3ADC%252BD2cXivVGgsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=563&publication_year=2004&pages=191-196&author=S.+Schillingauthor=T.+Hoffmannauthor=S.+Manhartauthor=M.+Hoffmannauthor=H.+U.+Demuth&title=Glutaminyl+cyclases+unfold+glutamyl+cyclase+activity+under+mild+acid+conditions&doi=10.1016%2FS0014-5793%2804%2900300-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Glutaminyl cyclases unfold glutamyl cyclase activity under mild acid conditions</span></div><div class="casAuthors">Schilling, Stephan; Hoffmann, Torsten; Manhart, Susanne; Hoffmann, Matthias; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">563</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">191-196</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">N-terminal pyroglutamate (pGlu) formation from glutaminyl precursors is a posttranslational event in the processing of bioactive neuropeptides such as TSH-releasing hormone and neurotensin during their maturation in the secretory pathway.  The reaction is facilitated by glutaminyl cyclase (QC), an enzyme highly abundant in mammalian brain.  Here, we describe for the first time that human and papaya QC also catalyze N-terminal glutamate cyclization.  Surprisingly, the enzymic Glu1 conversion is favored at pH 6.0 while Gln1 conversion occurs with an optimum at pH 8.0.  This unexpected finding might be of importance for deciphering the events leading to deposition of highly toxic pyroglutamyl peptides in amyloidotic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUU5BTU0iZI7Vg90H21EOLACvtfcHk0lhWOSCuF2_ZFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXivVGgsrY%253D&md5=43c6d9f6def6e4a6948171a58e961471</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2FS0014-5793%2804%2900300-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-5793%252804%252900300-X%26sid%3Dliteratum%253Aachs%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DManhart%26aufirst%3DS.%26aulast%3DHoffmann%26aufirst%3DM.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DGlutaminyl%2520cyclases%2520unfold%2520glutamyl%2520cyclase%2520activity%2520under%2520mild%2520acid%2520conditions%26jtitle%3DFEBS%2520Lett.%26date%3D2004%26volume%3D563%26spage%3D191%26epage%3D196%26doi%3D10.1016%2FS0014-5793%2804%2900300-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Schilling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manhart, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludwig, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wasternack, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demuth, H. U.</span><span> </span><span class="NLM_article-title">Substrate specificity of glutaminyl cyclases from plants and animals</span> <span class="citation_source-journal">Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">384</span><span class="NLM_x">, </span> <span class="NLM_fpage">1583</span><span class="NLM_x">–</span> <span class="NLM_lpage">1592</span><span class="refDoi"> DOI: 10.1515/BC.2003.175</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=10.1515%2FBC.2003.175" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=14719800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVSksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=384&publication_year=2003&pages=1583-1592&author=S.+Schillingauthor=S.+Manhartauthor=T.+Hoffmannauthor=H.+H.+Ludwigauthor=C.+Wasternackauthor=H.+U.+Demuth&title=Substrate+specificity+of+glutaminyl+cyclases+from+plants+and+animals&doi=10.1515%2FBC.2003.175"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Substrate specificity of glutaminyl cyclases from plants and animals</span></div><div class="casAuthors">Schilling, Stephan; Manhart, Susanne; Hoffmann, Torsten; Ludwig, Hans-henning; Wasternack, Claus; Demuth, Hans-ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">384</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1583-1592</span>CODEN:
                <span class="NLM_cas:coden">BICHF3</span>;
        ISSN:<span class="NLM_cas:issn">1431-6730</span>.
    
            (<span class="NLM_cas:orgname">Walter de Gruyter GmbH & Co. KG</span>)
        </div><div class="casAbstract">Glutaminyl cyclases (QC) catalyze the intramol. cyclization of N-terminal glutamine residues of peptides and proteins.  For a comparison of the substrate specificity of human and papaya QC enzymes, a novel continuous assay was established by adapting an existing discontinuous method.  Specificity consts. (kcat/Km) of dipeptides and dipeptide surrogates were higher for plant QC, whereas the selectivity for oligopeptides was similar for both enzymes.  However, only the specificity consts. of mammalian QC were dependent on size and compn. of the substrates.  Specificity consts. of both enzymes were equally pH-dependent in the acidic pH-region, revealing a pKa value identical to the pKa of the substrate, suggesting similarities in the substrate conversion mode.  Accordingly, both QCs converted the L-βhomoglutaminyl residue in the peptide H-βhomoGln-Phe-Lys-Arg-Leu-Ala-NH2 and the glutaminyl residues of the branched peptide H-Gln-Lys(Gln)-Arg-Leu-Ala-NH2 as well as the partially cyclized peptide H-Gln-cyclo(Nε-Lys-Arg-Pro-Ala-Gly-Phe).  In contrast, only QC from C. papaya was able to cyclize a methylated glutamine residue, while this compd. did not even inhibit human QC-catalysis, suggesting distinct substrate recognition pattern.  The conversion of the potential physiol. substrates [Gln1]-gastrin, [Gln1]-neurotensin and [Gln1]-fertilization promoting peptide indicates that human QC may play a key role in posttranslational modification of most if not all pGlu-contg. hormones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWs7SWbYbyQLVg90H21EOLACvtfcHk0lhWOSCuF2_ZFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVSksQ%253D%253D&md5=3e011093800699f46513a309b29647c8</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1515%2FBC.2003.175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252FBC.2003.175%26sid%3Dliteratum%253Aachs%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DManhart%26aufirst%3DS.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DLudwig%26aufirst%3DH.%2BH.%26aulast%3DWasternack%26aufirst%3DC.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DSubstrate%2520specificity%2520of%2520glutaminyl%2520cyclases%2520from%2520plants%2520and%2520animals%26jtitle%3DBiol.%2520Chem.%26date%3D2003%26volume%3D384%26spage%3D1583%26epage%3D1592%26doi%3D10.1515%2FBC.2003.175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Huang, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chou, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A. H.</span><span> </span><span class="NLM_article-title">A conserved hydrogen-bond network in the catalytic centre of animal glutaminyl cyclases is critical for catalysis</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">411</span><span class="NLM_x">, </span> <span class="NLM_fpage">181</span><span class="NLM_x">–</span> <span class="NLM_lpage">190</span><span class="refDoi"> DOI: 10.1042/BJ20071073</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=10.1042%2FBJ20071073" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=18072935" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjt1ers7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=411&publication_year=2008&pages=181-190&author=K.+F.+Huangauthor=Y.+R.+Wangauthor=E.+C.+Changauthor=T.+L.+Chouauthor=A.+H.+Wang&title=A+conserved+hydrogen-bond+network+in+the+catalytic+centre+of+animal+glutaminyl+cyclases+is+critical+for+catalysis&doi=10.1042%2FBJ20071073"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">A conserved hydrogen-bond network in the catalytic centre of animal glutaminyl cyclases is critical for catalysis</span></div><div class="casAuthors">Huang, Kai-Fa; Wang, Yu-Ruei; Chang, En-Cheng; Chou, Tsung-Lin; Wang, Andrew H.-J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">411</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">181-190</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">QCs (glutaminyl cyclases; glutaminyl-peptide cyclotransferases, E.C. 2.3.2.5) catalyze N-terminal pyroglutamate formation in numerous bioactive peptides and proteins.  The enzymes were reported to be involved in several pathol. conditions such as amyloidotic disease, osteoporosis, rheumatoid arthritis and melanoma.  The crystal structure of human QC revealed an unusual H-bond (hydrogen-bond) network in the active site, formed by several highly conserved residues (Ser160, Glu201, Asp248, Asp305 and His319), within which Glu201 and Asp248 were found to bind to substrate.  In the present study we combined steady-state enzyme kinetic and x-ray structural analyses of 11 single-mutation human QCs to investigate the roles of the H-bond network in catalysis.  Our results showed that disrupting one or both of the central H-bonds, i.e., Glu201···Asp305 and Asp248···Asp305, reduced the steady-state catalysis dramatically.  The roles of these two COOH···COOH bonds on catalysis could be partly replaced by COOH···water bonds, but not by COOH···CONH2 bonds, reminiscent of the low-barrier Asp···Asp H-bond in the active site of pepsin-like aspartic peptidases.  Mutations on Asp305, a residue located at the center of the H-bond network, raised the Km value of the enzyme by 4.4-19-fold, but decreased the kcat value by 79-2842-fold, indicating that Asp305 primarily plays a catalytic role.  In addn., results from mutational studies on Ser160 and His319 suggest that these two residues might help to stabilize the conformations of Asp248 and Asp305 resp.  These data allow us to propose an essential proton transfer between Glu201, Asp305 and Asp248 during the catalysis by animal QCs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4EKjUIwutAbVg90H21EOLACvtfcHk0lhWOSCuF2_ZFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjt1ers7w%253D&md5=2e5104776acc97f920d9502be3a041b4</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1042%2FBJ20071073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20071073%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DK.%2BF.%26aulast%3DWang%26aufirst%3DY.%2BR.%26aulast%3DChang%26aufirst%3DE.%2BC.%26aulast%3DChou%26aufirst%3DT.%2BL.%26aulast%3DWang%26aufirst%3DA.%2BH.%26atitle%3DA%2520conserved%2520hydrogen-bond%2520network%2520in%2520the%2520catalytic%2520centre%2520of%2520animal%2520glutaminyl%2520cyclases%2520is%2520critical%2520for%2520catalysis%26jtitle%3DBiochem.%2520J.%26date%3D2008%26volume%3D411%26spage%3D181%26epage%3D190%26doi%3D10.1042%2FBJ20071073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Valenti, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanatta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donatelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Innamorati, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pampanin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanusso, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zatta, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carbonare, L. D.</span><span> </span><span class="NLM_article-title">Increased glutaminyl cyclase expression in peripheral blood of Alzheimer’s disease patients</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">263</span><span class="NLM_x">–</span> <span class="NLM_lpage">271</span><span class="refDoi"> DOI: 10.3233/JAD-120517</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=10.3233%2FJAD-120517" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=23207485" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=1%3ACAS%3A528%3ADC%252BC3sXit1Wlu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=263-271&author=M.+T.+Valentiauthor=S.+Bologninauthor=C.+Zanattaauthor=L.+Donatelliauthor=G.+Innamoratiauthor=M.+Pampaninauthor=G.+Zanussoauthor=P.+Zattaauthor=L.+D.+Carbonare&title=Increased+glutaminyl+cyclase+expression+in+peripheral+blood+of+Alzheimer%E2%80%99s+disease+patients&doi=10.3233%2FJAD-120517"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Increased Glutaminyl Cyclase Expression in Peripheral Blood of Alzheimer's Disease Patients</span></div><div class="casAuthors">Valenti, Maria Teresa; Bolognin, Silvia; Zanatta, Cristina; Donatelli, Luca; Innamorati, Giulio; Pampanin, Maria; Zanusso, Gianluigi; Zatta, Paolo; Dalle Carbonare, Luca</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">263-271</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">N-truncated and N-modified forms of amyloid-β (Aβ) peptide are found in diffused and dense core plaques in Alzheimer's disease (AD) brain.  Among them, the most abundant N-truncated peptide starts with pyroglutamyl at residue 3 (AβpE3).  AβpE3 has increased aggregation potential and toxicity and its abundance has been reported to correlate with the severity of the clin. phenotype in AD patients.  N-terminal glutamate conversion generating AβpE3 is catalyzed by glutaminyl cyclase.  This enzyme was found to be upregulated in the cortex of patients with AD.  In the present study, we investigated glutaminyl cyclase mRNA and protein expression in peripheral blood from AD patients and age-matched controls.  Higher levels of glutaminyl cyclase mRNA and protein were present in AD patients compared with controls.  Interestingly, we obsd. a correlation between glutaminyl cyclase expression and the severity of dementia (value of Mini-Mental State Examn.).  Therefore, we propose glutaminyl cyclase dosage in peripheral blood as a potential biomarker of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqs4A4V35WXLrVg90H21EOLACvtfcHk0ljLn0uEGGbRFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXit1Wlu7c%253D&md5=3dbaabc4cc2a16e1b3589040578591c1</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.3233%2FJAD-120517&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-120517%26sid%3Dliteratum%253Aachs%26aulast%3DValenti%26aufirst%3DM.%2BT.%26aulast%3DBolognin%26aufirst%3DS.%26aulast%3DZanatta%26aufirst%3DC.%26aulast%3DDonatelli%26aufirst%3DL.%26aulast%3DInnamorati%26aufirst%3DG.%26aulast%3DPampanin%26aufirst%3DM.%26aulast%3DZanusso%26aufirst%3DG.%26aulast%3DZatta%26aufirst%3DP.%26aulast%3DCarbonare%26aufirst%3DL.%2BD.%26atitle%3DIncreased%2520glutaminyl%2520cyclase%2520expression%2520in%2520peripheral%2520blood%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520patients%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2013%26volume%3D34%26spage%3D263%26epage%3D271%26doi%3D10.3233%2FJAD-120517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Schilling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeitschel, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiser, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francke, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kehlen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holzer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutter-Paier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prokesch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Windisch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagla, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlenzig, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudolph, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reuter, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cynis, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montag, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demuth, H. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossner, S.</span><span> </span><span class="NLM_article-title">Glutaminyl cyclase inhibition attenuates pyroglutamate Abeta and Alzheimer’s disease-like pathology</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1106</span><span class="NLM_x">–</span> <span class="NLM_lpage">1111</span><span class="refDoi"> DOI: 10.1038/nm.1872</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=10.1038%2Fnm.1872" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=18836460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Slu7zL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=1106-1111&author=S.+Schillingauthor=U.+Zeitschelauthor=T.+Hoffmannauthor=U.+Heiserauthor=M.+Franckeauthor=A.+Kehlenauthor=M.+Holzerauthor=B.+Hutter-Paierauthor=M.+Prokeschauthor=M.+Windischauthor=W.+Jaglaauthor=D.+Schlenzigauthor=C.+Lindnerauthor=T.+Rudolphauthor=G.+Reuterauthor=H.+Cynisauthor=D.+Montagauthor=H.+U.+Demuthauthor=S.+Rossner&title=Glutaminyl+cyclase+inhibition+attenuates+pyroglutamate+Abeta+and+Alzheimer%E2%80%99s+disease-like+pathology&doi=10.1038%2Fnm.1872"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Glutaminyl cyclase inhibition attenuates pyroglutamate Aβ and Alzheimer's disease-like pathology</span></div><div class="casAuthors">Schilling, Stephan; Zeitschel, Ulrike; Hoffmann, Torsten; Heiser, Ulrich; Francke, Mike; Kehlen, Astrid; Holzer, Max; Hutter-Paier, Birgit; Prokesch, Manuela; Windisch, Manfred; Jagla, Wolfgang; Schlenzig, Dagmar; Lindner, Christiane; Rudolph, Thomas; Reuter, Gunter; Cynis, Holger; Montag, Dirk; Demuth, Hans-Ulrich; Rossner, Steffen</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1106-1111</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Because of their abundance, resistance to proteolysis, rapid aggregation and neurotoxicity, N-terminally truncated and, in particular, pyroglutamate (pE)-modified Aβ peptides have been suggested as being important in the initiation of pathol. cascades resulting in the development of Alzheimer's disease.  We found that the N-terminal pE-formation is catalyzed by glutaminyl cyclase in vivo.  Glutaminyl cyclase expression was upregulated in the cortices of individuals with Alzheimer's disease and correlated with the appearance of pE-modified Aβ.  Oral application of a glutaminyl cyclase inhibitor resulted in reduced Aβ3(pE)-42 burden in two different transgenic mouse models of Alzheimer's disease and in a new Drosophila model.  Treatment of mice was accompanied by redns. in Aβx-40/42, diminished plaque formation and gliosis and improved performance in context memory and spatial learning tests.  These observations are consistent with the hypothesis that Aβ3(pE)-42 acts as a seed for Aβ aggregation by self-aggregation and co-aggregation with Aβ1-40/42.  Therefore, Aβ3(pE)-40/42 peptides seem to represent Aβ forms with exceptional potency for disturbing neuronal function.  The redn. of brain pE-Aβ by inhibition of glutaminyl cyclase offers a new therapeutic option for the treatment of Alzheimer's disease and provides implications for other amyloidoses, such as familial Danish dementia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQl4XiuOJSmrVg90H21EOLACvtfcHk0ljLn0uEGGbRFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Slu7zL&md5=30f8f53b27c6c9580fe71f867e1ab670</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fnm.1872&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.1872%26sid%3Dliteratum%253Aachs%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DZeitschel%26aufirst%3DU.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DHeiser%26aufirst%3DU.%26aulast%3DFrancke%26aufirst%3DM.%26aulast%3DKehlen%26aufirst%3DA.%26aulast%3DHolzer%26aufirst%3DM.%26aulast%3DHutter-Paier%26aufirst%3DB.%26aulast%3DProkesch%26aufirst%3DM.%26aulast%3DWindisch%26aufirst%3DM.%26aulast%3DJagla%26aufirst%3DW.%26aulast%3DSchlenzig%26aufirst%3DD.%26aulast%3DLindner%26aufirst%3DC.%26aulast%3DRudolph%26aufirst%3DT.%26aulast%3DReuter%26aufirst%3DG.%26aulast%3DCynis%26aufirst%3DH.%26aulast%3DMontag%26aufirst%3DD.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DRossner%26aufirst%3DS.%26atitle%3DGlutaminyl%2520cyclase%2520inhibition%2520attenuates%2520pyroglutamate%2520Abeta%2520and%2520Alzheimer%25E2%2580%2599s%2520disease-like%2520pathology%26jtitle%3DNat.%2520Med.%26date%3D2008%26volume%3D14%26spage%3D1106%26epage%3D1111%26doi%3D10.1038%2Fnm.1872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Schilling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appl, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cynis, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagla, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedrich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wermann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchholz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiser, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Horsten, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demuth, H. U.</span><span> </span><span class="NLM_article-title">Inhibition of glutaminyl cyclase prevents pGlu-Abeta formation after intracortical/hippocampal microinjection in vivo/in situ</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">1225</span><span class="NLM_x">–</span> <span class="NLM_lpage">1236</span><span class="refDoi"> DOI: 10.1111/j.1471-4159.2008.05471.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=10.1111%2Fj.1471-4159.2008.05471.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=18627432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpsFOis7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2008&pages=1225-1236&author=S.+Schillingauthor=T.+Applauthor=T.+Hoffmannauthor=H.+Cynisauthor=K.+Schulzauthor=W.+Jaglaauthor=D.+Friedrichauthor=M.+Wermannauthor=M.+Buchholzauthor=U.+Heiserauthor=S.+von+Horstenauthor=H.+U.+Demuth&title=Inhibition+of+glutaminyl+cyclase+prevents+pGlu-Abeta+formation+after+intracortical%2Fhippocampal+microinjection+in+vivo%2Fin+situ&doi=10.1111%2Fj.1471-4159.2008.05471.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of glutaminyl cyclase prevents pGlu-Aβ formation after intracortical/hippocampal microinjection in vivo/in situ</span></div><div class="casAuthors">Schilling, Stephan; Appl, Thomas; Hoffmann, Torsten; Cynis, Holger; Schulz, Katrin; Jagla, Wolfgang; Friedrich, Daniel; Wermann, Michael; Buchholz, Mirko; Heiser, Ulrich; von Hoersten, Stephan; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1225-1236</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Modified amyloid β (Aβ) peptides represent major constituents of the amyloid deposits in Alzheimer's disease and Down's syndrome.  In particular, N-terminal pyroglutamate (pGlu) following truncation renders Aβ more stable, increases hydrophobicity and the aggregation velocity.  Recent evidence based on in vitro studies suggests that the cyclization of glutamic acid, leading to pGlu-Aβ, is catalyzed by the enzyme glutaminyl cyclase (QC) following limited proteolysis of Aβ at the N-terminus.  Here, we studied the pGlu-formation by rat QC in vitro as well as after microinjection of Aβ(1-40) and Aβ(3-40) into the rat cortex in vivo/in situ with and without pharmacol. QC inhibition.  Significant pGlu-Aβ formation was obsd. following injection of Aβ(3-40) after 24 h, indicating a catalyzed process.  The generation of pGlu-Aβ from Aβ(3-40) was significantly inhibited by intracortical microinjection of a QC inhibitor.  The study provides first evidence that generation of pGlu-Aβ is a QC-catalyzed process in vivo.  The approach per se offers a strategy for a rapid evaluation of compds. targeting a redn. of pGlu formation at the N-terminus of amyloid peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIz9fnOIjlVbVg90H21EOLACvtfcHk0ljLn0uEGGbRFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpsFOis7Y%253D&md5=8450718510d281c928abaa1e20a870ad</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2008.05471.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2008.05471.x%26sid%3Dliteratum%253Aachs%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DAppl%26aufirst%3DT.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DCynis%26aufirst%3DH.%26aulast%3DSchulz%26aufirst%3DK.%26aulast%3DJagla%26aufirst%3DW.%26aulast%3DFriedrich%26aufirst%3DD.%26aulast%3DWermann%26aufirst%3DM.%26aulast%3DBuchholz%26aufirst%3DM.%26aulast%3DHeiser%26aufirst%3DU.%26aulast%3Dvon%2BHorsten%26aufirst%3DS.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DInhibition%2520of%2520glutaminyl%2520cyclase%2520prevents%2520pGlu-Abeta%2520formation%2520after%2520intracortical%252Fhippocampal%2520microinjection%2520in%2520vivo%252Fin%2520situ%26jtitle%3DJ.%2520Neurochem.%26date%3D2008%26volume%3D106%26spage%3D1225%26epage%3D1236%26doi%3D10.1111%2Fj.1471-4159.2008.05471.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Hennekens, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">A Bensadon, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zivin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaziano, J. M.</span><span> </span><span class="NLM_article-title">Hypothesis: glutaminyl cyclase inhibitors decrease risks of Alzheimer’s disease and related dementias</span> <span class="citation_source-journal">Expert Rev. Neurother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1245</span><span class="NLM_x">–</span> <span class="NLM_lpage">1248</span><span class="refDoi"> DOI: 10.1586/14737175.2015.1088784</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=10.1586%2F14737175.2015.1088784" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=26450764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVGmsrnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=1245-1248&author=C.+H.+Hennekensauthor=B.+A+Bensadonauthor=R.+Zivinauthor=J.+M.+Gaziano&title=Hypothesis%3A+glutaminyl+cyclase+inhibitors+decrease+risks+of+Alzheimer%E2%80%99s+disease+and+related+dementias&doi=10.1586%2F14737175.2015.1088784"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Hypothesis: glutaminyl cyclase inhibitors decrease risks of Alzheimer's disease and related dementias</span></div><div class="casAuthors">Hennekens, Charles H.; Bensadon, Benjamin A.; Zivin, Robert; Gaziano, J. Michael</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Neurotherapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1245-1248</span>CODEN:
                <span class="NLM_cas:coden">ERNXAR</span>;
        ISSN:<span class="NLM_cas:issn">1473-7175</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease and related dementias (ADRD) comprise several progressive and incurable neurodegenerative disorders that some have classified as amyloidosis.  With increased aging of the world's population, the prevalence of the sporadic form of ADRD, which comprises over 99% of cases, continues to rise at an alarming rate.  The enormous societal burdens of ADRD already rival those of the many other major chronic diseases causing premature morbidity and mortality in the USA and worldwide such as cardiovascular disease and cancer.  At present, there is an insufficient totality of evidence concerning the efficacy and safety of any pharmacol. agents to delay slow progression or reduce complications of ADRD.  In this context, glutaminyl cyclase (QC) inhibitors have shown some early possible evidence of efficacy with a reassuring safety profile.  To reliably test the glutaminyl cyclase (QC) and any other promising hypotheses will require cogent data from large-scale randomized trials of sufficient size and duration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrh2s8nTowdx7Vg90H21EOLACvtfcHk0ljNuJPPsTIYww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVGmsrnI&md5=f098733e6e4f05dce39581b04d5df230</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1586%2F14737175.2015.1088784&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F14737175.2015.1088784%26sid%3Dliteratum%253Aachs%26aulast%3DHennekens%26aufirst%3DC.%2BH.%26aulast%3DA%2BBensadon%26aufirst%3DB.%26aulast%3DZivin%26aufirst%3DR.%26aulast%3DGaziano%26aufirst%3DJ.%2BM.%26atitle%3DHypothesis%253A%2520glutaminyl%2520cyclase%2520inhibitors%2520decrease%2520risks%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520related%2520dementias%26jtitle%3DExpert%2520Rev.%2520Neurother.%26date%3D2015%26volume%3D15%26spage%3D1245%26epage%3D1248%26doi%3D10.1586%2F14737175.2015.1088784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Buchholz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiser, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schilling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niestroj, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zunkel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demuth, H. U.</span><span> </span><span class="NLM_article-title">The first potent inhibitors for human glutaminyl cyclase: synthesis and structure-activity relationship</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">664</span><span class="NLM_x">–</span> <span class="NLM_lpage">677</span><span class="refDoi"> DOI: 10.1021/jm050756e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050756e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=1%3ACAS%3A528%3ADC%252BD28XotlWrug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=664-677&author=M.+Buchholzauthor=U.+Heiserauthor=S.+Schillingauthor=A.+J.+Niestrojauthor=K.+Zunkelauthor=H.+U.+Demuth&title=The+first+potent+inhibitors+for+human+glutaminyl+cyclase%3A+synthesis+and+structure-activity+relationship&doi=10.1021%2Fjm050756e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">The first potent inhibitors for human glutaminyl cyclase: synthesis and structure-activity relationship</span></div><div class="casAuthors">Buchholz, Mirko; Heiser, Ulrich; Schilling, Stephan; Niestroj, Andre J.; Zunkel, Katrin; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">664-677</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The first effective inhibitors for human glutaminyl cyclase (QC) are described.  The structures are developed by applying a ligand-based optimization approach starting from imidazole.  Screening of derivs. of that heterocycle led to compds. of the imidazol-1-yl-alkyl thiourea type as a lead scaffold.  A library of thiourea derivs. was synthesized, resulting in an inhibitory improvement by 2 orders of magnitude, leading to 1-(3-(1H-imidazol-1-yl)propyl)-3-(3,4-dimethoxyphenyl)thiourea as a potent inhibitor.  Systematic exploitation of the scaffold revealed a strong impact on the inhibitory efficacy and resulted in the development of imidazole-propyl-thioamides as another new class of potent inhibitors.  A flexible alignment of the most potent compds. of the thioamide and thiourea class and a QC substrate revealed a good match of characteristic features of the mols., which suggests a similar binding mode of both inhibitors and the substrate to the active site of QC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo88OPnC7vM57Vg90H21EOLACvtfcHk0ljNuJPPsTIYww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotlWrug%253D%253D&md5=584302fd2d356f680bb4df9e10f26b93</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm050756e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050756e%26sid%3Dliteratum%253Aachs%26aulast%3DBuchholz%26aufirst%3DM.%26aulast%3DHeiser%26aufirst%3DU.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DNiestroj%26aufirst%3DA.%2BJ.%26aulast%3DZunkel%26aufirst%3DK.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DThe%2520first%2520potent%2520inhibitors%2520for%2520human%2520glutaminyl%2520cyclase%253A%2520synthesis%2520and%2520structure-activity%2520relationship%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D664%26epage%3D677%26doi%3D10.1021%2Fjm050756e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Buchholz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aust, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandt, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohme, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schilling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demuth, H. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiser, U.</span><span> </span><span class="NLM_article-title">Inhibitors for human glutaminyl cyclase by structure based design and bioisosteric replacement</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">7069</span><span class="NLM_x">–</span> <span class="NLM_lpage">7080</span><span class="refDoi"> DOI: 10.1021/jm900969p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900969p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlagsbnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7069-7080&author=M.+Buchholzauthor=A.+Hamannauthor=S.+Austauthor=W.+Brandtauthor=L.+Bohmeauthor=T.+Hoffmannauthor=S.+Schillingauthor=H.+U.+Demuthauthor=U.+Heiser&title=Inhibitors+for+human+glutaminyl+cyclase+by+structure+based+design+and+bioisosteric+replacement&doi=10.1021%2Fjm900969p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors for Human Glutaminyl Cyclase by Structure Based Design and Bioisosteric Replacement</span></div><div class="casAuthors">Buchholz, Mirko; Hamann, Antje; Aust, Susanne; Brandt, Wolfgang; Boehme, Livia; Hoffmann, Torsten; Schilling, Stephan; Demuth, Hans-Ulrich; Heiser, Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7069-7080</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The inhibition of human glutaminyl cyclase (hQC) has come into focus as a new potential approach for the treatment of Alzheimer's disease.  The hallmark of this principle is the prevention of the formation of Aβ3,11(pE)-40,42, as these Aβ-species were shown to be of elevated neurotoxicity and likely to act as a seeding core leading to an accelerated formation of Aβ-oligomers and fibrils.  Starting from 1-(3-(1H-imidazol-1-yl)propyl)-3-(3,4-dimethoxyphenyl)thiourea, bioisosteric replacements led to the development of new classes of inhibitors.  The optimization of the metal-binding group was achieved by homol. modeling and afforded a first insight into the probable binding mode of the inhibitors in the hQC active site.  The efficacy assessment of the hQC inhibitors was performed in cell culture, directly monitoring the inhibition of Aβ3,11(pE)-40,42 formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZG_jswBXx2LVg90H21EOLACvtfcHk0ljqsxui5pIxSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlagsbnJ&md5=262248c3c91f344aacb530288aa46471</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm900969p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900969p%26sid%3Dliteratum%253Aachs%26aulast%3DBuchholz%26aufirst%3DM.%26aulast%3DHamann%26aufirst%3DA.%26aulast%3DAust%26aufirst%3DS.%26aulast%3DBrandt%26aufirst%3DW.%26aulast%3DBohme%26aufirst%3DL.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DHeiser%26aufirst%3DU.%26atitle%3DInhibitors%2520for%2520human%2520glutaminyl%2520cyclase%2520by%2520structure%2520based%2520design%2520and%2520bioisosteric%2520replacement%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7069%26epage%3D7080%26doi%3D10.1021%2Fjm900969p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Ramsbeck, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchholz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohme, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demuth, H. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiser, U.</span><span> </span><span class="NLM_article-title">Structure-activity relationships of benzimidazole-based glutaminyl cyclase inhibitors featuring a heteroaryl scaffold</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">6613</span><span class="NLM_x">–</span> <span class="NLM_lpage">6625</span><span class="refDoi"> DOI: 10.1021/jm4001709</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4001709" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFOltrvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=6613-6625&author=D.+Ramsbeckauthor=M.+Buchholzauthor=B.+Kochauthor=L.+Bohmeauthor=T.+Hoffmannauthor=H.+U.+Demuthauthor=U.+Heiser&title=Structure-activity+relationships+of+benzimidazole-based+glutaminyl+cyclase+inhibitors+featuring+a+heteroaryl+scaffold&doi=10.1021%2Fjm4001709"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationships of Benzimidazole-Based Glutaminyl Cyclase Inhibitors Featuring a Heteroaryl Scaffold</span></div><div class="casAuthors">Ramsbeck, Daniel; Buchholz, Mirko; Koch, Birgit; Boehme, Livia; Hoffmann, Torsten; Demuth, Hans-Ulrich; Heiser, Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6613-6625</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Glutaminyl cyclase (hQC) has emerged as a new potential target for the treatment of Alzheimer's disease (AD).  The inhibition of hQC prevents of the formation of the Aβ3(pE)-40,42 species which were shown to be of elevated neurotoxicity and are likely to act as a seeding core, leading to an accelerated formation of Aβ-oligomers and fibrils.  This work presents a new class of inhibitors of hQC, resulting from a pharmacophore-based screen.  Hit mols. were identified, contg. benzimidazole as the metal binding group connected to 1,3,4-oxadiazole as the central scaffold.  The subsequent optimization resulted in benzimidazolyl-1,3,4-thiadiazoles and -1,2,3-triazoles with an inhibitory potency in the nanomolar range.  Further investigation into the potential binding mode of the new compd. classes combined mol. docking and site directed mutagenesis studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrj2cbdhUrX_bVg90H21EOLACvtfcHk0ljqsxui5pIxSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFOltrvL&md5=eaff2e3df3c955881a158b5efd012c0d</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm4001709&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4001709%26sid%3Dliteratum%253Aachs%26aulast%3DRamsbeck%26aufirst%3DD.%26aulast%3DBuchholz%26aufirst%3DM.%26aulast%3DKoch%26aufirst%3DB.%26aulast%3DBohme%26aufirst%3DL.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DHeiser%26aufirst%3DU.%26atitle%3DStructure-activity%2520relationships%2520of%2520benzimidazole-based%2520glutaminyl%2520cyclase%2520inhibitors%2520featuring%2520a%2520heteroaryl%2520scaffold%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D6613%26epage%3D6625%26doi%3D10.1021%2Fjm4001709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Tran, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoang, V. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorat, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nam, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mook-Jung, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span> </span><span class="NLM_article-title">Structure-activity relationship of human glutaminyl cyclase inhibitors having an N-(5-methyl-1H-imidazol-1-yl)propyl thiourea template</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">3821</span><span class="NLM_x">–</span> <span class="NLM_lpage">3830</span><span class="refDoi"> DOI: 10.1016/j.bmc.2013.04.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=10.1016%2Fj.bmc.2013.04.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=23643900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmvF2mtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=3821-3830&author=P.+T.+Tranauthor=V.+H.+Hoangauthor=S.+A.+Thoratauthor=S.+E.+Kimauthor=J.+Annauthor=Y.+J.+Changauthor=D.+W.+Namauthor=H.+Songauthor=I.+Mook-Jungauthor=J.+Leeauthor=J.+Lee&title=Structure-activity+relationship+of+human+glutaminyl+cyclase+inhibitors+having+an+N-%285-methyl-1H-imidazol-1-yl%29propyl+thiourea+template&doi=10.1016%2Fj.bmc.2013.04.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationship of human glutaminyl cyclase inhibitors having an N-(5-methyl-1H-imidazol-1-yl)propyl thiourea template</span></div><div class="casAuthors">Tran, Phuong-Thao; Hoang, Van-Hai; Thorat, Shivaji A.; Kim, Sung Eun; Ann, Jihyae; Chang, Yu Jin; Nam, Dong Woo; Song, Hyundong; Mook-Jung, Inhee; Lee, Jiyoun; Lee, Jeewoo</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3821-3830</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In an effort to design inhibitors of human glutaminyl cyclase (QC), the authors have synthesized a library of N-aryl N-(5-methyl-1H-imidazol-1-yl)propyl thioureas and investigated the contribution of the aryl region of these compds. to their structure-activity relationships as cyclase inhibitors.  The authors' design was guided by the proposed binding mode of the preferred substrate for the cyclase.  In this series, 1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-3-(3-(5-methyl-1H-imidazol-1-yl)propyl)thiourea (compd. 52) was identified as the most potent QC inhibitor with an IC50 value of 58 nM, which was two-fold more potent than the previously reported lead (II).  Compd. 52 is a most promising candidate for future evaluation to monitor its ability to reduce the formation of pGlu-Aβ and Aβ plaques in cells and transgenic animals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5aCpSObyf3rVg90H21EOLACvtfcHk0liWxT4kINr30A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmvF2mtL0%253D&md5=a8d7ad244e262c7bb26681c64393551a</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.04.005%26sid%3Dliteratum%253Aachs%26aulast%3DTran%26aufirst%3DP.%2BT.%26aulast%3DHoang%26aufirst%3DV.%2BH.%26aulast%3DThorat%26aufirst%3DS.%2BA.%26aulast%3DKim%26aufirst%3DS.%2BE.%26aulast%3DAnn%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DY.%2BJ.%26aulast%3DNam%26aufirst%3DD.%2BW.%26aulast%3DSong%26aufirst%3DH.%26aulast%3DMook-Jung%26aufirst%3DI.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DJ.%26atitle%3DStructure-activity%2520relationship%2520of%2520human%2520glutaminyl%2520cyclase%2520inhibitors%2520having%2520an%2520N-%25285-methyl-1H-imidazol-1-yl%2529propyl%2520thiourea%2520template%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D3821%26epage%3D3830%26doi%3D10.1016%2Fj.bmc.2013.04.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Brooks, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kropog, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quesada, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, P. J.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of [11C]PBD150, a radiolabeled glutaminyl cyclase inhibitor for the potential detection of Alzheimer’s disease prior to amyloid β aggregation</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1065</span><span class="NLM_x">–</span> <span class="NLM_lpage">1068</span><span class="refDoi"> DOI: 10.1039/C5MD00148J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=10.1039%2FC5MD00148J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=26101580" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmvFartLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=1065-1068&author=A.+F.+Brooksauthor=I.+M.+Jacksonauthor=X.+Shaoauthor=G.+W.+Kropogauthor=P.+Shermanauthor=C.+A.+Quesadaauthor=P.+J.+Scott&title=Synthesis+and+evaluation+of+%5B11C%5DPBD150%2C+a+radiolabeled+glutaminyl+cyclase+inhibitor+for+the+potential+detection+of+Alzheimer%E2%80%99s+disease+prior+to+amyloid+%CE%B2+aggregation&doi=10.1039%2FC5MD00148J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of [11C]PBD150, a radiolabeled glutaminyl cyclase inhibitor for the potential detection of Alzheimer's disease prior to amyloid β aggregation</span></div><div class="casAuthors">Brooks, Allen F.; Jackson, Isaac M.; Shao, Xia; Kropog, George W.; Sherman, Phillip; Quesada, Carole A.; Scott, Peter J. H.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1065-1068</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The hydroxy moiety of 1-[3-(1H-imidazol-1-yl)propyl]-3-(4-hydroxy-3-methoxyphenyl)thiourea was selectively carbon-11 labeled to generate [11C]PBD150 in 7.3% yield from [11C]methyl triflate (non-decay cor.; radiochem. purity ≥95%, specific activity = 5.7 Ci μmol-1, n = 5).  Evaluation of [11C]PBD150 by small animal PET imaging (mouse and rat) detd. that it did not permeate the blood brain barrier, indicating that a previously described therapeutic effect in transgenic mice was likely not the result of inhibiting central nervous system glutaminyl cyclase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmg-DpdoFU-7Vg90H21EOLACvtfcHk0liWxT4kINr30A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmvFartLk%253D&md5=eaea24571848b33c06b92756ff873161</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1039%2FC5MD00148J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5MD00148J%26sid%3Dliteratum%253Aachs%26aulast%3DBrooks%26aufirst%3DA.%2BF.%26aulast%3DJackson%26aufirst%3DI.%2BM.%26aulast%3DShao%26aufirst%3DX.%26aulast%3DKropog%26aufirst%3DG.%2BW.%26aulast%3DSherman%26aufirst%3DP.%26aulast%3DQuesada%26aufirst%3DC.%2BA.%26aulast%3DScott%26aufirst%3DP.%2BJ.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520%255B11C%255DPBD150%252C%2520a%2520radiolabeled%2520glutaminyl%2520cyclase%2520inhibitor%2520for%2520the%2520potential%2520detection%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520prior%2520to%2520amyloid%2520%25CE%25B2%2520aggregation%26jtitle%3DMedChemComm%26date%3D2015%26volume%3D6%26spage%3D1065%26epage%3D1068%26doi%3D10.1039%2FC5MD00148J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Huang, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liaw, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chia, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A. H.</span><span> </span><span class="NLM_article-title">Structures of human Golgi-resident glutaminyl cyclase and its complexes with inhibitors reveal a large loop movement upon inhibitor binding</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">12439</span><span class="NLM_x">–</span> <span class="NLM_lpage">12449</span><span class="refDoi"> DOI: 10.1074/jbc.M110.208595</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=10.1074%2Fjbc.M110.208595" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=21288892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVKqu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=12439-12449&author=K.+F.+Huangauthor=S.+S.+Liawauthor=W.+L.+Huangauthor=C.+Y.+Chiaauthor=Y.+C.+Loauthor=Y.+L.+Chenauthor=A.+H.+Wang&title=Structures+of+human+Golgi-resident+glutaminyl+cyclase+and+its+complexes+with+inhibitors+reveal+a+large+loop+movement+upon+inhibitor+binding&doi=10.1074%2Fjbc.M110.208595"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of Human Golgi-resident Glutaminyl Cyclase and its Complexes with Inhibitors Reveal a Large Loop Movement upon Inhibitor Binding</span></div><div class="casAuthors">Huang, Kai-Fa; Liaw, Su-Sen; Huang, Wei-Lin; Chia, Cho-Yun; Lo, Yan-Chung; Chen, Yi-Ling; Wang, Andrew H.-J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">12439-12449</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Aberrant pyroglutamate formation at the N terminus of certain peptides and proteins, catalyzed by glutaminyl cyclases (QCs), is linked to some pathol. conditions, such as Alzheimer disease.  Recently, a glutaminyl cyclase (QC) inhibitor, PBD150, was shown to be able to reduce the deposition of pyroglutamate-modified amyloid-β peptides in brain of transgenic mouse models of Alzheimer disease, leading to a significant improvement of learning and memory in those transgenic animals.  Here, we report the 1.05-1.40 Å resoln. structures, solved by the sulfur single-wavelength anomalous dispersion phasing method, of the Golgi-luminal catalytic domain of the recently identified Golgi-resident QC (gQC) and its complex with PBD150.  We also describe the high-resoln. structures of secretory QC (sQC)-PBD150 complex and two other gQC-inhibitor complexes.  The gQC structure has a scaffold similar to that of sQC but with a relatively wider and neg. charged active site, suggesting a distinct substrate specificity from sQC.  Upon binding to PBD150, a large loop movement in gQC allows the inhibitor to be tightly held in its active site primarily by hydrophobic interactions.  Further comparisons of the inhibitor-bound structures revealed distinct interactions of the inhibitors with gQC and sQC, which are consistent with the results from our inhibitor assays reported here.  Because gQC and sQC may play different biol. roles in vivo, the different inhibitor binding modes allow the design of specific inhibitors toward gQC and sQC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeL8K3B1TxsLVg90H21EOLACvtfcHk0liWxT4kINr30A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVKqu7c%253D&md5=ef9018b9dc4ff40db7cac0ddac9fadb1</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.208595&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.208595%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DK.%2BF.%26aulast%3DLiaw%26aufirst%3DS.%2BS.%26aulast%3DHuang%26aufirst%3DW.%2BL.%26aulast%3DChia%26aufirst%3DC.%2BY.%26aulast%3DLo%26aufirst%3DY.%2BC.%26aulast%3DChen%26aufirst%3DY.%2BL.%26aulast%3DWang%26aufirst%3DA.%2BH.%26atitle%3DStructures%2520of%2520human%2520Golgi-resident%2520glutaminyl%2520cyclase%2520and%2520its%2520complexes%2520with%2520inhibitors%2520reveal%2520a%2520large%2520loop%2520movement%2520upon%2520inhibitor%2520binding%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D12439%26epage%3D12449%26doi%3D10.1074%2Fjbc.M110.208595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Camps, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Formosa, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galdeano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz-Torrero, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramirez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isambert, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavilla, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clos, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mancini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arce, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez-Franco, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huertas, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dafni, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span> </span><span class="NLM_article-title">Pyrano[3,2-c]quinoline-6-chlorotacrine hybrids as a novel family of acetylcholinesterase- and beta-amyloid-directed anti-Alzheimer compounds</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">5365</span><span class="NLM_x">–</span> <span class="NLM_lpage">5379</span><span class="refDoi"> DOI: 10.1021/jm900859q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900859q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5365-5379&author=P.+Campsauthor=X.+Formosaauthor=C.+Galdeanoauthor=D.+Munoz-Torreroauthor=L.+Ramirezauthor=E.+Gomezauthor=N.+Isambertauthor=R.+Lavillaauthor=A.+Badiaauthor=M.+V.+Closauthor=M.+Bartoliniauthor=F.+Manciniauthor=V.+Andrisanoauthor=M.+P.+Arceauthor=M.+I.+Rodriguez-Francoauthor=O.+Huertasauthor=T.+Dafniauthor=F.+J.+Luque&title=Pyrano%5B3%2C2-c%5Dquinoline-6-chlorotacrine+hybrids+as+a+novel+family+of+acetylcholinesterase-+and+beta-amyloid-directed+anti-Alzheimer+compounds&doi=10.1021%2Fjm900859q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm900859q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900859q%26sid%3Dliteratum%253Aachs%26aulast%3DCamps%26aufirst%3DP.%26aulast%3DFormosa%26aufirst%3DX.%26aulast%3DGaldeano%26aufirst%3DC.%26aulast%3DMunoz-Torrero%26aufirst%3DD.%26aulast%3DRamirez%26aufirst%3DL.%26aulast%3DGomez%26aufirst%3DE.%26aulast%3DIsambert%26aufirst%3DN.%26aulast%3DLavilla%26aufirst%3DR.%26aulast%3DBadia%26aufirst%3DA.%26aulast%3DClos%26aufirst%3DM.%2BV.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DMancini%26aufirst%3DF.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DArce%26aufirst%3DM.%2BP.%26aulast%3DRodriguez-Franco%26aufirst%3DM.%2BI.%26aulast%3DHuertas%26aufirst%3DO.%26aulast%3DDafni%26aufirst%3DT.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26atitle%3DPyrano%255B3%252C2-c%255Dquinoline-6-chlorotacrine%2520hybrids%2520as%2520a%2520novel%2520family%2520of%2520acetylcholinesterase-%2520and%2520beta-amyloid-directed%2520anti-Alzheimer%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D5365%26epage%3D5379%26doi%3D10.1021%2Fjm900859q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Di, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerns, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McConnell, O. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, G. T.</span><span> </span><span class="NLM_article-title">High throughput artificial membrane permeability assay for blood–brain barrier</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">223</span><span class="NLM_x">–</span> <span class="NLM_lpage">232</span><span class="refDoi"> DOI: 10.1016/S0223-5234(03)00012-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=10.1016%2FS0223-5234%2803%2900012-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=12667689" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitlKju7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2003&pages=223-232&author=L.+Diauthor=E.+H.+Kernsauthor=K.+Fanauthor=O.+J.+McConnellauthor=G.+T.+Carter&title=High+throughput+artificial+membrane+permeability+assay+for+blood%E2%80%93brain+barrier&doi=10.1016%2FS0223-5234%2803%2900012-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">High throughput artificial membrane permeability assay for blood-brain barrier</span></div><div class="casAuthors">Di, Li; Kerns, Edward H.; Fan, Kristi; McConnell, Oliver J.; Carter, Guy T.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">223-232</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Editions Scientifiques et Medicales Elsevier</span>)
        </div><div class="casAbstract">The recent advances in high throughput screening for biol. activities and combinatorial chem. have greatly expanded the no. of drug candidates.  Rapid screening for BBB penetration potential early in drug discovery programs provides important information for compd. selection and guidance of synthesis for desirable CNS properties.  In this paper, we discuss a modification of the parallel artificial membrane permeation assay (PAMPA) for the prediction of blood-brain barrier penetration (PAMPA-BBB).  The assay was developed with 30 structurally diverse com. drugs and validated with 14 Wyeth Research compds.  The PAMPA-BBB assay has the advantages of: predicting passive blood-brain barrier penetration with high success, high throughput, low cost, and reproducibility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZCg9Ka4mziLVg90H21EOLACvtfcHk0lg61rCvI8uceg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitlKju7c%253D&md5=d228d5808ba8df23deed92c5e2bf3863</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2FS0223-5234%2803%2900012-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0223-5234%252803%252900012-6%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DKerns%26aufirst%3DE.%2BH.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DMcConnell%26aufirst%3DO.%2BJ.%26aulast%3DCarter%26aufirst%3DG.%2BT.%26atitle%3DHigh%2520throughput%2520artificial%2520membrane%2520permeability%2520assay%2520for%2520blood%25E2%2580%2593brain%2520barrier%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2003%26volume%3D38%26spage%3D223%26epage%3D232%26doi%3D10.1016%2FS0223-5234%2803%2900012-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Zhu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, T.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, K.-K.</span><span> </span><span class="NLM_article-title">A comparative study of artificial membrane permeability assay for high throughput profiling of drug absorption potential</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">399</span><span class="NLM_x">–</span> <span class="NLM_lpage">407</span><span class="refDoi"> DOI: 10.1016/S0223-5234(02)01360-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=10.1016%2FS0223-5234%2802%2901360-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=12008054" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=1%3ACAS%3A528%3ADC%252BD38XjtlKksLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2002&pages=399-407&author=C.+Zhuauthor=L.+Jiangauthor=T.-M.+Chenauthor=K.-K.+Hwang&title=A+comparative+study+of+artificial+membrane+permeability+assay+for+high+throughput+profiling+of+drug+absorption+potential&doi=10.1016%2FS0223-5234%2802%2901360-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">A comparative study of artificial membrane permeability assay for high throughput profiling of drug absorption potential</span></div><div class="casAuthors">Zhu, Chengyue; Jiang, Lan; Chen, Teng-Man; Hwang, Kin-Kai</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">399-407</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Editions Scientifiques et Medicales Elsevier</span>)
        </div><div class="casAbstract">Artificial membrane permeability measurement is a potentially high throughput and low cost alternative for in vitro assessment of drug absorption potential.  It will be an ideal screening/profiling tool in the lead generation program of drug discovery research if it is proven to be generally applicable for classifying drug absorption potential and is advantageous over other in vitro or in silico methods.  This study provides an in-depth evaluation of the method in close comparison to Caco-2, Log D, Log P, polar surface area (PSA), and quant. structure-property relationship (QSPR) predictions using a large and diverse compd. set.  It showed that the accuracy of using artificial membrane permeability in assessing drug absorption is comparable to Caco-2, but significantly better than Log P, Log D, PSA, and QSPR predictions.  This study also explored the artificial membrane compn. by adopting a hydrophilic filter membrane for artificial membrane (lecithin-dodecane) support.  The use of hydrophilic filter membrane increased the rate of permeation significantly and reduced the transport time to 2 h or less as compared with over 10 h when a hydrophobic filter membrane is used.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnV2XGwbLMnLVg90H21EOLACvtfcHk0lg61rCvI8uceg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjtlKksLY%253D&md5=4bfab862f5872f6abf0d0d18f5b5e28f</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2FS0223-5234%2802%2901360-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0223-5234%252802%252901360-0%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DC.%26aulast%3DJiang%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DT.-M.%26aulast%3DHwang%26aufirst%3DK.-K.%26atitle%3DA%2520comparative%2520study%2520of%2520artificial%2520membrane%2520permeability%2520assay%2520for%2520high%2520throughput%2520profiling%2520of%2520drug%2520absorption%2520potential%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2002%26volume%3D37%26spage%3D399%26epage%3D407%26doi%3D10.1016%2FS0223-5234%2802%2901360-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Deacon, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cholerton, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talbot, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nair-Roberts, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanderson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romberg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koros, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bornemann, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rawlins, J. N.</span><span> </span><span class="NLM_article-title">Age-dependent and -independent behavioral deficits in Tg2576 mice</span> <span class="citation_source-journal">Behav. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">189</span><span class="NLM_x">, </span> <span class="NLM_fpage">126</span><span class="NLM_x">–</span> <span class="NLM_lpage">138</span><span class="refDoi"> DOI: 10.1016/j.bbr.2007.12.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=10.1016%2Fj.bbr.2007.12.024" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=189&publication_year=2008&pages=126-138&author=R.+M.+Deaconauthor=L.+L.+Cholertonauthor=K.+Talbotauthor=R.+G.+Nair-Robertsauthor=D.+J.+Sandersonauthor=C.+Rombergauthor=E.+Korosauthor=K.+D.+Bornemannauthor=J.+N.+Rawlins&title=Age-dependent+and+-independent+behavioral+deficits+in+Tg2576+mice&doi=10.1016%2Fj.bbr.2007.12.024"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.bbr.2007.12.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbr.2007.12.024%26sid%3Dliteratum%253Aachs%26aulast%3DDeacon%26aufirst%3DR.%2BM.%26aulast%3DCholerton%26aufirst%3DL.%2BL.%26aulast%3DTalbot%26aufirst%3DK.%26aulast%3DNair-Roberts%26aufirst%3DR.%2BG.%26aulast%3DSanderson%26aufirst%3DD.%2BJ.%26aulast%3DRomberg%26aufirst%3DC.%26aulast%3DKoros%26aufirst%3DE.%26aulast%3DBornemann%26aufirst%3DK.%2BD.%26aulast%3DRawlins%26aufirst%3DJ.%2BN.%26atitle%3DAge-dependent%2520and%2520-independent%2520behavioral%2520deficits%2520in%2520Tg2576%2520mice%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2008%26volume%3D189%26spage%3D126%26epage%3D138%26doi%3D10.1016%2Fj.bbr.2007.12.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Deacon, R. M.</span><span> </span><span class="NLM_article-title">Assessing nest building in mice</span> <span class="citation_source-journal">Nat. Protoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">1117</span><span class="NLM_x">–</span> <span class="NLM_lpage">1119</span><span class="refDoi"> DOI: 10.1038/nprot.2006.170</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=10.1038%2Fnprot.2006.170" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=1117-1119&author=R.+M.+Deacon&title=Assessing+nest+building+in+mice&doi=10.1038%2Fnprot.2006.170"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2006.170&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2006.170%26sid%3Dliteratum%253Aachs%26aulast%3DDeacon%26aufirst%3DR.%2BM.%26atitle%3DAssessing%2520nest%2520building%2520in%2520mice%26jtitle%3DNat.%2520Protoc.%26date%3D2006%26volume%3D1%26spage%3D1117%26epage%3D1119%26doi%3D10.1038%2Fnprot.2006.170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Koch, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchholz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wermann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiser, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schilling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demuth, H. U.</span><span> </span><span class="NLM_article-title">Probing secondary glutaminyl cyclase (QC) inhibitor interactions applying an in silico-modeling/site-directed mutagenesis approach: implications for drug development</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">937</span><span class="NLM_x">–</span> <span class="NLM_lpage">946</span><span class="refDoi"> DOI: 10.1111/cbdd.12046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=10.1111%2Fcbdd.12046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=22967026" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslCmu7fE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2012&pages=937-946&author=B.+Kochauthor=M.+Buchholzauthor=M.+Wermannauthor=U.+Heiserauthor=S.+Schillingauthor=H.+U.+Demuth&title=Probing+secondary+glutaminyl+cyclase+%28QC%29+inhibitor+interactions+applying+an+in+silico-modeling%2Fsite-directed+mutagenesis+approach%3A+implications+for+drug+development&doi=10.1111%2Fcbdd.12046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Probing secondary glutaminyl cyclase (QC) inhibitor interactions applying an in silico-modeling/site-directed mutagenesis approach: implications for drug development</span></div><div class="casAuthors">Koch, Birgit; Buchholz, Mirko; Wermann, Michael; Heiser, Ulrich; Schilling, Stephan; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">937-946</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Glutaminyl cyclases (QCs) catalyze the formation of pyroglutamate-modified amyloid peptides deposited in neurodegenerative disorders such as Alzheimer's disease.  Inhibitors of QC are currently in development as potential therapeutics.  The crystal structures of the potent inhibitor PBD150 bound to human and murine QC (hQC, mQC) have been described recently.  The binding modes of a dimethoxyphenyl moiety of the inhibitor are significantly different between the structures, which contrasts with a similar Ki value.  We show the conformation of PBD150 prone to disturbance by protein-protein interactions within the crystals.  Semi-empirical calcns. of the enzyme-inhibitor interaction within the crystal suggest significant differences in the dissocn. consts. between the binding modes.  To probe for interactions in soln., a site-directed mutagenesis on hQC was performed.  The replacement of F325 and I303 by alanine or asparagine resulted in a 800-fold lower activity of the inhibitor, whereas the exchange of S323 by alanine or valine led to a 20-fold higher activity of PBD150.  The results provide an example of deciphering the interaction mode between a target enzyme and lead substance in soln., if co-crystn. does not mirror such interactions properly.  Thus, the study might provide implications for rapid screening of binding modes also for other drug targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqG1xHVETpdubVg90H21EOLACvtfcHk0lgMFaDwAZioEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslCmu7fE&md5=826cc42ff98381d0a09f6bec93f2a878</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1111%2Fcbdd.12046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcbdd.12046%26sid%3Dliteratum%253Aachs%26aulast%3DKoch%26aufirst%3DB.%26aulast%3DBuchholz%26aufirst%3DM.%26aulast%3DWermann%26aufirst%3DM.%26aulast%3DHeiser%26aufirst%3DU.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DProbing%2520secondary%2520glutaminyl%2520cyclase%2520%2528QC%2529%2520inhibitor%2520interactions%2520applying%2520an%2520in%2520silico-modeling%252Fsite-directed%2520mutagenesis%2520approach%253A%2520implications%2520for%2520drug%2520development%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2012%26volume%3D80%26spage%3D937%26epage%3D946%26doi%3D10.1111%2Fcbdd.12046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Schilling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosche, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manhart, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wasternack, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demuth, H. U.</span><span> </span><span class="NLM_article-title">Heterologous expression and characterization of human glutaminyl cyclase: evidence for a disulfide bond with importance for catalytic activity</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">10849</span><span class="NLM_x">–</span> <span class="NLM_lpage">10857</span><span class="refDoi"> DOI: 10.1021/bi0260381</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi0260381" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=1%3ACAS%3A528%3ADC%252BD38XlvFSmtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2002&pages=10849-10857&author=S.+Schillingauthor=T.+Hoffmannauthor=F.+Roscheauthor=S.+Manhartauthor=C.+Wasternackauthor=H.+U.+Demuth&title=Heterologous+expression+and+characterization+of+human+glutaminyl+cyclase%3A+evidence+for+a+disulfide+bond+with+importance+for+catalytic+activity&doi=10.1021%2Fbi0260381"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Heterologous Expression and Characterization of Human Glutaminyl Cyclase: Evidence for a Disulfide Bond with Importance for Catalytic Activity</span></div><div class="casAuthors">Schilling, Stephan; Hoffmann, Torsten; Rosche, Fred; Manhart, Susanne; Wasternack, Claus; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">10849-10857</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Glutaminyl cyclase (QC, EC 2.3.2.5) catalyzes the formation of pyroglutamate residues from glutamine at the N-terminus of peptides and proteins.  In the current study, human QC was functionally expressed in the secretory pathway of Pichia pastoris, yielding milligram quantities after purifn. from the supernatant of a 5 L fermn.  Initial characterization studies of the recombinant QC using MALDI-TOF mass spectrometry revealed correct proteolytic processing and N-glycosylation at both potential sites with similar 2 kDa extensions.  CD spectral anal. indicated a high α-helical content, which contrasts with plant QC from Carica papaya.  The kinetic parameters for conversion of H-Gln-Tyr-Ala-OH by recombinant human QC were almost identical to those previously reported for purified bovine pituitary QC.  However, the results obtained for conversion of H-Gln-Gln-OH, H-Gln-NH2, and H-Gln-AMC were found to be contradictory to previous studies on human QC expressed intracellularly in E. coli.  Expression of QC in E. coli showed that approx. 50% of the protein did not contain a disulfide bond that is present in the entire QC expressed in P. pastoris.  Further, the enzyme was consistently inactivated by treatment with 15 mM DTT, whereas deglycosylation had no effect on enzymic activity.  Anal. of the fluorescence spectra of the native, reduced, and unfolded human QC point to a conformational change of the protein upon treatment with DTT.  In terms of the different enzymic properties, the consequences of QC expression in different environments are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJohsxahWb8bVg90H21EOLACvtfcHk0lgMFaDwAZioEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlvFSmtro%253D&md5=c7d449a36576aec362a0b17bb7de2d4c</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fbi0260381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi0260381%26sid%3Dliteratum%253Aachs%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DRosche%26aufirst%3DF.%26aulast%3DManhart%26aufirst%3DS.%26aulast%3DWasternack%26aufirst%3DC.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DHeterologous%2520expression%2520and%2520characterization%2520of%2520human%2520glutaminyl%2520cyclase%253A%2520evidence%2520for%2520a%2520disulfide%2520bond%2520with%2520importance%2520for%2520catalytic%2520activity%26jtitle%3DBiochemistry%26date%3D2002%26volume%3D41%26spage%3D10849%26epage%3D10857%26doi%3D10.1021%2Fbi0260381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Ruiz-Carrillo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parthier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wermann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dambe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchholz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludwig, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiser, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahfeld, J. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stubbs, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schilling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demuth, H. U.</span><span> </span><span class="NLM_article-title">Structures of glycosylated mammalian glutaminyl cyclases reveal conformational variability near the active center</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">6280</span><span class="NLM_x">–</span> <span class="NLM_lpage">6288</span><span class="refDoi"> DOI: 10.1021/bi200249h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi200249h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnvF2jsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=6280-6288&author=D.+Ruiz-Carrilloauthor=B.+Kochauthor=C.+Parthierauthor=M.+Wermannauthor=T.+Dambeauthor=M.+Buchholzauthor=H.+H.+Ludwigauthor=U.+Heiserauthor=J.+U.+Rahfeldauthor=M.+T.+Stubbsauthor=S.+Schillingauthor=H.+U.+Demuth&title=Structures+of+glycosylated+mammalian+glutaminyl+cyclases+reveal+conformational+variability+near+the+active+center&doi=10.1021%2Fbi200249h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of Glycosylated Mammalian Glutaminyl Cyclases Reveal Conformational Variability near the Active Center</span></div><div class="casAuthors">Ruiz-Carrillo, David; Koch, Birgit; Parthier, Christoph; Wermann, Michael; Dambe, Tresfore; Buchholz, Mirko; Ludwig, Hans-Henning; Heiser, Ulrich; Rahfeld, Jens-Ulrich; Stubbs, Milton T.; Schilling, Stephan; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">6280-6288</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Formation of N-terminal pyroglutamate (pGlu or pE) from glutaminyl or glutamyl precursors is catalyzed by glutaminyl cyclases (QC).  As the formation of pGlu-amyloid has been linked with Alzheimer's disease, inhibitors of QCs are currently the subject of intense development.  Here, we report three crystal structures of N-glycosylated mammalian QC from humans (hQC) and mice (mQC).  Whereas the overall structures of the enzymes are similar to those reported previously, two surface loops in the neighborhood of the active center exhibit conformational variability.  Furthermore, two conserved cysteine residues form a disulfide bond at the base of the active center that was not present in previous reports of hQC structure.  Site-directed mutagenesis suggests a structure-stabilizing role of the disulfide bond.  At the entrance to the active center, the conserved tryptophan residue, W207, which displayed multiple orientations in previous structure, shows a single conformation in both glycosylated human and murine QCs.  Although mutagenesis of W207 into leucine or glutamine altered substrate conversion significantly, the binding consts. of inhibitors such as the highly potent PQ50 (PBD150) were minimally affected.  The crystal structure of PQ50 bound to the active center of murine QC reveals principal binding determinants provided by the catalytic zinc ion and a hydrophobic funnel.  This study presents a first comparison of two mammalian QCs contg. typical, conserved post-translational modifications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrsCCptP2CFLVg90H21EOLACvtfcHk0lhia3P252roMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnvF2jsbw%253D&md5=2306b3661a368105f6f2dd84f8527efb</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fbi200249h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi200249h%26sid%3Dliteratum%253Aachs%26aulast%3DRuiz-Carrillo%26aufirst%3DD.%26aulast%3DKoch%26aufirst%3DB.%26aulast%3DParthier%26aufirst%3DC.%26aulast%3DWermann%26aufirst%3DM.%26aulast%3DDambe%26aufirst%3DT.%26aulast%3DBuchholz%26aufirst%3DM.%26aulast%3DLudwig%26aufirst%3DH.%2BH.%26aulast%3DHeiser%26aufirst%3DU.%26aulast%3DRahfeld%26aufirst%3DJ.%2BU.%26aulast%3DStubbs%26aufirst%3DM.%2BT.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DStructures%2520of%2520glycosylated%2520mammalian%2520glutaminyl%2520cyclases%2520reveal%2520conformational%2520variability%2520near%2520the%2520active%2520center%26jtitle%3DBiochemistry%26date%3D2011%26volume%3D50%26spage%3D6280%26epage%3D6288%26doi%3D10.1021%2Fbi200249h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Schilling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niestroj, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahfeld, J. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wermann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zunkel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wasternack, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demuth, H. U.</span><span> </span><span class="NLM_article-title">Identification of human glutaminyl cyclase as a metalloenzyme. Potent inhibition by imidazole derivatives and heterocyclic chelators</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">49773</span><span class="NLM_x">–</span> <span class="NLM_lpage">49779</span><span class="refDoi"> DOI: 10.1074/jbc.M309077200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=10.1074%2Fjbc.M309077200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=14522962" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpslSrurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=49773-49779&author=S.+Schillingauthor=A.+J.+Niestrojauthor=J.+U.+Rahfeldauthor=T.+Hoffmannauthor=M.+Wermannauthor=K.+Zunkelauthor=C.+Wasternackauthor=H.+U.+Demuth&title=Identification+of+human+glutaminyl+cyclase+as+a+metalloenzyme.+Potent+inhibition+by+imidazole+derivatives+and+heterocyclic+chelators&doi=10.1074%2Fjbc.M309077200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Human Glutaminyl Cyclase as a Metalloenzyme: Potent inhibition by imidazole derivatives and heterocyclic chelators</span></div><div class="casAuthors">Schilling, Stephan; Niestroj, Andre J.; Rahfeld, Jens-Ulrich; Hoffmann, Torsten; Wermann, Michael; Zunkel, Katrin; Wasternack, Claus; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">49773-49779</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Human glutaminyl cyclase (QC) was identified as a metalloenzyme as suggested by the time-dependent inhibition by the heterocyclic chelators 1,10-phenanthroline and dipicolinic acid.  The effect of EDTA on QC catalysis was negligible.  Inactivated enzyme could be fully restored by the addn. of Zn2+ in the presence of equimolar concns. of EDTA.  Little reactivation was obsd. with Co2+ and Mn2+.  Other metal ions such as K+, Ca2+, and Ni2+ were inactive under the same conditions.  Addnl., imidazole and imidazole derivs. were identified as competitive inhibitors of QC.  An initial structure activity-based inhibitor screening of imidazole-derived compds. revealed potent inhibition of QC by imidazole N-1 derivs.  Subsequent data base screening led to the identification of two highly potent inhibitors, 3-[3-(1H-imidazol-1-yl)propyl]-2-thioxoimidazolidin-4-one and 1,4-bis-(imidazol-1-yl)-methyl-2,5-dimethylbenzene, which exhibited resp. Ki values of 818 and 295 nM.  The binding properties of the imidazole derivs. were further analyzed by the pH dependence of QC inhibition.  The kinetically obtained pKa values of 6.94, 6.93, and 5.60 for imidazole, methylimidazole, and benzimidazole, resp., match the values obtained by titrimetric pKa detn., indicating the requirement for an unprotonated nitrogen for binding to QC.  Similarly, the pH dependence of the kinetic parameter Km for the QC-catalyzed conversion of H-Gln-7-amino-4-methylcoumarin also implies that only N-terminally unprotonated substrate mols. are bound to the active site of the enzyme, whereas turnover is not affected.  The results reveal human QC as a metal-dependent transferase, suggesting that the active site-bound metal is a potential site for interaction with novel, highly potent competitive inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolRoNA9eEuXrVg90H21EOLACvtfcHk0lhia3P252roMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpslSrurw%253D&md5=372bdb3cf7603da16c3c2cc888a54cb1</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M309077200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M309077200%26sid%3Dliteratum%253Aachs%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DNiestroj%26aufirst%3DA.%2BJ.%26aulast%3DRahfeld%26aufirst%3DJ.%2BU.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DWermann%26aufirst%3DM.%26aulast%3DZunkel%26aufirst%3DK.%26aulast%3DWasternack%26aufirst%3DC.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DIdentification%2520of%2520human%2520glutaminyl%2520cyclase%2520as%2520a%2520metalloenzyme.%2520Potent%2520inhibition%2520by%2520imidazole%2520derivatives%2520and%2520heterocyclic%2520chelators%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D49773%26epage%3D49779%26doi%3D10.1074%2Fjbc.M309077200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 24 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Chenshu Xu, Yi-nan Wang, <span class="NLM_string-name hlFld-ContribAuthor">Haiqiang Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Glutaminyl Cyclase, Diseases, and Development of Glutaminyl Cyclase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (10)
                                     , 6549-6565. <a href="https://doi.org/10.1021/acs.jmedchem.1c00325" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00325</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00325%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DGlutaminyl%252BCyclase%25252C%252BDiseases%25252C%252Band%252BDevelopment%252Bof%252BGlutaminyl%252BCyclase%252BInhibitors%26aulast%3DXu%26aufirst%3DChenshu%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D21022021%26date%3D18052021%26volume%3D64%26issue%3D10%26spage%3D6549%26epage%3D6565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Van-Hai Hoang, Van T. H. Ngo, Minghua Cui, Nguyen Van Manh, Phuong-Thao Tran, Jihyae Ann, Hee-Jin Ha, Hee Kim, Kwanghyun Choi, Young-Ho Kim, Hyerim Chang, Stephani Joy Y. Macalino, Jiyoun Lee, Sun Choi, <span class="NLM_string-name hlFld-ContribAuthor">Jeewoo Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Conformationally Restricted Human Glutaminyl Cyclase Inhibitors as Potent Anti-Alzheimer’s Agents by Structure-Based Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (17)
                                     , 8011-8027. <a href="https://doi.org/10.1021/acs.jmedchem.9b00751" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00751</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00751&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00751%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BConformationally%252BRestricted%252BHuman%252BGlutaminyl%252BCyclase%252BInhibitors%252Bas%252BPotent%252BAnti-Alzheimer%2525E2%252580%252599s%252BAgents%252Bby%252BStructure-Based%252BDesign%26aulast%3DHoang%26aufirst%3DVan-Hai%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D08052019%26date%3D27082019%26date%3D14082019%26volume%3D62%26issue%3D17%26spage%3D8011%26epage%3D8027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Qiong Wu, Kangdi Zheng, Xiaoting Huang, Li Li, <span class="NLM_string-name hlFld-ContribAuthor">Wenjie Mei</span>. </span><span class="cited-content_cbyCitation_article-title">Tanshinone-IIA-Based Analogues of Imidazole Alkaloid Act as Potent Inhibitors To Block Breast Cancer Invasion and Metastasis in Vivo. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (23)
                                     , 10488-10501. <a href="https://doi.org/10.1021/acs.jmedchem.8b01018" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01018%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTanshinone-IIA-Based%252BAnalogues%252Bof%252BImidazole%252BAlkaloid%252BAct%252Bas%252BPotent%252BInhibitors%252BTo%252BBlock%252BBreast%252BCancer%252BInvasion%252Band%252BMetastasis%252Bin%252BVivo%26aulast%3DWu%26aufirst%3DQiong%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D27062018%26date%3D19112018%26date%3D06112018%26volume%3D61%26issue%3D23%26spage%3D10488%26epage%3D10501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Judite R.M.  Coimbra</span>, <span class="hlFld-ContribAuthor ">Jorge A.R.  Salvador</span>. </span><span class="cited-content_cbyCitation_article-title">A patent review of glutaminyl cyclase inhibitors (2004–present). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2021,</strong> <em>276 </em>, 1-28. <a href="https://doi.org/10.1080/13543776.2021.1917549" title="DOI URL">https://doi.org/10.1080/13543776.2021.1917549</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2021.1917549&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2021.1917549%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DA%252Bpatent%252Breview%252Bof%252Bglutaminyl%252Bcyclase%252Binhibitors%252B%2525282004%2525E2%252580%252593present%252529%26aulast%3DCoimbra%26aufirst%3DJudite%2BR.M.%26date%3D2021%26date%3D2021%26volume%3D276%26spage%3D1%26epage%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cauê Benito  Scarim</span>, <span class="hlFld-ContribAuthor ">Chung Man  Chin</span>. </span><span class="cited-content_cbyCitation_article-title">The use of heterocyclic-based azo compounds bearing pyrrolidine, imidazole, triazole, and thiazole moieties for the treatment of neglected tropical disease caused by Schistosoma mansoni. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry Reports</span><span> <strong>2021,</strong> <em>1 </em>, 100001. <a href="https://doi.org/10.1016/j.ejmcr.2021.100001" title="DOI URL">https://doi.org/10.1016/j.ejmcr.2021.100001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmcr.2021.100001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmcr.2021.100001%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%2520Reports%26atitle%3DThe%252Buse%252Bof%252Bheterocyclic-based%252Bazo%252Bcompounds%252Bbearing%252Bpyrrolidine%25252C%252Bimidazole%25252C%252Btriazole%25252C%252Band%252Bthiazole%252Bmoieties%252Bfor%252Bthe%252Btreatment%252Bof%252Bneglected%252Btropical%252Bdisease%252Bcaused%252Bby%252BSchistosoma%252Bmansoni%26aulast%3DScarim%26aufirst%3DCau%25C3%25AA%2BBenito%26date%3D2021%26volume%3D1%26spage%3D100001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kai-Fa  Huang</span>, <span class="hlFld-ContribAuthor ">Jing-Siou  Huang</span>, <span class="hlFld-ContribAuthor ">Mao-Lun  Wu</span>, <span class="hlFld-ContribAuthor ">Wan-Ling  Hsieh</span>, <span class="hlFld-ContribAuthor ">Kai-Cheng  Hsu</span>, <span class="hlFld-ContribAuthor ">Hui-Ling  Hsu</span>, <span class="hlFld-ContribAuthor ">Tzu-Ping  Ko</span>, <span class="hlFld-ContribAuthor ">Andrew H.-J.  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">A Unique Carboxylic-Acid Hydrogen-Bond Network (CAHBN) Confers Glutaminyl Cyclase Activity on M28 Family Enzymes. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Biology</span><span> <strong>2021,</strong> <em>433 </em>
                                    (13)
                                     , 166960. <a href="https://doi.org/10.1016/j.jmb.2021.166960" title="DOI URL">https://doi.org/10.1016/j.jmb.2021.166960</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmb.2021.166960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmb.2021.166960%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Biology%26atitle%3DA%252BUnique%252BCarboxylic-Acid%252BHydrogen-Bond%252BNetwork%252B%252528CAHBN%252529%252BConfers%252BGlutaminyl%252BCyclase%252BActivity%252Bon%252BM28%252BFamily%252BEnzymes%26aulast%3DHuang%26aufirst%3DKai-Fa%26date%3D2021%26volume%3D433%26issue%3D13%26spage%3D166960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sandeep  Rulhania</span>, <span class="hlFld-ContribAuthor ">Shubham  Kumar</span>, <span class="hlFld-ContribAuthor ">Bhupender  Nehra</span>, <span class="hlFld-ContribAuthor ">GD  Gupta</span>, <span class="hlFld-ContribAuthor ">Vikramdeep  Monga</span>. </span><span class="cited-content_cbyCitation_article-title">An insight into the medicinal perspective of synthetic analogs of imidazole. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2021,</strong> <em>1232 </em>, 129982. <a href="https://doi.org/10.1016/j.molstruc.2021.129982" title="DOI URL">https://doi.org/10.1016/j.molstruc.2021.129982</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2021.129982&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2021.129982%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DAn%252Binsight%252Binto%252Bthe%252Bmedicinal%252Bperspective%252Bof%252Bsynthetic%252Banalogs%252Bof%252Bimidazole%26aulast%3DRulhania%26aufirst%3DSandeep%26date%3D2021%26volume%3D1232%26spage%3D129982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A G  Eliewi</span>, <span class="hlFld-ContribAuthor ">Z S  Al-Garawi</span>, <span class="hlFld-ContribAuthor ">F F  Al-Kazzaz</span>, <span class="hlFld-ContribAuthor ">A J K  Atia</span>. </span><span class="cited-content_cbyCitation_article-title">Multi target-directed imidazole derivatives for neurodegenerative diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Physics: Conference Series</span><span> <strong>2021,</strong> <em>1853 </em>
                                    (1)
                                     , 012066. <a href="https://doi.org/10.1088/1742-6596/1853/1/012066" title="DOI URL">https://doi.org/10.1088/1742-6596/1853/1/012066</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1088/1742-6596/1853/1/012066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1088%2F1742-6596%2F1853%2F1%2F012066%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Physics%253A%2520Conference%2520Series%26atitle%3DMulti%252Btarget-directed%252Bimidazole%252Bderivatives%252Bfor%252Bneurodegenerative%252Bdiseases%26aulast%3DEliewi%26aufirst%3DA%2BG%26date%3D2021%26volume%3D1853%26issue%3D1%26spage%3D012066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adam P.  Gunn</span>, <span class="hlFld-ContribAuthor ">Bruce X.  Wong</span>, <span class="hlFld-ContribAuthor ">Catriona  McLean</span>, <span class="hlFld-ContribAuthor ">Chris  Fowler</span>, <span class="hlFld-ContribAuthor ">Peter J.  Barnard</span>, <span class="hlFld-ContribAuthor ">James A.  Duce</span>, <span class="hlFld-ContribAuthor ">Blaine R.  Roberts</span>, . </span><span class="cited-content_cbyCitation_article-title">Increased glutaminyl cyclase activity in brains of Alzheimer’s disease individuals. </span><span class="cited-content_cbyCitation_journal-name">Journal of Neurochemistry</span><span> <strong>2021,</strong> <em>156 </em>
                                    (6)
                                     , 979-987. <a href="https://doi.org/10.1111/jnc.15114" title="DOI URL">https://doi.org/10.1111/jnc.15114</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/jnc.15114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fjnc.15114%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Neurochemistry%26atitle%3DIncreased%252Bglutaminyl%252Bcyclase%252Bactivity%252Bin%252Bbrains%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%252Bindividuals%26aulast%3DGunn%26aufirst%3DAdam%2BP.%26date%3D2021%26date%3D2020%26volume%3D156%26issue%3D6%26spage%3D979%26epage%3D987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Akshay  Kapadia</span>, <span class="hlFld-ContribAuthor ">Krishna K.  Sharma</span>, <span class="hlFld-ContribAuthor ">Indresh Kumar  Maurya</span>, <span class="hlFld-ContribAuthor ">Varinder  Singh</span>, <span class="hlFld-ContribAuthor ">Madhu  Khullar</span>, <span class="hlFld-ContribAuthor ">Rahul  Jain</span>. </span><span class="cited-content_cbyCitation_article-title">Structural and mechanistic insights into the inhibition of amyloid-β aggregation by Aβ39-42 fragment derived synthetic peptides. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>212 </em>, 113126. <a href="https://doi.org/10.1016/j.ejmech.2020.113126" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.113126</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.113126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.113126%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructural%252Band%252Bmechanistic%252Binsights%252Binto%252Bthe%252Binhibition%252Bof%252Bamyloid-%2525CE%2525B2%252Baggregation%252Bby%252BA%2525CE%2525B239-42%252Bfragment%252Bderived%252Bsynthetic%252Bpeptides%26aulast%3DKapadia%26aufirst%3DAkshay%26date%3D2021%26volume%3D212%26spage%3D113126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">K.V.  Dileep</span>, <span class="hlFld-ContribAuthor ">Naoki  Sakai</span>, <span class="hlFld-ContribAuthor ">Kentaro  Ihara</span>, <span class="hlFld-ContribAuthor ">Miyuki  Kato-Murayama</span>, <span class="hlFld-ContribAuthor ">Akiko  Nakata</span>, <span class="hlFld-ContribAuthor ">Akihiro  Ito</span>, <span class="hlFld-ContribAuthor ">D.M.  Sivaraman</span>, <span class="hlFld-ContribAuthor ">Jay W.  Shin</span>, <span class="hlFld-ContribAuthor ">Minoru  Yoshida</span>, <span class="hlFld-ContribAuthor ">Mikako  Shirouzu</span>, <span class="hlFld-ContribAuthor ">Kam Y.J.  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Piperidine-4-carboxamide as a new scaffold for designing secretory glutaminyl cyclase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Biological Macromolecules</span><span> <strong>2021,</strong> <em>170 </em>, 415-423. <a href="https://doi.org/10.1016/j.ijbiomac.2020.12.118" title="DOI URL">https://doi.org/10.1016/j.ijbiomac.2020.12.118</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ijbiomac.2020.12.118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ijbiomac.2020.12.118%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Biological%2520Macromolecules%26atitle%3DPiperidine-4-carboxamide%252Bas%252Ba%252Bnew%252Bscaffold%252Bfor%252Bdesigning%252Bsecretory%252Bglutaminyl%252Bcyclase%252Binhibitors%26aulast%3DDileep%26aufirst%3DK.V.%26date%3D2021%26volume%3D170%26spage%3D415%26epage%3D423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chenshu  Xu</span>, <span class="hlFld-ContribAuthor ">Haoman  Zou</span>, <span class="hlFld-ContribAuthor ">Xi  Yu</span>, <span class="hlFld-ContribAuthor ">Yazhou  Xie</span>, <span class="hlFld-ContribAuthor ">Jiaxin  Cai</span>, <span class="hlFld-ContribAuthor ">Qi  Shang</span>, <span class="hlFld-ContribAuthor ">Na  Ouyang</span>, <span class="hlFld-ContribAuthor ">Yinan  Wang</span>, <span class="hlFld-ContribAuthor ">Pan  Xu</span>, <span class="hlFld-ContribAuthor ">Zhendan  He</span>, <span class="hlFld-ContribAuthor ">Haiqiang  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Repurposing FDA‐Approved Compounds for the Discovery of Glutaminyl Cyclase Inhibitors as Drugs Against Alzheimer's Disease. </span><span class="cited-content_cbyCitation_journal-name">ChemistryOpen</span><span> <strong>2020,</strong> <em>35 </em><a href="https://doi.org/10.1002/open.202000235" title="DOI URL">https://doi.org/10.1002/open.202000235</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/open.202000235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fopen.202000235%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistryOpen%26atitle%3DRepurposing%252BFDA%2525E2%252580%252590Approved%252BCompounds%252Bfor%252Bthe%252BDiscovery%252Bof%252BGlutaminyl%252BCyclase%252BInhibitors%252Bas%252BDrugs%252BAgainst%252BAlzheimer%252527s%252BDisease%26aulast%3DXu%26aufirst%3DChenshu%26date%3D2020%26date%3D2020%26volume%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas C.  Malig</span>, <span class="hlFld-ContribAuthor ">Yichen  Tan</span>, <span class="hlFld-ContribAuthor ">Steven R.  Wisniewski</span>, <span class="hlFld-ContribAuthor ">Carolyn S.  Higman</span>, <span class="hlFld-ContribAuthor ">Ronald  Carrasquillo-Flores</span>, <span class="hlFld-ContribAuthor ">Adrian  Ortiz</span>, <span class="hlFld-ContribAuthor ">Geoffrey E.  Purdum</span>, <span class="hlFld-ContribAuthor ">Sergei  Kolotuchin</span>, <span class="hlFld-ContribAuthor ">Jason E.  Hein</span>. </span><span class="cited-content_cbyCitation_article-title">Development of a telescoped synthesis of 4-(1
              H
              )-cyanoimidazole core accelerated by orthogonal reaction monitoring. </span><span class="cited-content_cbyCitation_journal-name">Reaction Chemistry & Engineering</span><span> <strong>2020,</strong> <em>5 </em>
                                    (8)
                                     , 1421-1428. <a href="https://doi.org/10.1039/D0RE00234H" title="DOI URL">https://doi.org/10.1039/D0RE00234H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0RE00234H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0RE00234H%26sid%3Dliteratum%253Aachs%26jtitle%3DReaction%2520Chemistry%2520%2526%2520Engineering%26atitle%3DDevelopment%252Bof%252Ba%252Btelescoped%252Bsynthesis%252Bof%252B4-%2525281%252BH%252B%252529-cyanoimidazole%252Bcore%252Baccelerated%252Bby%252Borthogonal%252Breaction%252Bmonitoring%26aulast%3DMalig%26aufirst%3DThomas%2BC.%26date%3D2020%26date%3D2020%26volume%3D5%26issue%3D8%26spage%3D1421%26epage%3D1428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Akshay  Kapadia</span>, <span class="hlFld-ContribAuthor ">Aesan  Patel</span>, <span class="hlFld-ContribAuthor ">Krishna K.  Sharma</span>, <span class="hlFld-ContribAuthor ">Indresh Kumar  Maurya</span>, <span class="hlFld-ContribAuthor ">Varinder  Singh</span>, <span class="hlFld-ContribAuthor ">Madhu  Khullar</span>, <span class="hlFld-ContribAuthor ">Rahul  Jain</span>. </span><span class="cited-content_cbyCitation_article-title">Effect of C-terminus amidation of Aβ
              39–42
              fragment derived peptides as potential inhibitors of Aβ aggregation. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2020,</strong> <em>10 </em>
                                    (45)
                                     , 27137-27151. <a href="https://doi.org/10.1039/D0RA04788K" title="DOI URL">https://doi.org/10.1039/D0RA04788K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0RA04788K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0RA04788K%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DEffect%252Bof%252BC-terminus%252Bamidation%252Bof%252BA%2525CE%2525B2%252B39%2525E2%252580%25259342%252Bfragment%252Bderived%252Bpeptides%252Bas%252Bpotential%252Binhibitors%252Bof%252BA%2525CE%2525B2%252Baggregation%26aulast%3DKapadia%26aufirst%3DAkshay%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D45%26spage%3D27137%26epage%3D27151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Judite RM  Coimbra</span>, <span class="hlFld-ContribAuthor ">Pedro JM  Sobral</span>, <span class="hlFld-ContribAuthor ">Armanda E  Santos</span>, <span class="hlFld-ContribAuthor ">Paula I  Moreira</span>, <span class="hlFld-ContribAuthor ">Jorge AR  Salvador</span>. </span><span class="cited-content_cbyCitation_article-title">An overview of glutaminyl cyclase inhibitors for Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2019,</strong> <em>11 </em>
                                    (24)
                                     , 3179-3194. <a href="https://doi.org/10.4155/fmc-2019-0163" title="DOI URL">https://doi.org/10.4155/fmc-2019-0163</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2019-0163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2019-0163%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DAn%252Boverview%252Bof%252Bglutaminyl%252Bcyclase%252Binhibitors%252Bfor%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DCoimbra%26aufirst%3DJudite%2BRM%26date%3D2019%26volume%3D11%26issue%3D24%26spage%3D3179%26epage%3D3194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaojuan  Wang</span>, <span class="hlFld-ContribAuthor ">Li  Wang</span>, <span class="hlFld-ContribAuthor ">Xi  Yu</span>, <span class="hlFld-ContribAuthor ">Yue  Li</span>, <span class="hlFld-ContribAuthor ">Zhigang  Liu</span>, <span class="hlFld-ContribAuthor ">Yongdong  Zou</span>, <span class="hlFld-ContribAuthor ">Yizhi  Zheng</span>, <span class="hlFld-ContribAuthor ">Zhendan  He</span>, <span class="hlFld-ContribAuthor ">Haiqiang  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Glutaminyl cyclase inhibitor exhibits anti-inflammatory effects in both AD and LPS-induced inflammatory model mice. </span><span class="cited-content_cbyCitation_journal-name">International Immunopharmacology</span><span> <strong>2019,</strong> <em>75 </em>, 105770. <a href="https://doi.org/10.1016/j.intimp.2019.105770" title="DOI URL">https://doi.org/10.1016/j.intimp.2019.105770</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.intimp.2019.105770&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.intimp.2019.105770%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Immunopharmacology%26atitle%3DGlutaminyl%252Bcyclase%252Binhibitor%252Bexhibits%252Banti-inflammatory%252Beffects%252Bin%252Bboth%252BAD%252Band%252BLPS-induced%252Binflammatory%252Bmodel%252Bmice%26aulast%3DWang%26aufirst%3DXiaojuan%26date%3D2019%26volume%3D75%26spage%3D105770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ana  Xu</span>, <span class="hlFld-ContribAuthor ">Feng  He</span>, <span class="hlFld-ContribAuthor ">Chenggong  Yu</span>, <span class="hlFld-ContribAuthor ">Ying  Qu</span>, <span class="hlFld-ContribAuthor ">Qiuqiong  Zhang</span>, <span class="hlFld-ContribAuthor ">Jiahui  Lv</span>, <span class="hlFld-ContribAuthor ">Xiangna  Zhang</span>, <span class="hlFld-ContribAuthor ">Yingying  Ran</span>, <span class="hlFld-ContribAuthor ">Chao  Wei</span>, <span class="hlFld-ContribAuthor ">Jingde  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">The Development of Small Molecule Inhibitors of Glutaminyl Cyclase and Isoglutaminyl Cyclase for Alzheimer's Disease. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2019,</strong> <em>4 </em>
                                    (35)
                                     , 10591-10600. <a href="https://doi.org/10.1002/slct.201902852" title="DOI URL">https://doi.org/10.1002/slct.201902852</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201902852&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201902852%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DThe%252BDevelopment%252Bof%252BSmall%252BMolecule%252BInhibitors%252Bof%252BGlutaminyl%252BCyclase%252Band%252BIsoglutaminyl%252BCyclase%252Bfor%252BAlzheimer%252527s%252BDisease%26aulast%3DXu%26aufirst%3DAna%26date%3D2019%26date%3D2019%26volume%3D4%26issue%3D35%26spage%3D10591%26epage%3D10600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dileep K.  Vijayan</span>, <span class="hlFld-ContribAuthor ">Kam Y.J.  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Human glutaminyl cyclase: Structure, function, inhibitors and involvement in Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2019,</strong> <em>147 </em>, 104342. <a href="https://doi.org/10.1016/j.phrs.2019.104342" title="DOI URL">https://doi.org/10.1016/j.phrs.2019.104342</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2019.104342&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2019.104342%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DHuman%252Bglutaminyl%252Bcyclase%25253A%252BStructure%25252C%252Bfunction%25252C%252Binhibitors%252Band%252Binvolvement%252Bin%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DVijayan%26aufirst%3DDileep%2BK.%26date%3D2019%26volume%3D147%26spage%3D104342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wael Abdelgayed Ahmed  Arafa</span>, <span class="hlFld-ContribAuthor ">Hamada Mohamed  Ibrahim</span>. </span><span class="cited-content_cbyCitation_article-title">Sustainable and scalable synthesis of polysubstituted bis-1,2,4-triazoles, bis-2-iminothiazolines and bis-thiobarbiturates using bis-
              N
              ,
              N
              -disubstituted thioureas as versatile substrate. </span><span class="cited-content_cbyCitation_journal-name">Royal Society Open Science</span><span> <strong>2019,</strong> <em>6 </em>
                                    (6)
                                     , 181963. <a href="https://doi.org/10.1098/rsos.181963" title="DOI URL">https://doi.org/10.1098/rsos.181963</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1098/rsos.181963&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1098%2Frsos.181963%26sid%3Dliteratum%253Aachs%26jtitle%3DRoyal%2520Society%2520Open%2520Science%26atitle%3DSustainable%252Band%252Bscalable%252Bsynthesis%252Bof%252Bpolysubstituted%252Bbis-1%25252C2%25252C4-triazoles%25252C%252Bbis-2-iminothiazolines%252Band%252Bbis-thiobarbiturates%252Busing%252Bbis-%252BN%252B%25252C%252BN%252B-disubstituted%252Bthioureas%252Bas%252Bversatile%252Bsubstrate%26aulast%3DArafa%26aufirst%3DWael%2BAbdelgayed%2BAhmed%26date%3D2019%26date%3D2019%26volume%3D6%26issue%3D6%26spage%3D181963" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xi  Yu</span>, <span class="hlFld-ContribAuthor ">Yue  Li</span>, <span class="hlFld-ContribAuthor ">Yongdong  Zou</span>, <span class="hlFld-ContribAuthor ">Yizhi  Zheng</span>, <span class="hlFld-ContribAuthor ">Zhendan  He</span>, <span class="hlFld-ContribAuthor ">Zhigang  Liu</span>, <span class="hlFld-ContribAuthor ">Wenlin  Xie</span>, <span class="hlFld-ContribAuthor ">Haiqiang  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Glutaminyl cyclase inhibitor contributes to the regulation of HSP70, HSP90, actin, and ribosome on gene and protein levels in vitro. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cellular Biochemistry</span><span> <strong>2019,</strong> <em>120 </em>
                                    (6)
                                     , 9460-9471. <a href="https://doi.org/10.1002/jcb.28222" title="DOI URL">https://doi.org/10.1002/jcb.28222</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jcb.28222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjcb.28222%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cellular%2520Biochemistry%26atitle%3DGlutaminyl%252Bcyclase%252Binhibitor%252Bcontributes%252Bto%252Bthe%252Bregulation%252Bof%252BHSP70%25252C%252BHSP90%25252C%252Bactin%25252C%252Band%252Bribosome%252Bon%252Bgene%252Band%252Bprotein%252Blevels%252Bin%252Bvitro%26aulast%3DYu%26aufirst%3DXi%26date%3D2019%26date%3D2018%26volume%3D120%26issue%3D6%26spage%3D9460%26epage%3D9471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cecilia  Pozzi</span>, <span class="hlFld-ContribAuthor ">Flavio  Di Pisa</span>, <span class="hlFld-ContribAuthor ">Manuela  Benvenuti</span>, <span class="hlFld-ContribAuthor ">Stefano  Mangani</span>. </span><span class="cited-content_cbyCitation_article-title">The structure of the human glutaminyl cyclase–SEN177 complex indicates routes for developing new potent inhibitors as possible agents for the treatment of neurological disorders. </span><span class="cited-content_cbyCitation_journal-name">JBIC Journal of Biological Inorganic Chemistry</span><span> <strong>2018,</strong> <em>23 </em>
                                    (8)
                                     , 1219-1226. <a href="https://doi.org/10.1007/s00775-018-1605-1" title="DOI URL">https://doi.org/10.1007/s00775-018-1605-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00775-018-1605-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00775-018-1605-1%26sid%3Dliteratum%253Aachs%26jtitle%3DJBIC%2520Journal%2520of%2520Biological%2520Inorganic%2520Chemistry%26atitle%3DThe%252Bstructure%252Bof%252Bthe%252Bhuman%252Bglutaminyl%252Bcyclase%2525E2%252580%252593SEN177%252Bcomplex%252Bindicates%252Broutes%252Bfor%252Bdeveloping%252Bnew%252Bpotent%252Binhibitors%252Bas%252Bpossible%252Bagents%252Bfor%252Bthe%252Btreatment%252Bof%252Bneurological%252Bdisorders%26aulast%3DPozzi%26aufirst%3DCecilia%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D8%26spage%3D1219%26epage%3D1226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Van T.H.  Ngo</span>, <span class="hlFld-ContribAuthor ">Van-Hai  Hoang</span>, <span class="hlFld-ContribAuthor ">Phuong-Thao  Tran</span>, <span class="hlFld-ContribAuthor ">Nguyen  Van Manh</span>, <span class="hlFld-ContribAuthor ">Jihyae  Ann</span>, <span class="hlFld-ContribAuthor ">Eunhye  Kim</span>, <span class="hlFld-ContribAuthor ">Minghua  Cui</span>, <span class="hlFld-ContribAuthor ">Sun  Choi</span>, <span class="hlFld-ContribAuthor ">Jiyoun  Lee</span>, <span class="hlFld-ContribAuthor ">Hee  Kim</span>, <span class="hlFld-ContribAuthor ">Hee-Jin  Ha</span>, <span class="hlFld-ContribAuthor ">Kwanghyun  Choi</span>, <span class="hlFld-ContribAuthor ">Young-Ho  Kim</span>, <span class="hlFld-ContribAuthor ">Jeewoo  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-activity relationship investigation of Phe-Arg mimetic region of human glutaminyl cyclase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (12)
                                     , 3133-3144. <a href="https://doi.org/10.1016/j.bmc.2018.04.040" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.04.040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.04.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.04.040%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DStructure-activity%252Brelationship%252Binvestigation%252Bof%252BPhe-Arg%252Bmimetic%252Bregion%252Bof%252Bhuman%252Bglutaminyl%252Bcyclase%252Binhibitors%26aulast%3DNgo%26aufirst%3DVan%2BT.H.%26date%3D2018%26volume%3D26%26issue%3D12%26spage%3D3133%26epage%3D3144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qiwei  Wang</span>, <span class="hlFld-ContribAuthor ">Chen  Ma</span>, <span class="hlFld-ContribAuthor ">Xueyan  Li</span>, <span class="hlFld-ContribAuthor ">Xiaofen  Wang</span>, <span class="hlFld-ContribAuthor ">Ruixue  Rong</span>, <span class="hlFld-ContribAuthor ">Chao  Wei</span>, <span class="hlFld-ContribAuthor ">Pingzhu  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiaoliu  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of novel sugar or azasugar modified anthra[1,2- d ] imidazole-6,11-dione derivatives and biological evaluation. </span><span class="cited-content_cbyCitation_journal-name">Carbohydrate Research</span><span> <strong>2018,</strong> <em>460 </em>, 29-33. <a href="https://doi.org/10.1016/j.carres.2018.02.012" title="DOI URL">https://doi.org/10.1016/j.carres.2018.02.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.carres.2018.02.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.carres.2018.02.012%26sid%3Dliteratum%253Aachs%26jtitle%3DCarbohydrate%2520Research%26atitle%3DSynthesis%252Bof%252Bnovel%252Bsugar%252Bor%252Bazasugar%252Bmodified%252Banthra%25255B1%25252C2-%252Bd%252B%25255D%252Bimidazole-6%25252C11-dione%252Bderivatives%252Band%252Bbiological%252Bevaluation%26aulast%3DWang%26aufirst%3DQiwei%26date%3D2018%26volume%3D460%26spage%3D29%26epage%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haiqiang  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Can small molecule inhibitors of glutaminyl cyclase be used as a therapeutic for Alzheimer's disease?. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2017,</strong> <em>9 </em>
                                    (17)
                                     , 1979-1981. <a href="https://doi.org/10.4155/fmc-2017-0190" title="DOI URL">https://doi.org/10.4155/fmc-2017-0190</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2017-0190&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2017-0190%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DCan%252Bsmall%252Bmolecule%252Binhibitors%252Bof%252Bglutaminyl%252Bcyclase%252Bbe%252Bused%252Bas%252Ba%252Btherapeutic%252Bfor%252BAlzheimer%252527s%252Bdisease%25253F%26aulast%3DWu%26aufirst%3DHaiqiang%26date%3D2017%26volume%3D9%26issue%3D17%26spage%3D1979%26epage%3D1981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00648/20170804/images/medium/jm-2017-00648m_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00648/20170804/images/large/jm-2017-00648m_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00648&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00648/20170804/images/medium/jm-2017-00648m_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00648/20170804/images/large/jm-2017-00648m_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Proposed skeleton of DPCIs and the docked model with hQC. (A) Structure of <b>1</b> (top) and prototypical DPCI (<b>2</b>, bottom); (B, C) Overlay pose of <b>1</b> (green) and <b>2</b> (brown) in the catalytically active region of hQC (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PBB">3PBB</a>). Protein surface is illustrated in panel B. Compound <b>2</b> was predicted to interact with hQC in a manner similar to <b>1</b>; the important residues are shown using stick format in panel C.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00648/20170804/images/large/jm-2017-00648m_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00648&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00648/20170804/images/medium/jm-2017-00648m_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00648/20170804/images/large/jm-2017-00648m_0006.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00648/20170804/images/large/jm-2017-00648m_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00648&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Pd(DPPF)<sub>2</sub>Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, reflux, 3 h, 100 °C, Ar; (b) acetonitrile, K<sub>2</sub>CO<sub>3</sub>, reflux, overnight; (c) acetonitrile, K<sub>2</sub>CO<sub>3</sub>, reflux, overnight.</p></p></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00648/20170804/images/medium/jm-2017-00648m_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00648/20170804/images/large/jm-2017-00648m_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Docked conformations of DPCIs with hQC. (A) Binding mode of <b>1</b> with hQC (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PBB">3PBB</a>) in the crystal structure; (B–D) docked poses of potent inhibitors <b>2</b>, <b>23</b>, and <b>28</b>, respectively, with hQC; (E, F) docked poses of inactive inhibitors <b>36</b> and <b>37</b>, respectively, with hQC. The inhibitors are shown in stick mode, and hQC is shown in yellow cartoons. Interactions between the protein residues and inhibitors with the catalytic zinc ion at the bottom of the pocket are shown in dash lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00648/20170804/images/large/jm-2017-00648m_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00648&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00648/20170804/images/medium/jm-2017-00648m_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00648/20170804/images/large/jm-2017-00648m_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Permeability of <b>28</b> determined by the PAMPA-BBB assay.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00648/20170804/images/large/jm-2017-00648m_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00648&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00648/20170804/images/medium/jm-2017-00648m_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00648/20170804/images/large/jm-2017-00648m_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Analysis of the inhibitory potency of <b>28</b> in transfected HEK293T cells. (A) Inhibitory effects of <b>28</b> on hQC in PCMV3-QPCT (hQC) and APP695-A673V transfected HEK293T cells, which were treated for 6, 12, 24, and 48 h at the concentration of 10 μM; (B) inhibitory effects of <b>28</b> on hQC in transfected HEK293T cells, which were treated for 24 h at the concentrations of 1, 10, 50, and 100 μM; (C) quantification of the pE-Aβ<sub>3–42</sub> in transfected HEK293T cells, which were treated with <b>28</b> for 24 h at the concentrations of 0, 1, 10, 50, and 100 μM using amyloid-β (N 3pE-42) ELISA kit. All experiments were performed in triplicate. Data are expressed as mean ± SD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00648/20170804/images/large/jm-2017-00648m_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00648&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00648/20170804/images/medium/jm-2017-00648m_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00648/20170804/images/large/jm-2017-00648m_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effects of <b>28</b> on the AD pathogenesis in the B6C3-Tg (APPswe/PSEN1dE9) double-transgenic mice. (A) Determination of QC activities in hippocampus, cortex, and total brain of AD mice treated with <b>28</b> at concentrations of 0 (C), 2 mg (L), and 10 mg/kg weight (H) by intraperitoneal injection for 2 months by SensoLyte green glutaminyl cyclase activity assay kit; (B) determination of QC activities in hippocampus, cortex, and total brain of AD mice by GD-QC assay; (C) quantification of pE-Aβ<sub>3–42</sub> in hippocampus, cortex, and total brain of AD mice using amyloid-β (N3pE-42) ELISA kit; (D) quantification of total soluble Aβs in the supernatants of hippocampus, cortex, and total brain of AD mice using ELISA analysis; (E) immunohistochemical detection of pE-Aβ<sub>3–42</sub> plaques in hippocampus and cortex area in the brain of AD mice; (F) quantification of the pE-Aβ<sub>3–42</sub> plaque load based on the histochemical staining in panel E; (G) immunohistochemical detection of total Aβ plaques in hippocampous and cortex area in the brain of AD mice; (H) quantification of the Aβ plaque load based on the histochemical staining in panel G; (I) evaluation of the house building capacity of the AD mice by Nesting test. To reduce the within group variance, only female mice were used in the study (<i>n</i> = 4 per group). Data are expressed as mean ± SE; * means <i>p</i> < 0.05 versus control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-15/acs.jmedchem.7b00648/20170804/images/large/jm-2017-00648m_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00648&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i75">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64005" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64005" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 35 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Dobson, C. M.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease: addressing a twenty-first century plague</span> <span class="citation_source-journal">Rend. Fis. Accad. Lincei</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">251</span><span class="NLM_x">–</span> <span class="NLM_lpage">262</span><span class="refDoi"> DOI: 10.1007/s12210-015-0453-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=10.1007%2Fs12210-015-0453-y" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2015&pages=251-262&author=C.+M.+Dobson&title=Alzheimer%E2%80%99s+disease%3A+addressing+a+twenty-first+century+plague&doi=10.1007%2Fs12210-015-0453-y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1007%2Fs12210-015-0453-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12210-015-0453-y%26sid%3Dliteratum%253Aachs%26aulast%3DDobson%26aufirst%3DC.%2BM.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520addressing%2520a%2520twenty-first%2520century%2520plague%26jtitle%3DRend.%2520Fis.%2520Accad.%2520Lincei%26date%3D2015%26volume%3D26%26spage%3D251%26epage%3D262%26doi%3D10.1007%2Fs12210-015-0453-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Snyder, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendrix, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bain, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrillo, M. C.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease research in the context of the national plan to address Alzheimer’s disease</span> <span class="citation_source-journal">Mol. Aspects Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">43–44</span><span class="NLM_x">, </span> <span class="NLM_fpage">16</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span><span class="refDoi"> DOI: 10.1016/j.mam.2015.06.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=10.1016%2Fj.mam.2015.06.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=26096321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=1%3ACAS%3A280%3ADC%252BC2MblsFGnsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43%E2%80%9344&publication_year=2015&pages=16-24&author=H.+M.+Snyderauthor=J.+Hendrixauthor=L.+J.+Bainauthor=M.+C.+Carrillo&title=Alzheimer%E2%80%99s+disease+research+in+the+context+of+the+national+plan+to+address+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.mam.2015.06.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease research in the context of the national plan to address Alzheimer's disease</span></div><div class="casAuthors">Snyder Heather M; Hendrix James; Carrillo Maria C; Bain Lisa J</div><div class="citationInfo"><span class="NLM_cas:title">Molecular aspects of medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">43-44</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">16-24</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">In 2012, the first National Plan to Address Alzheimer's Disease in the United States (U.S.) was released, a component of the National Alzheimer's Project Act legislation.  Since that time, there have been incremental increases in U.S. federal funding for Alzheimer's disease and related dementia research, particularly in the areas of biomarker discovery, genetic link and related biological underpinnings, and prevention studies for Alzheimer's.  A central theme in each of these areas has been the emphasis of cross-sector collaboration and private-public partnerships between government, non-profit organizations and for-profit organizations.  This paper will highlight multiple private-public partnerships supporting the advancement of Alzheimer's research in the context of the National Plan to Address Alzheimer's.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQzU-y67cBwVq_dlEzl_fBafW6udTcc2eYB2SUUWyFbmLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MblsFGnsA%253D%253D&md5=872d588c0d16ffe40f650cf876fffd72</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.mam.2015.06.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mam.2015.06.005%26sid%3Dliteratum%253Aachs%26aulast%3DSnyder%26aufirst%3DH.%2BM.%26aulast%3DHendrix%26aufirst%3DJ.%26aulast%3DBain%26aufirst%3DL.%2BJ.%26aulast%3DCarrillo%26aufirst%3DM.%2BC.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%2520research%2520in%2520the%2520context%2520of%2520the%2520national%2520plan%2520to%2520address%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DMol.%2520Aspects%2520Med.%26date%3D2015%26volume%3D43%25E2%2580%259344%26spage%3D16%26epage%3D24%26doi%3D10.1016%2Fj.mam.2015.06.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Eisele, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monteiro, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fearns, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Encalada, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiseman, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, J. W.</span><span> </span><span class="NLM_article-title">Targeting protein aggregation for the treatment of degenerative diseases</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">759</span><span class="NLM_x">–</span> <span class="NLM_lpage">780</span><span class="refDoi"> DOI: 10.1038/nrd4593</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=10.1038%2Fnrd4593" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=26338154" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVCrt7rI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=759-780&author=Y.+S.+Eiseleauthor=C.+Monteiroauthor=C.+Fearnsauthor=S.+E.+Encaladaauthor=R.+L.+Wisemanauthor=E.+T.+Powersauthor=J.+W.+Kelly&title=Targeting+protein+aggregation+for+the+treatment+of+degenerative+diseases&doi=10.1038%2Fnrd4593"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting protein aggregation for the treatment of degenerative diseases</span></div><div class="casAuthors">Eisele, Yvonne S.; Monteiro, Cecilia; Fearns, Colleen; Encalada, Sandra E.; Wiseman, R. Luke; Powers, Evan T.; Kelly, Jeffery W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">759-780</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The aggregation of specific proteins is hypothesized to underlie several degenerative diseases, which are collectively known as amyloid disorders.  However, the mechanistic connection between the process of protein aggregation and tissue degeneration is not yet fully understood.  Here, we review current and emerging strategies to ameliorate aggregation-assocd. degenerative disorders, with a focus on disease-modifying strategies that prevent the formation of and/or eliminate protein aggregates.  Persuasive pharmacol. and genetic evidence now supports protein aggregation as the cause of postmitotic tissue dysfunction or loss.  However, a more detailed understanding of the factors that trigger and sustain aggregate formation and of the structure-activity relationships underlying proteotoxicity is needed to develop future disease-modifying therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom0hmQxYx0MrVg90H21EOLACvtfcHk0lg68Oif2RI-jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVCrt7rI&md5=26a6a0e986547aea92da63242fe02292</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnrd4593&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4593%26sid%3Dliteratum%253Aachs%26aulast%3DEisele%26aufirst%3DY.%2BS.%26aulast%3DMonteiro%26aufirst%3DC.%26aulast%3DFearns%26aufirst%3DC.%26aulast%3DEncalada%26aufirst%3DS.%2BE.%26aulast%3DWiseman%26aufirst%3DR.%2BL.%26aulast%3DPowers%26aufirst%3DE.%2BT.%26aulast%3DKelly%26aufirst%3DJ.%2BW.%26atitle%3DTargeting%2520protein%2520aggregation%2520for%2520the%2520treatment%2520of%2520degenerative%2520diseases%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2015%26volume%3D14%26spage%3D759%26epage%3D780%26doi%3D10.1038%2Fnrd4593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Hamley, I. W.</span><span> </span><span class="NLM_article-title">The amyloid beta peptide: a chemist’s perspective. Role in Alzheimer’s and fibrillization</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">5147</span><span class="NLM_x">–</span> <span class="NLM_lpage">5192</span><span class="refDoi"> DOI: 10.1021/cr3000994</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr3000994" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVKgtLzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2012&pages=5147-5192&author=I.+W.+Hamley&title=The+amyloid+beta+peptide%3A+a+chemist%E2%80%99s+perspective.+Role+in+Alzheimer%E2%80%99s+and+fibrillization&doi=10.1021%2Fcr3000994"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The Amyloid Beta Peptide: A Chemist's Perspective Role in Alzheimer's and Fibrillization</span></div><div class="casAuthors">Hamley, I. W.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5147-5192</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review, discussing the role of fibrillization of the amyloid β (Aβ)-peptide in Alzheimer's disease (AD).  The perspective is that of a phys. chemist, and one aim is to introduce relevant key findings on physicochem. properties.  However, in addn., key aspects of the biol. and biochem. assocd. with the role of Aβ in AD are also summarized (more detailed reviews of these aspects can be found elsewhere), as are developments in potential therapies and biomarkers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4Zs86qZNALbVg90H21EOLACvtfcHk0liVZZhOGrIS_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVKgtLzM&md5=647d2b3f9e9243b3a373f6aadd2d1376</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Fcr3000994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr3000994%26sid%3Dliteratum%253Aachs%26aulast%3DHamley%26aufirst%3DI.%2BW.%26atitle%3DThe%2520amyloid%2520beta%2520peptide%253A%2520a%2520chemist%25E2%2580%2599s%2520perspective.%2520Role%2520in%2520Alzheimer%25E2%2580%2599s%2520and%2520fibrillization%26jtitle%3DChem.%2520Rev.%26date%3D2012%26volume%3D112%26spage%3D5147%26epage%3D5192%26doi%3D10.1021%2Fcr3000994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">LaFerla, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oddo, S.</span><span> </span><span class="NLM_article-title">Intracellular amyloid-beta in Alzheimer’s disease</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">499</span><span class="NLM_x">–</span> <span class="NLM_lpage">509</span><span class="refDoi"> DOI: 10.1038/nrn2168</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=10.1038%2Fnrn2168" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=17551515" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmslWjsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=499-509&author=F.+M.+LaFerlaauthor=K.+N.+Greenauthor=S.+Oddo&title=Intracellular+amyloid-beta+in+Alzheimer%E2%80%99s+disease&doi=10.1038%2Fnrn2168"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Intracellular amyloid-β in Alzheimer's disease</span></div><div class="casAuthors">LaFerla, Frank M.; Green, Kim N.; Oddo, Salvatore</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">499-509</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The primal role that the amyloid-β (Aβ) peptide has in the development of Alzheimer's disease is now almost universally accepted.  It is also well recognized that Aβ exists in multiple assembly states, which have different physiol. or pathophysiol. effects.  Although the classical view is that Aβ is deposited extracellularly, emerging evidence from transgenic mice and human patients indicates that this peptide can also accumulate intraneuronally, which may contribute to disease progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_7YmF12y-hbVg90H21EOLACvtfcHk0liVZZhOGrIS_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmslWjsr8%253D&md5=35993dacf1599863e6e1a8ac508c4dc0</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrn2168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn2168%26sid%3Dliteratum%253Aachs%26aulast%3DLaFerla%26aufirst%3DF.%2BM.%26aulast%3DGreen%26aufirst%3DK.%2BN.%26aulast%3DOddo%26aufirst%3DS.%26atitle%3DIntracellular%2520amyloid-beta%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2007%26volume%3D8%26spage%3D499%26epage%3D509%26doi%3D10.1038%2Fnrn2168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Demetrius, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Driver, J. A.</span><span> </span><span class="NLM_article-title">Preventing Alzheimer’s disease by means of natural selection</span> <span class="citation_source-journal">J. R. Soc., Interface</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">20140919</span><span class="refDoi"> DOI: 10.1098/rsif.2014.0919</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=10.1098%2Frsif.2014.0919" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=25551134" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=1%3ACAS%3A280%3ADC%252BC2MvivFCisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=20140919&author=L.+A.+Demetriusauthor=J.+A.+Driver&title=Preventing+Alzheimer%E2%80%99s+disease+by+means+of+natural+selection&doi=10.1098%2Frsif.2014.0919"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Preventing Alzheimer's disease by means of natural selection</span></div><div class="casAuthors">Demetrius Lloyd A; Driver Jane A</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Royal Society, Interface</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">102</span>),
    <span class="NLM_cas:pages">20140919</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The amyloid cascade model for the origin of sporadic forms of Alzheimer's disease (AD) posits that the imbalance in the production and clearance of beta-amyloid is a necessary condition for the disease.  A competing theory called the entropic selection hypothesis asserts that the primary cause of sporadic AD is age-induced mitochondrial dysregulation and the following cascade of events: (i) metabolic reprogramming--the upregulation of oxidative phosphorylation in compensation for insufficient energy production in neurons, (ii) natural selection--competition between intact and reprogrammed neurons for energy substrates and (iii) propagation--the spread of the disease due to the selective advantage of neurons with upregulated metabolism.  Experimental studies to evaluate the predictions of the amyloid cascade model are being continually retuned to accommodate conflicts of the predictions with empirical data.  Clinical trials of treatments for AD based on anti-amyloid therapy have been unsuccessful.  We contend that these anomalies and failures stem from a fundamental deficit of the amyloid hypothesis: the model derives from a nuclear-genomic perspective of sporadic AD and discounts the bioenergetic processes that characterize the progression of most age-related disorders.  In this article, we review the anomalies of the amyloid model and the theoretical and empirical support for the entropic selection theory.  We also discuss the new therapeutic strategies based on natural selection which the model proposes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRiZ6E5KZeY3JVVjGoY74BafW6udTcc2eZOO5N44MrzHLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MvivFCisA%253D%253D&md5=dad1b98deb282cfddcf0c8a1f1325495</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1098%2Frsif.2014.0919&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1098%252Frsif.2014.0919%26sid%3Dliteratum%253Aachs%26aulast%3DDemetrius%26aufirst%3DL.%2BA.%26aulast%3DDriver%26aufirst%3DJ.%2BA.%26atitle%3DPreventing%2520Alzheimer%25E2%2580%2599s%2520disease%2520by%2520means%2520of%2520natural%2520selection%26jtitle%3DJ.%2520R.%2520Soc.%252C%2520Interface%26date%3D2015%26volume%3D12%26spage%3D20140919%26doi%3D10.1098%2Frsif.2014.0919" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Bayer, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wirths, O.</span><span> </span><span class="NLM_article-title">Focusing the amyloid cascade hypothesis on N-truncated Abeta peptides as drug targets against Alzheimer’s disease</span> <span class="citation_source-journal">Acta Neuropathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">787</span><span class="NLM_x">–</span> <span class="NLM_lpage">801</span><span class="refDoi"> DOI: 10.1007/s00401-014-1287-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=10.1007%2Fs00401-014-1287-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=24803226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnvVSrsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2014&pages=787-801&author=T.+A.+Bayerauthor=O.+Wirths&title=Focusing+the+amyloid+cascade+hypothesis+on+N-truncated+Abeta+peptides+as+drug+targets+against+Alzheimer%E2%80%99s+disease&doi=10.1007%2Fs00401-014-1287-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Focusing the amyloid cascade hypothesis on N-truncated Abeta peptides as drug targets against Alzheimer's disease</span></div><div class="casAuthors">Bayer, Thomas A.; Wirths, Oliver</div><div class="citationInfo"><span class="NLM_cas:title">Acta Neuropathologica</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">787-801</span>CODEN:
                <span class="NLM_cas:coden">ANPTAL</span>;
        ISSN:<span class="NLM_cas:issn">0001-6322</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Although N-truncated Aβ variants are known to be the main constituent of amyloid plaques in the brains of patients with Alzheimer's disease, their potential as targets for pharmacol. intervention has only recently been investigated.  In the last few years, the Alzheimer field has experienced a paradigm shift with the ever increasing understanding that targeting amyloid plaques has not led to a successful immunotherapy.  On the other hand, there can be no doubt that the amyloid cascade hypothesis is central to the etiol. of Alzheimer's disease, raising the question as to why it is apparently failing to translate into the clinic.  In this review, we aim to refocus the amyloid hypothesis integrating N-truncated Aβ peptides based on mounting evidence that they may represent better targets than full-length Aβ.  In addn. to Aβ peptides starting with an Asp at position 1, a variety of different N-truncated Aβ peptides have been identified starting with amino residue Ala-2, pyroglutamylated Glu-3, Phe-4, Arg-5, His-6, Asp-7, Ser-8, Gly-9, Tyr-10 and pyroglutamylated Glu-11.  Certain forms of N-truncated species are better correlates for early pathol. changes found pre-symptomatically more often than others.  There is also evidence that, together with full-length Aβ, they might be physiol. detectable and are naturally secreted by neurons.  Others are known to form sol. aggregates, which have neurotoxic properties in transgenic mouse models.  It has been clearly demonstrated by several groups that some N-truncated Aβs dominate full-length Aβ in the brains of Alzheimer's patients.  We try to address which of the N-truncated variants may be promising therapeutic targets and which enzymes might be involved in the generation of these peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpONpP9jWQ-X7Vg90H21EOLACvtfcHk0lj-zG7MfdcuVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnvVSrsLs%253D&md5=5374727ba0b50e40ed87a122da1c65bd</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1007%2Fs00401-014-1287-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00401-014-1287-x%26sid%3Dliteratum%253Aachs%26aulast%3DBayer%26aufirst%3DT.%2BA.%26aulast%3DWirths%26aufirst%3DO.%26atitle%3DFocusing%2520the%2520amyloid%2520cascade%2520hypothesis%2520on%2520N-truncated%2520Abeta%2520peptides%2520as%2520drug%2520targets%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DActa%2520Neuropathol.%26date%3D2014%26volume%3D127%26spage%3D787%26epage%3D801%26doi%3D10.1007%2Fs00401-014-1287-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Mehta, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Short, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilmer, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolazzo, J. A.</span><span> </span><span class="NLM_article-title">Drug access to the central nervous system in Alzheimer’s disease: preclinical and clinical insights</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">819</span><span class="NLM_x">–</span> <span class="NLM_lpage">839</span><span class="refDoi"> DOI: 10.1007/s11095-014-1522-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=10.1007%2Fs11095-014-1522-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2015&pages=819-839&author=D.+C.+Mehtaauthor=J.+L.+Shortauthor=S.+N.+Hilmerauthor=J.+A.+Nicolazzo&title=Drug+access+to+the+central+nervous+system+in+Alzheimer%E2%80%99s+disease%3A+preclinical+and+clinical+insights&doi=10.1007%2Fs11095-014-1522-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1007%2Fs11095-014-1522-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11095-014-1522-0%26sid%3Dliteratum%253Aachs%26aulast%3DMehta%26aufirst%3DD.%2BC.%26aulast%3DShort%26aufirst%3DJ.%2BL.%26aulast%3DHilmer%26aufirst%3DS.%2BN.%26aulast%3DNicolazzo%26aufirst%3DJ.%2BA.%26atitle%3DDrug%2520access%2520to%2520the%2520central%2520nervous%2520system%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520preclinical%2520and%2520clinical%2520insights%26jtitle%3DPharm.%2520Res.%26date%3D2015%26volume%3D32%26spage%3D819%26epage%3D839%26doi%3D10.1007%2Fs11095-014-1522-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Saido, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwatsubo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mann, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawashima, S.</span><span> </span><span class="NLM_article-title">Dominant and differential deposition of distinct beta-amyloid peptide species, A beta N3(pE), in senile plaques</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">457</span><span class="NLM_x">–</span> <span class="NLM_lpage">466</span><span class="refDoi"> DOI: 10.1016/0896-6273(95)90301-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=10.1016%2F0896-6273%2895%2990301-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=7857653" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=1%3ACAS%3A528%3ADyaK2MXjvFejsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1995&pages=457-466&author=T.+C.+Saidoauthor=T.+Iwatsuboauthor=D.+M.+Mannauthor=H.+Shimadaauthor=Y.+Iharaauthor=S.+Kawashima&title=Dominant+and+differential+deposition+of+distinct+beta-amyloid+peptide+species%2C+A+beta+N3%28pE%29%2C+in+senile+plaques&doi=10.1016%2F0896-6273%2895%2990301-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Dominant and differential deposition of distinct β-amyloid peptide species, AβN3(pE), in senile plaques</span></div><div class="casAuthors">Saido, Takaomi C.; Iwatsubo, Takeshi; Mann, David M. A.; Shimada, Hiroyuki; Ihara, Yasuo; Kawashima, Selichi</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">457-66</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">We analyzed an amino-terminal modification of β-amyloid (Aβ) peptide in brain, using anti-Aβ antibodies that distinguish distinct mol. species.  Examn. of cortical sections from 28 aged individuals with a wide range in senile plaque d. revealed that a mol. species distinct from the std. Aβ is deposited in the brain in a dominant and differential manner.  This modified Aβ peptide (AβN3(pE)) starts at the 3rd amino-terminal residue of the std. αβ, glutamate, converted to pyroglutamate through intramol. dehydration.  Because plaques composed of αβN3(pE) are present in equiv. or greater densities than those composed of std. Aβ bearing the first amino-terminal residue (AβN1) and because deposition of the former species appears to precede deposition of the latter, as confirmed with specimens from Down's syndrome patients, the processes involved in AβNe(pE) prodn. and retention may play an early and crit. role in senile plaque formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEs7XnR_KCcbVg90H21EOLACvtfcHk0lj-zG7MfdcuVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjvFejsLk%253D&md5=8405ddfabcebe721ccd5b1dc1e222069</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2F0896-6273%2895%2990301-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0896-6273%252895%252990301-1%26sid%3Dliteratum%253Aachs%26aulast%3DSaido%26aufirst%3DT.%2BC.%26aulast%3DIwatsubo%26aufirst%3DT.%26aulast%3DMann%26aufirst%3DD.%2BM.%26aulast%3DShimada%26aufirst%3DH.%26aulast%3DIhara%26aufirst%3DY.%26aulast%3DKawashima%26aufirst%3DS.%26atitle%3DDominant%2520and%2520differential%2520deposition%2520of%2520distinct%2520beta-amyloid%2520peptide%2520species%252C%2520A%2520beta%2520N3%2528pE%2529%252C%2520in%2520senile%2520plaques%26jtitle%3DNeuron%26date%3D1995%26volume%3D14%26spage%3D457%26epage%3D466%26doi%3D10.1016%2F0896-6273%2895%2990301-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Wirths, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillmann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pradier, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartig, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayer, T. A.</span><span> </span><span class="NLM_article-title">Oligomeric pyroglutamate amyloid-beta is present in microglia and a subfraction of vessels in patients with Alzheimer’s disease: implications for immunotherapy</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">741</span><span class="NLM_x">–</span> <span class="NLM_lpage">749</span><span class="refDoi"> DOI: 10.3233/JAD-121945</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=10.3233%2FJAD-121945" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=23481684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=1%3ACAS%3A280%3ADC%252BC3svltlWhsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2013&pages=741-749&author=O.+Wirthsauthor=A.+Hillmannauthor=L.+Pradierauthor=W.+Hartigauthor=T.+A.+Bayer&title=Oligomeric+pyroglutamate+amyloid-beta+is+present+in+microglia+and+a+subfraction+of+vessels+in+patients+with+Alzheimer%E2%80%99s+disease%3A+implications+for+immunotherapy&doi=10.3233%2FJAD-121945"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Oligomeric pyroglutamate amyloid-β is present in microglia and a subfraction of vessels in patients with Alzheimer's disease: implications for immunotherapy</span></div><div class="casAuthors">Wirths Oliver; Hillmann Antje; Pradier Laurent; Hartig Wolfgang; Bayer Thomas A</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's disease : JAD</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">741-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">N-terminally truncated pyroglutamate amyloid-β (Aβ) starting at position 3 (AβpE3) represents a major fraction of Aβ peptides in Alzheimer's disease (AD).  Recently, we have identified low molecular weight AβpE3 oligomers, which can be detected by 9D5, a novel mouse monoclonal antibody.  In the present study, we analyzed the immunohistochemical staining profile in the brain of patients with AD and in the APP/PS1KI mouse model, as well as in aged rhesus monkeys. 9D5-positive microglia and blood vessels were found in many AD cases, in the transgenic mouse model, and in an aged macaque.  The presence of 9D5-immunoreactivity in microglia indicates that low molecular weight AβpE3 oligomers may be phagocytosed, since in the APP/PS1KI model, Aβ is exclusively produced in neurons due to neuronal expression of transgenic AβPP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSSrGT8hETg2JZoeNcnHOQ9fW6udTcc2eZx4cy0Snwen7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3svltlWhsg%253D%253D&md5=944c79a17a2570d10b12d39fdf73c264</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.3233%2FJAD-121945&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-121945%26sid%3Dliteratum%253Aachs%26aulast%3DWirths%26aufirst%3DO.%26aulast%3DHillmann%26aufirst%3DA.%26aulast%3DPradier%26aufirst%3DL.%26aulast%3DHartig%26aufirst%3DW.%26aulast%3DBayer%26aufirst%3DT.%2BA.%26atitle%3DOligomeric%2520pyroglutamate%2520amyloid-beta%2520is%2520present%2520in%2520microglia%2520and%2520a%2520subfraction%2520of%2520vessels%2520in%2520patients%2520with%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520implications%2520for%2520immunotherapy%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2013%26volume%3D35%26spage%3D741%26epage%3D749%26doi%3D10.3233%2FJAD-121945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Gunn, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masters, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherny, R. A.</span><span> </span><span class="NLM_article-title">Pyroglutamate-Abeta: role in the natural history of Alzheimer’s disease</span> <span class="citation_source-journal">Int. J. Biochem. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1915</span><span class="NLM_x">–</span> <span class="NLM_lpage">1918</span><span class="refDoi"> DOI: 10.1016/j.biocel.2010.08.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=10.1016%2Fj.biocel.2010.08.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=20833262" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtl2itLrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2010&pages=1915-1918&author=A.+P.+Gunnauthor=C.+L.+Mastersauthor=R.+A.+Cherny&title=Pyroglutamate-Abeta%3A+role+in+the+natural+history+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.biocel.2010.08.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Pyroglutamate-Aβ: Role in the natural history of Alzheimer's disease</span></div><div class="casAuthors">Gunn, Adam P.; Masters, Colin L.; Cherny, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biochemistry & Cell Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1915-1918</span>CODEN:
                <span class="NLM_cas:coden">IJBBFU</span>;
        ISSN:<span class="NLM_cas:issn">1357-2725</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The accumulation of amyloid-beta (Aβ) peptides is believed to be a central contributor to the neurodegeneration typically seen in Alzheimer's disease (AD) brain.  Aβ extd. from AD brains invariably possesses extensive truncations, yielding peptides of differing N- and C-terminal compn.  While Aβ is often abundant in the brains of cognitively normal elderly people, the brains of AD patients are highly enriched for N-terminally truncated Aβ bearing the pyroglutamate modification.  Pyroglutamate-Aβ (pE-Aβ) has a higher propensity for oligomerization and aggregation than full-length Aβ, potentially seeding the accumulation of neurotoxic Aβ oligomers and amyloid deposits.  In addn., pE-Aβ has increased resistance to clearance by peptidases, causing these peptides to persist in biol. fluids and tissues.  The extensive deposition of pE-Aβ in human AD brain is under-represented in many transgenic mouse models of AD, reflecting major differences in the prodn. and processing of Aβ peptides in these models compared to the human disease state.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorztlGScimnrVg90H21EOLACvtfcHk0ljiEsMD7Sxj6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtl2itLrO&md5=1139e1d56c89eed8e3ac3b08bd3b89ed</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.biocel.2010.08.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biocel.2010.08.015%26sid%3Dliteratum%253Aachs%26aulast%3DGunn%26aufirst%3DA.%2BP.%26aulast%3DMasters%26aufirst%3DC.%2BL.%26aulast%3DCherny%26aufirst%3DR.%2BA.%26atitle%3DPyroglutamate-Abeta%253A%2520role%2520in%2520the%2520natural%2520history%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DInt.%2520J.%2520Biochem.%2520Cell%2520Biol.%26date%3D2010%26volume%3D42%26spage%3D1915%26epage%3D1918%26doi%3D10.1016%2Fj.biocel.2010.08.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Schlenzig, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manhart, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cinar, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleinschmidt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hause, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willbold, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funke, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schilling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demuth, H. U.</span><span> </span><span class="NLM_article-title">Pyroglutamate formation influences solubility and amyloidogenicity of amyloid peptides</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7072</span><span class="NLM_x">–</span> <span class="NLM_lpage">7078</span><span class="refDoi"> DOI: 10.1021/bi900818a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi900818a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnvFWkurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=7072-7078&author=D.+Schlenzigauthor=S.+Manhartauthor=Y.+Cinarauthor=M.+Kleinschmidtauthor=G.+Hauseauthor=D.+Willboldauthor=S.+A.+Funkeauthor=S.+Schillingauthor=H.+U.+Demuth&title=Pyroglutamate+formation+influences+solubility+and+amyloidogenicity+of+amyloid+peptides&doi=10.1021%2Fbi900818a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Pyroglutamate Formation Influences Solubility and Amyloidogenicity of Amyloid Peptides</span></div><div class="casAuthors">Schlenzig, Dagmar; Manhart, Susanne; Cinar, Yeliz; Kleinschmidt, Martin; Hause, Gerd; Willbold, Dieter; Funke, Susanne Aileen; Schilling, Stephan; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">7072-7078</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">N-Terminally truncated and pyroglutamate (pGlu) modified amyloid β (Aβ) peptides are major constituents of amyloid deposits in sporadic and inherited Alzheimer's disease (AD).  Formation of pGlu at the N-terminus confers resistance against cleavage by most aminopeptidases, increases toxicity of the peptides, and may seed Aβ aggregate formation.  Similarly, the deposited amyloid peptides ABri and ADan, which cause a very similar histopathol. in familial British dementia (FBD) and familial Danish dementia (FDD), are N-terminally blocked by pGlu.  Triggered by the coincidence of pGlu-modified amyloid peptides and similar pathol. in AD, FBD, and FDD, we investigated the impact of N-terminal pGlu on biochem. and biophys. properties of Aβ, ABri, and ADan.  N-Terminal pGlu increases the hydrophobicity and changes the pH-dependent soly. profile, rendering the pGlu-modified peptides less sol. in the basic pH range.  The pGlu residue increases the aggregation propensity of all amyloid peptides as evidenced by ThT fluorescence assays and dynamic light scattering.  The far-UV CD spectroscopic anal. points toward an enhanced β-sheet structure of the pGlu-Aβ.  Importantly, changes in fibril morphol. are clearly caused by the N-terminal pGlu, resulting in the formation of short fibers, which are frequently arranged in bundles.  The effect of pGlu on the morphol. is virtually indistinguishable between ABri, ADan, and Aβ.  The data provide evidence for a comparable influence of the pGlu modification on the aggregation process of structurally different amyloid peptides, thus likely contributing to the molecularly distinct neurodegenerative diseases AD, FBD, and FDD.  The main driving force for the aggregation is apparently an increase in the hydrophobicity and thus an accelerated seed formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo01m64gYKSRLVg90H21EOLACvtfcHk0ljiEsMD7Sxj6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnvFWkurk%253D&md5=f32a500d5c6e5f44fa2809256c8a90ca</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fbi900818a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi900818a%26sid%3Dliteratum%253Aachs%26aulast%3DSchlenzig%26aufirst%3DD.%26aulast%3DManhart%26aufirst%3DS.%26aulast%3DCinar%26aufirst%3DY.%26aulast%3DKleinschmidt%26aufirst%3DM.%26aulast%3DHause%26aufirst%3DG.%26aulast%3DWillbold%26aufirst%3DD.%26aulast%3DFunke%26aufirst%3DS.%2BA.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DPyroglutamate%2520formation%2520influences%2520solubility%2520and%2520amyloidogenicity%2520of%2520amyloid%2520peptides%26jtitle%3DBiochemistry%26date%3D2009%26volume%3D48%26spage%3D7072%26epage%3D7078%26doi%3D10.1021%2Fbi900818a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Nussbaum, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schilling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cynis, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silva, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swanson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wangsanut, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tayler, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiltgen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatami, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ronicke, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reymann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutter-Paier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexandru, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagla, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graubner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glabe, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demuth, H. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bloom, G. S.</span><span> </span><span class="NLM_article-title">Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-beta</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">485</span><span class="NLM_x">, </span> <span class="NLM_fpage">651</span><span class="NLM_x">–</span> <span class="NLM_lpage">655</span><span class="refDoi"> DOI: 10.1038/nature11060</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=10.1038%2Fnature11060" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=22660329" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=1%3ACAS%3A528%3ADC%252BC38XnvVymsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=485&publication_year=2012&pages=651-655&author=J.+M.+Nussbaumauthor=S.+Schillingauthor=H.+Cynisauthor=A.+Silvaauthor=E.+Swansonauthor=T.+Wangsanutauthor=K.+Taylerauthor=B.+Wiltgenauthor=A.+Hatamiauthor=R.+Ronickeauthor=K.+Reymannauthor=B.+Hutter-Paierauthor=A.+Alexandruauthor=W.+Jaglaauthor=S.+Graubnerauthor=C.+G.+Glabeauthor=H.+U.+Demuthauthor=G.+S.+Bloom&title=Prion-like+behaviour+and+tau-dependent+cytotoxicity+of+pyroglutamylated+amyloid-beta&doi=10.1038%2Fnature11060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Prion-like behavior and tau-dependent cytotoxicity of pyroglutamylated amyloid-β</span></div><div class="casAuthors">Nussbaum, Justin M.; Schilling, Stephan; Cynis, Holger; Silva, Antonia; Swanson, Eric; Wangsanut, Tanaporn; Tayler, Kaycie; Wiltgen, Brian; Hatami, Asa; Roenicke, Raik; Reymann, Klaus; Hutter-Paier, Birgit; Alexandru, Anca; Jagla, Wolfgang; Graubner, Sigrid; Glabe, Charles G.; Demuth, Hans-Ulrich; Bloom, George S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">485</span>
        (<span class="NLM_cas:issue">7400</span>),
    <span class="NLM_cas:pages">651-655</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Extracellular plaques of amyloid-β and intraneuronal neurofibrillary tangles made from tau are the histopathol. signatures of Alzheimer's disease.  Plaques comprise amyloid-β fibrils that assemble from monomeric and oligomeric intermediates, and are prognostic indicators of Alzheimer's disease.  Despite the importance of plaques to Alzheimer's disease, oligomers are considered to be the principal toxic forms of amyloid-β.  Interestingly, many adverse responses to amyloid-β, such as cytotoxicity, microtubule loss, impaired memory and learning, and neuritic degeneration, are greatly amplified by tau expression.  Amino-terminally truncated, pyroglutamylated (pE) forms of amyloid-β are strongly assocd. with Alzheimer's disease, are more toxic than amyloid-β, residues 1-42 (Aβ1-42) and Aβ1-40, and have been proposed as initiators of Alzheimer's disease pathogenesis.  Here we report a mechanism by which pE-Aβ may trigger Alzheimer's disease.  Aβ3(pE)-42 co-oligomerizes with excess Aβ1-42 to form metastable low-n oligomers (LNOs) that are structurally distinct and far more cytotoxic to cultured neurons than comparable LNOs made from Aβ1-42 alone.  Tau is required for cytotoxicity, and LNOs comprising 5% Aβ3(pE)-42 plus 95% Aβ1-42 (5% pE-Aβ) seed new cytotoxic LNOs through multiple serial dilns. into Aβ1-42 monomers in the absence of addnl. Aβ3(pE)-42.  LNOs isolated from human Alzheimer's disease brain contained Aβ3(pE)-42, and enhanced Aβ3(pE)-42 formation in mice triggered neuron loss and gliosis at 3 mo, but not in a tau-null background.  We conclude that Aβ3(pE)-42 confers tau-dependent neuronal death and causes template-induced misfolding of Aβ1-42 into structurally distinct LNOs that propagate by a prion-like mechanism.  Our results raise the possibility that Aβ3(pE)-42 acts similarly at a primary step in Alzheimer's disease pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotg6vra9ty9rVg90H21EOLACvtfcHk0lhf0__SBUcBLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnvVymsbc%253D&md5=67ba093a16fe5db1bea9f3873bd92ee5</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnature11060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11060%26sid%3Dliteratum%253Aachs%26aulast%3DNussbaum%26aufirst%3DJ.%2BM.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DCynis%26aufirst%3DH.%26aulast%3DSilva%26aufirst%3DA.%26aulast%3DSwanson%26aufirst%3DE.%26aulast%3DWangsanut%26aufirst%3DT.%26aulast%3DTayler%26aufirst%3DK.%26aulast%3DWiltgen%26aufirst%3DB.%26aulast%3DHatami%26aufirst%3DA.%26aulast%3DRonicke%26aufirst%3DR.%26aulast%3DReymann%26aufirst%3DK.%26aulast%3DHutter-Paier%26aufirst%3DB.%26aulast%3DAlexandru%26aufirst%3DA.%26aulast%3DJagla%26aufirst%3DW.%26aulast%3DGraubner%26aufirst%3DS.%26aulast%3DGlabe%26aufirst%3DC.%2BG.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DBloom%26aufirst%3DG.%2BS.%26atitle%3DPrion-like%2520behaviour%2520and%2520tau-dependent%2520cytotoxicity%2520of%2520pyroglutamylated%2520amyloid-beta%26jtitle%3DNature%26date%3D2012%26volume%3D485%26spage%3D651%26epage%3D655%26doi%3D10.1038%2Fnature11060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Schilling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manhart, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demuth, H. U.</span><span> </span><span class="NLM_article-title">Glutaminyl cyclases unfold glutamyl cyclase activity under mild acid conditions</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">563</span><span class="NLM_x">, </span> <span class="NLM_fpage">191</span><span class="NLM_x">–</span> <span class="NLM_lpage">196</span><span class="refDoi"> DOI: 10.1016/S0014-5793(04)00300-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=10.1016%2FS0014-5793%2804%2900300-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=15063747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=1%3ACAS%3A528%3ADC%252BD2cXivVGgsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=563&publication_year=2004&pages=191-196&author=S.+Schillingauthor=T.+Hoffmannauthor=S.+Manhartauthor=M.+Hoffmannauthor=H.+U.+Demuth&title=Glutaminyl+cyclases+unfold+glutamyl+cyclase+activity+under+mild+acid+conditions&doi=10.1016%2FS0014-5793%2804%2900300-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Glutaminyl cyclases unfold glutamyl cyclase activity under mild acid conditions</span></div><div class="casAuthors">Schilling, Stephan; Hoffmann, Torsten; Manhart, Susanne; Hoffmann, Matthias; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">563</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">191-196</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">N-terminal pyroglutamate (pGlu) formation from glutaminyl precursors is a posttranslational event in the processing of bioactive neuropeptides such as TSH-releasing hormone and neurotensin during their maturation in the secretory pathway.  The reaction is facilitated by glutaminyl cyclase (QC), an enzyme highly abundant in mammalian brain.  Here, we describe for the first time that human and papaya QC also catalyze N-terminal glutamate cyclization.  Surprisingly, the enzymic Glu1 conversion is favored at pH 6.0 while Gln1 conversion occurs with an optimum at pH 8.0.  This unexpected finding might be of importance for deciphering the events leading to deposition of highly toxic pyroglutamyl peptides in amyloidotic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUU5BTU0iZI7Vg90H21EOLACvtfcHk0lhf0__SBUcBLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXivVGgsrY%253D&md5=43c6d9f6def6e4a6948171a58e961471</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2FS0014-5793%2804%2900300-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-5793%252804%252900300-X%26sid%3Dliteratum%253Aachs%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DManhart%26aufirst%3DS.%26aulast%3DHoffmann%26aufirst%3DM.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DGlutaminyl%2520cyclases%2520unfold%2520glutamyl%2520cyclase%2520activity%2520under%2520mild%2520acid%2520conditions%26jtitle%3DFEBS%2520Lett.%26date%3D2004%26volume%3D563%26spage%3D191%26epage%3D196%26doi%3D10.1016%2FS0014-5793%2804%2900300-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Schilling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manhart, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludwig, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wasternack, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demuth, H. U.</span><span> </span><span class="NLM_article-title">Substrate specificity of glutaminyl cyclases from plants and animals</span> <span class="citation_source-journal">Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">384</span><span class="NLM_x">, </span> <span class="NLM_fpage">1583</span><span class="NLM_x">–</span> <span class="NLM_lpage">1592</span><span class="refDoi"> DOI: 10.1515/BC.2003.175</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=10.1515%2FBC.2003.175" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=14719800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVSksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=384&publication_year=2003&pages=1583-1592&author=S.+Schillingauthor=S.+Manhartauthor=T.+Hoffmannauthor=H.+H.+Ludwigauthor=C.+Wasternackauthor=H.+U.+Demuth&title=Substrate+specificity+of+glutaminyl+cyclases+from+plants+and+animals&doi=10.1515%2FBC.2003.175"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Substrate specificity of glutaminyl cyclases from plants and animals</span></div><div class="casAuthors">Schilling, Stephan; Manhart, Susanne; Hoffmann, Torsten; Ludwig, Hans-henning; Wasternack, Claus; Demuth, Hans-ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">384</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1583-1592</span>CODEN:
                <span class="NLM_cas:coden">BICHF3</span>;
        ISSN:<span class="NLM_cas:issn">1431-6730</span>.
    
            (<span class="NLM_cas:orgname">Walter de Gruyter GmbH & Co. KG</span>)
        </div><div class="casAbstract">Glutaminyl cyclases (QC) catalyze the intramol. cyclization of N-terminal glutamine residues of peptides and proteins.  For a comparison of the substrate specificity of human and papaya QC enzymes, a novel continuous assay was established by adapting an existing discontinuous method.  Specificity consts. (kcat/Km) of dipeptides and dipeptide surrogates were higher for plant QC, whereas the selectivity for oligopeptides was similar for both enzymes.  However, only the specificity consts. of mammalian QC were dependent on size and compn. of the substrates.  Specificity consts. of both enzymes were equally pH-dependent in the acidic pH-region, revealing a pKa value identical to the pKa of the substrate, suggesting similarities in the substrate conversion mode.  Accordingly, both QCs converted the L-βhomoglutaminyl residue in the peptide H-βhomoGln-Phe-Lys-Arg-Leu-Ala-NH2 and the glutaminyl residues of the branched peptide H-Gln-Lys(Gln)-Arg-Leu-Ala-NH2 as well as the partially cyclized peptide H-Gln-cyclo(Nε-Lys-Arg-Pro-Ala-Gly-Phe).  In contrast, only QC from C. papaya was able to cyclize a methylated glutamine residue, while this compd. did not even inhibit human QC-catalysis, suggesting distinct substrate recognition pattern.  The conversion of the potential physiol. substrates [Gln1]-gastrin, [Gln1]-neurotensin and [Gln1]-fertilization promoting peptide indicates that human QC may play a key role in posttranslational modification of most if not all pGlu-contg. hormones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWs7SWbYbyQLVg90H21EOLACvtfcHk0lgJKd1vcKLfaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVSksQ%253D%253D&md5=3e011093800699f46513a309b29647c8</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1515%2FBC.2003.175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252FBC.2003.175%26sid%3Dliteratum%253Aachs%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DManhart%26aufirst%3DS.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DLudwig%26aufirst%3DH.%2BH.%26aulast%3DWasternack%26aufirst%3DC.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DSubstrate%2520specificity%2520of%2520glutaminyl%2520cyclases%2520from%2520plants%2520and%2520animals%26jtitle%3DBiol.%2520Chem.%26date%3D2003%26volume%3D384%26spage%3D1583%26epage%3D1592%26doi%3D10.1515%2FBC.2003.175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Huang, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chou, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A. H.</span><span> </span><span class="NLM_article-title">A conserved hydrogen-bond network in the catalytic centre of animal glutaminyl cyclases is critical for catalysis</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">411</span><span class="NLM_x">, </span> <span class="NLM_fpage">181</span><span class="NLM_x">–</span> <span class="NLM_lpage">190</span><span class="refDoi"> DOI: 10.1042/BJ20071073</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=10.1042%2FBJ20071073" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=18072935" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjt1ers7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=411&publication_year=2008&pages=181-190&author=K.+F.+Huangauthor=Y.+R.+Wangauthor=E.+C.+Changauthor=T.+L.+Chouauthor=A.+H.+Wang&title=A+conserved+hydrogen-bond+network+in+the+catalytic+centre+of+animal+glutaminyl+cyclases+is+critical+for+catalysis&doi=10.1042%2FBJ20071073"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">A conserved hydrogen-bond network in the catalytic centre of animal glutaminyl cyclases is critical for catalysis</span></div><div class="casAuthors">Huang, Kai-Fa; Wang, Yu-Ruei; Chang, En-Cheng; Chou, Tsung-Lin; Wang, Andrew H.-J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">411</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">181-190</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">QCs (glutaminyl cyclases; glutaminyl-peptide cyclotransferases, E.C. 2.3.2.5) catalyze N-terminal pyroglutamate formation in numerous bioactive peptides and proteins.  The enzymes were reported to be involved in several pathol. conditions such as amyloidotic disease, osteoporosis, rheumatoid arthritis and melanoma.  The crystal structure of human QC revealed an unusual H-bond (hydrogen-bond) network in the active site, formed by several highly conserved residues (Ser160, Glu201, Asp248, Asp305 and His319), within which Glu201 and Asp248 were found to bind to substrate.  In the present study we combined steady-state enzyme kinetic and x-ray structural analyses of 11 single-mutation human QCs to investigate the roles of the H-bond network in catalysis.  Our results showed that disrupting one or both of the central H-bonds, i.e., Glu201···Asp305 and Asp248···Asp305, reduced the steady-state catalysis dramatically.  The roles of these two COOH···COOH bonds on catalysis could be partly replaced by COOH···water bonds, but not by COOH···CONH2 bonds, reminiscent of the low-barrier Asp···Asp H-bond in the active site of pepsin-like aspartic peptidases.  Mutations on Asp305, a residue located at the center of the H-bond network, raised the Km value of the enzyme by 4.4-19-fold, but decreased the kcat value by 79-2842-fold, indicating that Asp305 primarily plays a catalytic role.  In addn., results from mutational studies on Ser160 and His319 suggest that these two residues might help to stabilize the conformations of Asp248 and Asp305 resp.  These data allow us to propose an essential proton transfer between Glu201, Asp305 and Asp248 during the catalysis by animal QCs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4EKjUIwutAbVg90H21EOLACvtfcHk0lgJKd1vcKLfaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjt1ers7w%253D&md5=2e5104776acc97f920d9502be3a041b4</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1042%2FBJ20071073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20071073%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DK.%2BF.%26aulast%3DWang%26aufirst%3DY.%2BR.%26aulast%3DChang%26aufirst%3DE.%2BC.%26aulast%3DChou%26aufirst%3DT.%2BL.%26aulast%3DWang%26aufirst%3DA.%2BH.%26atitle%3DA%2520conserved%2520hydrogen-bond%2520network%2520in%2520the%2520catalytic%2520centre%2520of%2520animal%2520glutaminyl%2520cyclases%2520is%2520critical%2520for%2520catalysis%26jtitle%3DBiochem.%2520J.%26date%3D2008%26volume%3D411%26spage%3D181%26epage%3D190%26doi%3D10.1042%2FBJ20071073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Valenti, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanatta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donatelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Innamorati, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pampanin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanusso, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zatta, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carbonare, L. D.</span><span> </span><span class="NLM_article-title">Increased glutaminyl cyclase expression in peripheral blood of Alzheimer’s disease patients</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">263</span><span class="NLM_x">–</span> <span class="NLM_lpage">271</span><span class="refDoi"> DOI: 10.3233/JAD-120517</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=10.3233%2FJAD-120517" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=23207485" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=1%3ACAS%3A528%3ADC%252BC3sXit1Wlu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=263-271&author=M.+T.+Valentiauthor=S.+Bologninauthor=C.+Zanattaauthor=L.+Donatelliauthor=G.+Innamoratiauthor=M.+Pampaninauthor=G.+Zanussoauthor=P.+Zattaauthor=L.+D.+Carbonare&title=Increased+glutaminyl+cyclase+expression+in+peripheral+blood+of+Alzheimer%E2%80%99s+disease+patients&doi=10.3233%2FJAD-120517"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Increased Glutaminyl Cyclase Expression in Peripheral Blood of Alzheimer's Disease Patients</span></div><div class="casAuthors">Valenti, Maria Teresa; Bolognin, Silvia; Zanatta, Cristina; Donatelli, Luca; Innamorati, Giulio; Pampanin, Maria; Zanusso, Gianluigi; Zatta, Paolo; Dalle Carbonare, Luca</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">263-271</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">N-truncated and N-modified forms of amyloid-β (Aβ) peptide are found in diffused and dense core plaques in Alzheimer's disease (AD) brain.  Among them, the most abundant N-truncated peptide starts with pyroglutamyl at residue 3 (AβpE3).  AβpE3 has increased aggregation potential and toxicity and its abundance has been reported to correlate with the severity of the clin. phenotype in AD patients.  N-terminal glutamate conversion generating AβpE3 is catalyzed by glutaminyl cyclase.  This enzyme was found to be upregulated in the cortex of patients with AD.  In the present study, we investigated glutaminyl cyclase mRNA and protein expression in peripheral blood from AD patients and age-matched controls.  Higher levels of glutaminyl cyclase mRNA and protein were present in AD patients compared with controls.  Interestingly, we obsd. a correlation between glutaminyl cyclase expression and the severity of dementia (value of Mini-Mental State Examn.).  Therefore, we propose glutaminyl cyclase dosage in peripheral blood as a potential biomarker of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqs4A4V35WXLrVg90H21EOLACvtfcHk0lgJKd1vcKLfaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXit1Wlu7c%253D&md5=3dbaabc4cc2a16e1b3589040578591c1</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.3233%2FJAD-120517&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-120517%26sid%3Dliteratum%253Aachs%26aulast%3DValenti%26aufirst%3DM.%2BT.%26aulast%3DBolognin%26aufirst%3DS.%26aulast%3DZanatta%26aufirst%3DC.%26aulast%3DDonatelli%26aufirst%3DL.%26aulast%3DInnamorati%26aufirst%3DG.%26aulast%3DPampanin%26aufirst%3DM.%26aulast%3DZanusso%26aufirst%3DG.%26aulast%3DZatta%26aufirst%3DP.%26aulast%3DCarbonare%26aufirst%3DL.%2BD.%26atitle%3DIncreased%2520glutaminyl%2520cyclase%2520expression%2520in%2520peripheral%2520blood%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520patients%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2013%26volume%3D34%26spage%3D263%26epage%3D271%26doi%3D10.3233%2FJAD-120517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Schilling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeitschel, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiser, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francke, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kehlen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holzer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutter-Paier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prokesch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Windisch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagla, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlenzig, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudolph, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reuter, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cynis, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montag, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demuth, H. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossner, S.</span><span> </span><span class="NLM_article-title">Glutaminyl cyclase inhibition attenuates pyroglutamate Abeta and Alzheimer’s disease-like pathology</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1106</span><span class="NLM_x">–</span> <span class="NLM_lpage">1111</span><span class="refDoi"> DOI: 10.1038/nm.1872</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=10.1038%2Fnm.1872" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=18836460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Slu7zL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=1106-1111&author=S.+Schillingauthor=U.+Zeitschelauthor=T.+Hoffmannauthor=U.+Heiserauthor=M.+Franckeauthor=A.+Kehlenauthor=M.+Holzerauthor=B.+Hutter-Paierauthor=M.+Prokeschauthor=M.+Windischauthor=W.+Jaglaauthor=D.+Schlenzigauthor=C.+Lindnerauthor=T.+Rudolphauthor=G.+Reuterauthor=H.+Cynisauthor=D.+Montagauthor=H.+U.+Demuthauthor=S.+Rossner&title=Glutaminyl+cyclase+inhibition+attenuates+pyroglutamate+Abeta+and+Alzheimer%E2%80%99s+disease-like+pathology&doi=10.1038%2Fnm.1872"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Glutaminyl cyclase inhibition attenuates pyroglutamate Aβ and Alzheimer's disease-like pathology</span></div><div class="casAuthors">Schilling, Stephan; Zeitschel, Ulrike; Hoffmann, Torsten; Heiser, Ulrich; Francke, Mike; Kehlen, Astrid; Holzer, Max; Hutter-Paier, Birgit; Prokesch, Manuela; Windisch, Manfred; Jagla, Wolfgang; Schlenzig, Dagmar; Lindner, Christiane; Rudolph, Thomas; Reuter, Gunter; Cynis, Holger; Montag, Dirk; Demuth, Hans-Ulrich; Rossner, Steffen</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1106-1111</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Because of their abundance, resistance to proteolysis, rapid aggregation and neurotoxicity, N-terminally truncated and, in particular, pyroglutamate (pE)-modified Aβ peptides have been suggested as being important in the initiation of pathol. cascades resulting in the development of Alzheimer's disease.  We found that the N-terminal pE-formation is catalyzed by glutaminyl cyclase in vivo.  Glutaminyl cyclase expression was upregulated in the cortices of individuals with Alzheimer's disease and correlated with the appearance of pE-modified Aβ.  Oral application of a glutaminyl cyclase inhibitor resulted in reduced Aβ3(pE)-42 burden in two different transgenic mouse models of Alzheimer's disease and in a new Drosophila model.  Treatment of mice was accompanied by redns. in Aβx-40/42, diminished plaque formation and gliosis and improved performance in context memory and spatial learning tests.  These observations are consistent with the hypothesis that Aβ3(pE)-42 acts as a seed for Aβ aggregation by self-aggregation and co-aggregation with Aβ1-40/42.  Therefore, Aβ3(pE)-40/42 peptides seem to represent Aβ forms with exceptional potency for disturbing neuronal function.  The redn. of brain pE-Aβ by inhibition of glutaminyl cyclase offers a new therapeutic option for the treatment of Alzheimer's disease and provides implications for other amyloidoses, such as familial Danish dementia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQl4XiuOJSmrVg90H21EOLACvtfcHk0lgVY5NekofDrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Slu7zL&md5=30f8f53b27c6c9580fe71f867e1ab670</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fnm.1872&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.1872%26sid%3Dliteratum%253Aachs%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DZeitschel%26aufirst%3DU.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DHeiser%26aufirst%3DU.%26aulast%3DFrancke%26aufirst%3DM.%26aulast%3DKehlen%26aufirst%3DA.%26aulast%3DHolzer%26aufirst%3DM.%26aulast%3DHutter-Paier%26aufirst%3DB.%26aulast%3DProkesch%26aufirst%3DM.%26aulast%3DWindisch%26aufirst%3DM.%26aulast%3DJagla%26aufirst%3DW.%26aulast%3DSchlenzig%26aufirst%3DD.%26aulast%3DLindner%26aufirst%3DC.%26aulast%3DRudolph%26aufirst%3DT.%26aulast%3DReuter%26aufirst%3DG.%26aulast%3DCynis%26aufirst%3DH.%26aulast%3DMontag%26aufirst%3DD.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DRossner%26aufirst%3DS.%26atitle%3DGlutaminyl%2520cyclase%2520inhibition%2520attenuates%2520pyroglutamate%2520Abeta%2520and%2520Alzheimer%25E2%2580%2599s%2520disease-like%2520pathology%26jtitle%3DNat.%2520Med.%26date%3D2008%26volume%3D14%26spage%3D1106%26epage%3D1111%26doi%3D10.1038%2Fnm.1872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Schilling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appl, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cynis, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagla, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedrich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wermann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchholz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiser, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Horsten, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demuth, H. U.</span><span> </span><span class="NLM_article-title">Inhibition of glutaminyl cyclase prevents pGlu-Abeta formation after intracortical/hippocampal microinjection in vivo/in situ</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">1225</span><span class="NLM_x">–</span> <span class="NLM_lpage">1236</span><span class="refDoi"> DOI: 10.1111/j.1471-4159.2008.05471.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=10.1111%2Fj.1471-4159.2008.05471.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=18627432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpsFOis7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2008&pages=1225-1236&author=S.+Schillingauthor=T.+Applauthor=T.+Hoffmannauthor=H.+Cynisauthor=K.+Schulzauthor=W.+Jaglaauthor=D.+Friedrichauthor=M.+Wermannauthor=M.+Buchholzauthor=U.+Heiserauthor=S.+von+Horstenauthor=H.+U.+Demuth&title=Inhibition+of+glutaminyl+cyclase+prevents+pGlu-Abeta+formation+after+intracortical%2Fhippocampal+microinjection+in+vivo%2Fin+situ&doi=10.1111%2Fj.1471-4159.2008.05471.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of glutaminyl cyclase prevents pGlu-Aβ formation after intracortical/hippocampal microinjection in vivo/in situ</span></div><div class="casAuthors">Schilling, Stephan; Appl, Thomas; Hoffmann, Torsten; Cynis, Holger; Schulz, Katrin; Jagla, Wolfgang; Friedrich, Daniel; Wermann, Michael; Buchholz, Mirko; Heiser, Ulrich; von Hoersten, Stephan; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1225-1236</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Modified amyloid β (Aβ) peptides represent major constituents of the amyloid deposits in Alzheimer's disease and Down's syndrome.  In particular, N-terminal pyroglutamate (pGlu) following truncation renders Aβ more stable, increases hydrophobicity and the aggregation velocity.  Recent evidence based on in vitro studies suggests that the cyclization of glutamic acid, leading to pGlu-Aβ, is catalyzed by the enzyme glutaminyl cyclase (QC) following limited proteolysis of Aβ at the N-terminus.  Here, we studied the pGlu-formation by rat QC in vitro as well as after microinjection of Aβ(1-40) and Aβ(3-40) into the rat cortex in vivo/in situ with and without pharmacol. QC inhibition.  Significant pGlu-Aβ formation was obsd. following injection of Aβ(3-40) after 24 h, indicating a catalyzed process.  The generation of pGlu-Aβ from Aβ(3-40) was significantly inhibited by intracortical microinjection of a QC inhibitor.  The study provides first evidence that generation of pGlu-Aβ is a QC-catalyzed process in vivo.  The approach per se offers a strategy for a rapid evaluation of compds. targeting a redn. of pGlu formation at the N-terminus of amyloid peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIz9fnOIjlVbVg90H21EOLACvtfcHk0lgVY5NekofDrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpsFOis7Y%253D&md5=8450718510d281c928abaa1e20a870ad</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2008.05471.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2008.05471.x%26sid%3Dliteratum%253Aachs%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DAppl%26aufirst%3DT.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DCynis%26aufirst%3DH.%26aulast%3DSchulz%26aufirst%3DK.%26aulast%3DJagla%26aufirst%3DW.%26aulast%3DFriedrich%26aufirst%3DD.%26aulast%3DWermann%26aufirst%3DM.%26aulast%3DBuchholz%26aufirst%3DM.%26aulast%3DHeiser%26aufirst%3DU.%26aulast%3Dvon%2BHorsten%26aufirst%3DS.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DInhibition%2520of%2520glutaminyl%2520cyclase%2520prevents%2520pGlu-Abeta%2520formation%2520after%2520intracortical%252Fhippocampal%2520microinjection%2520in%2520vivo%252Fin%2520situ%26jtitle%3DJ.%2520Neurochem.%26date%3D2008%26volume%3D106%26spage%3D1225%26epage%3D1236%26doi%3D10.1111%2Fj.1471-4159.2008.05471.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Hennekens, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">A Bensadon, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zivin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaziano, J. M.</span><span> </span><span class="NLM_article-title">Hypothesis: glutaminyl cyclase inhibitors decrease risks of Alzheimer’s disease and related dementias</span> <span class="citation_source-journal">Expert Rev. Neurother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1245</span><span class="NLM_x">–</span> <span class="NLM_lpage">1248</span><span class="refDoi"> DOI: 10.1586/14737175.2015.1088784</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=10.1586%2F14737175.2015.1088784" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=26450764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVGmsrnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=1245-1248&author=C.+H.+Hennekensauthor=B.+A+Bensadonauthor=R.+Zivinauthor=J.+M.+Gaziano&title=Hypothesis%3A+glutaminyl+cyclase+inhibitors+decrease+risks+of+Alzheimer%E2%80%99s+disease+and+related+dementias&doi=10.1586%2F14737175.2015.1088784"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Hypothesis: glutaminyl cyclase inhibitors decrease risks of Alzheimer's disease and related dementias</span></div><div class="casAuthors">Hennekens, Charles H.; Bensadon, Benjamin A.; Zivin, Robert; Gaziano, J. Michael</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Neurotherapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1245-1248</span>CODEN:
                <span class="NLM_cas:coden">ERNXAR</span>;
        ISSN:<span class="NLM_cas:issn">1473-7175</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease and related dementias (ADRD) comprise several progressive and incurable neurodegenerative disorders that some have classified as amyloidosis.  With increased aging of the world's population, the prevalence of the sporadic form of ADRD, which comprises over 99% of cases, continues to rise at an alarming rate.  The enormous societal burdens of ADRD already rival those of the many other major chronic diseases causing premature morbidity and mortality in the USA and worldwide such as cardiovascular disease and cancer.  At present, there is an insufficient totality of evidence concerning the efficacy and safety of any pharmacol. agents to delay slow progression or reduce complications of ADRD.  In this context, glutaminyl cyclase (QC) inhibitors have shown some early possible evidence of efficacy with a reassuring safety profile.  To reliably test the glutaminyl cyclase (QC) and any other promising hypotheses will require cogent data from large-scale randomized trials of sufficient size and duration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrh2s8nTowdx7Vg90H21EOLACvtfcHk0lgVY5NekofDrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVGmsrnI&md5=f098733e6e4f05dce39581b04d5df230</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1586%2F14737175.2015.1088784&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F14737175.2015.1088784%26sid%3Dliteratum%253Aachs%26aulast%3DHennekens%26aufirst%3DC.%2BH.%26aulast%3DA%2BBensadon%26aufirst%3DB.%26aulast%3DZivin%26aufirst%3DR.%26aulast%3DGaziano%26aufirst%3DJ.%2BM.%26atitle%3DHypothesis%253A%2520glutaminyl%2520cyclase%2520inhibitors%2520decrease%2520risks%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520related%2520dementias%26jtitle%3DExpert%2520Rev.%2520Neurother.%26date%3D2015%26volume%3D15%26spage%3D1245%26epage%3D1248%26doi%3D10.1586%2F14737175.2015.1088784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Buchholz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiser, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schilling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niestroj, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zunkel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demuth, H. U.</span><span> </span><span class="NLM_article-title">The first potent inhibitors for human glutaminyl cyclase: synthesis and structure-activity relationship</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">664</span><span class="NLM_x">–</span> <span class="NLM_lpage">677</span><span class="refDoi"> DOI: 10.1021/jm050756e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050756e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=1%3ACAS%3A528%3ADC%252BD28XotlWrug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=664-677&author=M.+Buchholzauthor=U.+Heiserauthor=S.+Schillingauthor=A.+J.+Niestrojauthor=K.+Zunkelauthor=H.+U.+Demuth&title=The+first+potent+inhibitors+for+human+glutaminyl+cyclase%3A+synthesis+and+structure-activity+relationship&doi=10.1021%2Fjm050756e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">The first potent inhibitors for human glutaminyl cyclase: synthesis and structure-activity relationship</span></div><div class="casAuthors">Buchholz, Mirko; Heiser, Ulrich; Schilling, Stephan; Niestroj, Andre J.; Zunkel, Katrin; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">664-677</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The first effective inhibitors for human glutaminyl cyclase (QC) are described.  The structures are developed by applying a ligand-based optimization approach starting from imidazole.  Screening of derivs. of that heterocycle led to compds. of the imidazol-1-yl-alkyl thiourea type as a lead scaffold.  A library of thiourea derivs. was synthesized, resulting in an inhibitory improvement by 2 orders of magnitude, leading to 1-(3-(1H-imidazol-1-yl)propyl)-3-(3,4-dimethoxyphenyl)thiourea as a potent inhibitor.  Systematic exploitation of the scaffold revealed a strong impact on the inhibitory efficacy and resulted in the development of imidazole-propyl-thioamides as another new class of potent inhibitors.  A flexible alignment of the most potent compds. of the thioamide and thiourea class and a QC substrate revealed a good match of characteristic features of the mols., which suggests a similar binding mode of both inhibitors and the substrate to the active site of QC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo88OPnC7vM57Vg90H21EOLACvtfcHk0lgB-ReF7Feqtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotlWrug%253D%253D&md5=584302fd2d356f680bb4df9e10f26b93</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm050756e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050756e%26sid%3Dliteratum%253Aachs%26aulast%3DBuchholz%26aufirst%3DM.%26aulast%3DHeiser%26aufirst%3DU.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DNiestroj%26aufirst%3DA.%2BJ.%26aulast%3DZunkel%26aufirst%3DK.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DThe%2520first%2520potent%2520inhibitors%2520for%2520human%2520glutaminyl%2520cyclase%253A%2520synthesis%2520and%2520structure-activity%2520relationship%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D664%26epage%3D677%26doi%3D10.1021%2Fjm050756e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Buchholz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aust, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandt, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohme, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schilling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demuth, H. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiser, U.</span><span> </span><span class="NLM_article-title">Inhibitors for human glutaminyl cyclase by structure based design and bioisosteric replacement</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">7069</span><span class="NLM_x">–</span> <span class="NLM_lpage">7080</span><span class="refDoi"> DOI: 10.1021/jm900969p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900969p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlagsbnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7069-7080&author=M.+Buchholzauthor=A.+Hamannauthor=S.+Austauthor=W.+Brandtauthor=L.+Bohmeauthor=T.+Hoffmannauthor=S.+Schillingauthor=H.+U.+Demuthauthor=U.+Heiser&title=Inhibitors+for+human+glutaminyl+cyclase+by+structure+based+design+and+bioisosteric+replacement&doi=10.1021%2Fjm900969p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors for Human Glutaminyl Cyclase by Structure Based Design and Bioisosteric Replacement</span></div><div class="casAuthors">Buchholz, Mirko; Hamann, Antje; Aust, Susanne; Brandt, Wolfgang; Boehme, Livia; Hoffmann, Torsten; Schilling, Stephan; Demuth, Hans-Ulrich; Heiser, Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7069-7080</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The inhibition of human glutaminyl cyclase (hQC) has come into focus as a new potential approach for the treatment of Alzheimer's disease.  The hallmark of this principle is the prevention of the formation of Aβ3,11(pE)-40,42, as these Aβ-species were shown to be of elevated neurotoxicity and likely to act as a seeding core leading to an accelerated formation of Aβ-oligomers and fibrils.  Starting from 1-(3-(1H-imidazol-1-yl)propyl)-3-(3,4-dimethoxyphenyl)thiourea, bioisosteric replacements led to the development of new classes of inhibitors.  The optimization of the metal-binding group was achieved by homol. modeling and afforded a first insight into the probable binding mode of the inhibitors in the hQC active site.  The efficacy assessment of the hQC inhibitors was performed in cell culture, directly monitoring the inhibition of Aβ3,11(pE)-40,42 formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZG_jswBXx2LVg90H21EOLACvtfcHk0lgB-ReF7Feqtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlagsbnJ&md5=262248c3c91f344aacb530288aa46471</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm900969p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900969p%26sid%3Dliteratum%253Aachs%26aulast%3DBuchholz%26aufirst%3DM.%26aulast%3DHamann%26aufirst%3DA.%26aulast%3DAust%26aufirst%3DS.%26aulast%3DBrandt%26aufirst%3DW.%26aulast%3DBohme%26aufirst%3DL.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DHeiser%26aufirst%3DU.%26atitle%3DInhibitors%2520for%2520human%2520glutaminyl%2520cyclase%2520by%2520structure%2520based%2520design%2520and%2520bioisosteric%2520replacement%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7069%26epage%3D7080%26doi%3D10.1021%2Fjm900969p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Ramsbeck, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchholz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohme, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demuth, H. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiser, U.</span><span> </span><span class="NLM_article-title">Structure-activity relationships of benzimidazole-based glutaminyl cyclase inhibitors featuring a heteroaryl scaffold</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">6613</span><span class="NLM_x">–</span> <span class="NLM_lpage">6625</span><span class="refDoi"> DOI: 10.1021/jm4001709</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4001709" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFOltrvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=6613-6625&author=D.+Ramsbeckauthor=M.+Buchholzauthor=B.+Kochauthor=L.+Bohmeauthor=T.+Hoffmannauthor=H.+U.+Demuthauthor=U.+Heiser&title=Structure-activity+relationships+of+benzimidazole-based+glutaminyl+cyclase+inhibitors+featuring+a+heteroaryl+scaffold&doi=10.1021%2Fjm4001709"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationships of Benzimidazole-Based Glutaminyl Cyclase Inhibitors Featuring a Heteroaryl Scaffold</span></div><div class="casAuthors">Ramsbeck, Daniel; Buchholz, Mirko; Koch, Birgit; Boehme, Livia; Hoffmann, Torsten; Demuth, Hans-Ulrich; Heiser, Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6613-6625</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Glutaminyl cyclase (hQC) has emerged as a new potential target for the treatment of Alzheimer's disease (AD).  The inhibition of hQC prevents of the formation of the Aβ3(pE)-40,42 species which were shown to be of elevated neurotoxicity and are likely to act as a seeding core, leading to an accelerated formation of Aβ-oligomers and fibrils.  This work presents a new class of inhibitors of hQC, resulting from a pharmacophore-based screen.  Hit mols. were identified, contg. benzimidazole as the metal binding group connected to 1,3,4-oxadiazole as the central scaffold.  The subsequent optimization resulted in benzimidazolyl-1,3,4-thiadiazoles and -1,2,3-triazoles with an inhibitory potency in the nanomolar range.  Further investigation into the potential binding mode of the new compd. classes combined mol. docking and site directed mutagenesis studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrj2cbdhUrX_bVg90H21EOLACvtfcHk0lgB-ReF7Feqtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFOltrvL&md5=eaff2e3df3c955881a158b5efd012c0d</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm4001709&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4001709%26sid%3Dliteratum%253Aachs%26aulast%3DRamsbeck%26aufirst%3DD.%26aulast%3DBuchholz%26aufirst%3DM.%26aulast%3DKoch%26aufirst%3DB.%26aulast%3DBohme%26aufirst%3DL.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DHeiser%26aufirst%3DU.%26atitle%3DStructure-activity%2520relationships%2520of%2520benzimidazole-based%2520glutaminyl%2520cyclase%2520inhibitors%2520featuring%2520a%2520heteroaryl%2520scaffold%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D6613%26epage%3D6625%26doi%3D10.1021%2Fjm4001709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Tran, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoang, V. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorat, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nam, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mook-Jung, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span> </span><span class="NLM_article-title">Structure-activity relationship of human glutaminyl cyclase inhibitors having an N-(5-methyl-1H-imidazol-1-yl)propyl thiourea template</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">3821</span><span class="NLM_x">–</span> <span class="NLM_lpage">3830</span><span class="refDoi"> DOI: 10.1016/j.bmc.2013.04.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=10.1016%2Fj.bmc.2013.04.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=23643900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmvF2mtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=3821-3830&author=P.+T.+Tranauthor=V.+H.+Hoangauthor=S.+A.+Thoratauthor=S.+E.+Kimauthor=J.+Annauthor=Y.+J.+Changauthor=D.+W.+Namauthor=H.+Songauthor=I.+Mook-Jungauthor=J.+Leeauthor=J.+Lee&title=Structure-activity+relationship+of+human+glutaminyl+cyclase+inhibitors+having+an+N-%285-methyl-1H-imidazol-1-yl%29propyl+thiourea+template&doi=10.1016%2Fj.bmc.2013.04.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationship of human glutaminyl cyclase inhibitors having an N-(5-methyl-1H-imidazol-1-yl)propyl thiourea template</span></div><div class="casAuthors">Tran, Phuong-Thao; Hoang, Van-Hai; Thorat, Shivaji A.; Kim, Sung Eun; Ann, Jihyae; Chang, Yu Jin; Nam, Dong Woo; Song, Hyundong; Mook-Jung, Inhee; Lee, Jiyoun; Lee, Jeewoo</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3821-3830</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In an effort to design inhibitors of human glutaminyl cyclase (QC), the authors have synthesized a library of N-aryl N-(5-methyl-1H-imidazol-1-yl)propyl thioureas and investigated the contribution of the aryl region of these compds. to their structure-activity relationships as cyclase inhibitors.  The authors' design was guided by the proposed binding mode of the preferred substrate for the cyclase.  In this series, 1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-3-(3-(5-methyl-1H-imidazol-1-yl)propyl)thiourea (compd. 52) was identified as the most potent QC inhibitor with an IC50 value of 58 nM, which was two-fold more potent than the previously reported lead (II).  Compd. 52 is a most promising candidate for future evaluation to monitor its ability to reduce the formation of pGlu-Aβ and Aβ plaques in cells and transgenic animals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5aCpSObyf3rVg90H21EOLACvtfcHk0lgKPZ_AJJHfug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmvF2mtL0%253D&md5=a8d7ad244e262c7bb26681c64393551a</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.04.005%26sid%3Dliteratum%253Aachs%26aulast%3DTran%26aufirst%3DP.%2BT.%26aulast%3DHoang%26aufirst%3DV.%2BH.%26aulast%3DThorat%26aufirst%3DS.%2BA.%26aulast%3DKim%26aufirst%3DS.%2BE.%26aulast%3DAnn%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DY.%2BJ.%26aulast%3DNam%26aufirst%3DD.%2BW.%26aulast%3DSong%26aufirst%3DH.%26aulast%3DMook-Jung%26aufirst%3DI.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DJ.%26atitle%3DStructure-activity%2520relationship%2520of%2520human%2520glutaminyl%2520cyclase%2520inhibitors%2520having%2520an%2520N-%25285-methyl-1H-imidazol-1-yl%2529propyl%2520thiourea%2520template%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D3821%26epage%3D3830%26doi%3D10.1016%2Fj.bmc.2013.04.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Brooks, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kropog, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quesada, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, P. J.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of [11C]PBD150, a radiolabeled glutaminyl cyclase inhibitor for the potential detection of Alzheimer’s disease prior to amyloid β aggregation</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1065</span><span class="NLM_x">–</span> <span class="NLM_lpage">1068</span><span class="refDoi"> DOI: 10.1039/C5MD00148J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=10.1039%2FC5MD00148J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=26101580" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmvFartLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=1065-1068&author=A.+F.+Brooksauthor=I.+M.+Jacksonauthor=X.+Shaoauthor=G.+W.+Kropogauthor=P.+Shermanauthor=C.+A.+Quesadaauthor=P.+J.+Scott&title=Synthesis+and+evaluation+of+%5B11C%5DPBD150%2C+a+radiolabeled+glutaminyl+cyclase+inhibitor+for+the+potential+detection+of+Alzheimer%E2%80%99s+disease+prior+to+amyloid+%CE%B2+aggregation&doi=10.1039%2FC5MD00148J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of [11C]PBD150, a radiolabeled glutaminyl cyclase inhibitor for the potential detection of Alzheimer's disease prior to amyloid β aggregation</span></div><div class="casAuthors">Brooks, Allen F.; Jackson, Isaac M.; Shao, Xia; Kropog, George W.; Sherman, Phillip; Quesada, Carole A.; Scott, Peter J. H.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1065-1068</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The hydroxy moiety of 1-[3-(1H-imidazol-1-yl)propyl]-3-(4-hydroxy-3-methoxyphenyl)thiourea was selectively carbon-11 labeled to generate [11C]PBD150 in 7.3% yield from [11C]methyl triflate (non-decay cor.; radiochem. purity ≥95%, specific activity = 5.7 Ci μmol-1, n = 5).  Evaluation of [11C]PBD150 by small animal PET imaging (mouse and rat) detd. that it did not permeate the blood brain barrier, indicating that a previously described therapeutic effect in transgenic mice was likely not the result of inhibiting central nervous system glutaminyl cyclase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmg-DpdoFU-7Vg90H21EOLACvtfcHk0lgKPZ_AJJHfug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmvFartLk%253D&md5=eaea24571848b33c06b92756ff873161</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1039%2FC5MD00148J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5MD00148J%26sid%3Dliteratum%253Aachs%26aulast%3DBrooks%26aufirst%3DA.%2BF.%26aulast%3DJackson%26aufirst%3DI.%2BM.%26aulast%3DShao%26aufirst%3DX.%26aulast%3DKropog%26aufirst%3DG.%2BW.%26aulast%3DSherman%26aufirst%3DP.%26aulast%3DQuesada%26aufirst%3DC.%2BA.%26aulast%3DScott%26aufirst%3DP.%2BJ.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520%255B11C%255DPBD150%252C%2520a%2520radiolabeled%2520glutaminyl%2520cyclase%2520inhibitor%2520for%2520the%2520potential%2520detection%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520prior%2520to%2520amyloid%2520%25CE%25B2%2520aggregation%26jtitle%3DMedChemComm%26date%3D2015%26volume%3D6%26spage%3D1065%26epage%3D1068%26doi%3D10.1039%2FC5MD00148J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Huang, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liaw, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chia, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A. H.</span><span> </span><span class="NLM_article-title">Structures of human Golgi-resident glutaminyl cyclase and its complexes with inhibitors reveal a large loop movement upon inhibitor binding</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">12439</span><span class="NLM_x">–</span> <span class="NLM_lpage">12449</span><span class="refDoi"> DOI: 10.1074/jbc.M110.208595</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=10.1074%2Fjbc.M110.208595" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=21288892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVKqu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=12439-12449&author=K.+F.+Huangauthor=S.+S.+Liawauthor=W.+L.+Huangauthor=C.+Y.+Chiaauthor=Y.+C.+Loauthor=Y.+L.+Chenauthor=A.+H.+Wang&title=Structures+of+human+Golgi-resident+glutaminyl+cyclase+and+its+complexes+with+inhibitors+reveal+a+large+loop+movement+upon+inhibitor+binding&doi=10.1074%2Fjbc.M110.208595"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of Human Golgi-resident Glutaminyl Cyclase and its Complexes with Inhibitors Reveal a Large Loop Movement upon Inhibitor Binding</span></div><div class="casAuthors">Huang, Kai-Fa; Liaw, Su-Sen; Huang, Wei-Lin; Chia, Cho-Yun; Lo, Yan-Chung; Chen, Yi-Ling; Wang, Andrew H.-J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">12439-12449</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Aberrant pyroglutamate formation at the N terminus of certain peptides and proteins, catalyzed by glutaminyl cyclases (QCs), is linked to some pathol. conditions, such as Alzheimer disease.  Recently, a glutaminyl cyclase (QC) inhibitor, PBD150, was shown to be able to reduce the deposition of pyroglutamate-modified amyloid-β peptides in brain of transgenic mouse models of Alzheimer disease, leading to a significant improvement of learning and memory in those transgenic animals.  Here, we report the 1.05-1.40 Å resoln. structures, solved by the sulfur single-wavelength anomalous dispersion phasing method, of the Golgi-luminal catalytic domain of the recently identified Golgi-resident QC (gQC) and its complex with PBD150.  We also describe the high-resoln. structures of secretory QC (sQC)-PBD150 complex and two other gQC-inhibitor complexes.  The gQC structure has a scaffold similar to that of sQC but with a relatively wider and neg. charged active site, suggesting a distinct substrate specificity from sQC.  Upon binding to PBD150, a large loop movement in gQC allows the inhibitor to be tightly held in its active site primarily by hydrophobic interactions.  Further comparisons of the inhibitor-bound structures revealed distinct interactions of the inhibitors with gQC and sQC, which are consistent with the results from our inhibitor assays reported here.  Because gQC and sQC may play different biol. roles in vivo, the different inhibitor binding modes allow the design of specific inhibitors toward gQC and sQC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeL8K3B1TxsLVg90H21EOLACvtfcHk0lggbeS_1UDLAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVKqu7c%253D&md5=ef9018b9dc4ff40db7cac0ddac9fadb1</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.208595&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.208595%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DK.%2BF.%26aulast%3DLiaw%26aufirst%3DS.%2BS.%26aulast%3DHuang%26aufirst%3DW.%2BL.%26aulast%3DChia%26aufirst%3DC.%2BY.%26aulast%3DLo%26aufirst%3DY.%2BC.%26aulast%3DChen%26aufirst%3DY.%2BL.%26aulast%3DWang%26aufirst%3DA.%2BH.%26atitle%3DStructures%2520of%2520human%2520Golgi-resident%2520glutaminyl%2520cyclase%2520and%2520its%2520complexes%2520with%2520inhibitors%2520reveal%2520a%2520large%2520loop%2520movement%2520upon%2520inhibitor%2520binding%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D12439%26epage%3D12449%26doi%3D10.1074%2Fjbc.M110.208595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Camps, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Formosa, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galdeano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz-Torrero, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramirez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isambert, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavilla, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clos, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mancini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arce, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez-Franco, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huertas, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dafni, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span> </span><span class="NLM_article-title">Pyrano[3,2-c]quinoline-6-chlorotacrine hybrids as a novel family of acetylcholinesterase- and beta-amyloid-directed anti-Alzheimer compounds</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">5365</span><span class="NLM_x">–</span> <span class="NLM_lpage">5379</span><span class="refDoi"> DOI: 10.1021/jm900859q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900859q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5365-5379&author=P.+Campsauthor=X.+Formosaauthor=C.+Galdeanoauthor=D.+Munoz-Torreroauthor=L.+Ramirezauthor=E.+Gomezauthor=N.+Isambertauthor=R.+Lavillaauthor=A.+Badiaauthor=M.+V.+Closauthor=M.+Bartoliniauthor=F.+Manciniauthor=V.+Andrisanoauthor=M.+P.+Arceauthor=M.+I.+Rodriguez-Francoauthor=O.+Huertasauthor=T.+Dafniauthor=F.+J.+Luque&title=Pyrano%5B3%2C2-c%5Dquinoline-6-chlorotacrine+hybrids+as+a+novel+family+of+acetylcholinesterase-+and+beta-amyloid-directed+anti-Alzheimer+compounds&doi=10.1021%2Fjm900859q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm900859q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900859q%26sid%3Dliteratum%253Aachs%26aulast%3DCamps%26aufirst%3DP.%26aulast%3DFormosa%26aufirst%3DX.%26aulast%3DGaldeano%26aufirst%3DC.%26aulast%3DMunoz-Torrero%26aufirst%3DD.%26aulast%3DRamirez%26aufirst%3DL.%26aulast%3DGomez%26aufirst%3DE.%26aulast%3DIsambert%26aufirst%3DN.%26aulast%3DLavilla%26aufirst%3DR.%26aulast%3DBadia%26aufirst%3DA.%26aulast%3DClos%26aufirst%3DM.%2BV.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DMancini%26aufirst%3DF.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DArce%26aufirst%3DM.%2BP.%26aulast%3DRodriguez-Franco%26aufirst%3DM.%2BI.%26aulast%3DHuertas%26aufirst%3DO.%26aulast%3DDafni%26aufirst%3DT.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26atitle%3DPyrano%255B3%252C2-c%255Dquinoline-6-chlorotacrine%2520hybrids%2520as%2520a%2520novel%2520family%2520of%2520acetylcholinesterase-%2520and%2520beta-amyloid-directed%2520anti-Alzheimer%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D5365%26epage%3D5379%26doi%3D10.1021%2Fjm900859q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Di, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerns, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McConnell, O. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, G. T.</span><span> </span><span class="NLM_article-title">High throughput artificial membrane permeability assay for blood–brain barrier</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">223</span><span class="NLM_x">–</span> <span class="NLM_lpage">232</span><span class="refDoi"> DOI: 10.1016/S0223-5234(03)00012-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=10.1016%2FS0223-5234%2803%2900012-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=12667689" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitlKju7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2003&pages=223-232&author=L.+Diauthor=E.+H.+Kernsauthor=K.+Fanauthor=O.+J.+McConnellauthor=G.+T.+Carter&title=High+throughput+artificial+membrane+permeability+assay+for+blood%E2%80%93brain+barrier&doi=10.1016%2FS0223-5234%2803%2900012-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">High throughput artificial membrane permeability assay for blood-brain barrier</span></div><div class="casAuthors">Di, Li; Kerns, Edward H.; Fan, Kristi; McConnell, Oliver J.; Carter, Guy T.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">223-232</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Editions Scientifiques et Medicales Elsevier</span>)
        </div><div class="casAbstract">The recent advances in high throughput screening for biol. activities and combinatorial chem. have greatly expanded the no. of drug candidates.  Rapid screening for BBB penetration potential early in drug discovery programs provides important information for compd. selection and guidance of synthesis for desirable CNS properties.  In this paper, we discuss a modification of the parallel artificial membrane permeation assay (PAMPA) for the prediction of blood-brain barrier penetration (PAMPA-BBB).  The assay was developed with 30 structurally diverse com. drugs and validated with 14 Wyeth Research compds.  The PAMPA-BBB assay has the advantages of: predicting passive blood-brain barrier penetration with high success, high throughput, low cost, and reproducibility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZCg9Ka4mziLVg90H21EOLACvtfcHk0lgufrnh_EWtbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitlKju7c%253D&md5=d228d5808ba8df23deed92c5e2bf3863</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2FS0223-5234%2803%2900012-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0223-5234%252803%252900012-6%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DKerns%26aufirst%3DE.%2BH.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DMcConnell%26aufirst%3DO.%2BJ.%26aulast%3DCarter%26aufirst%3DG.%2BT.%26atitle%3DHigh%2520throughput%2520artificial%2520membrane%2520permeability%2520assay%2520for%2520blood%25E2%2580%2593brain%2520barrier%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2003%26volume%3D38%26spage%3D223%26epage%3D232%26doi%3D10.1016%2FS0223-5234%2803%2900012-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Zhu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, T.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, K.-K.</span><span> </span><span class="NLM_article-title">A comparative study of artificial membrane permeability assay for high throughput profiling of drug absorption potential</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">399</span><span class="NLM_x">–</span> <span class="NLM_lpage">407</span><span class="refDoi"> DOI: 10.1016/S0223-5234(02)01360-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=10.1016%2FS0223-5234%2802%2901360-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=12008054" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=1%3ACAS%3A528%3ADC%252BD38XjtlKksLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2002&pages=399-407&author=C.+Zhuauthor=L.+Jiangauthor=T.-M.+Chenauthor=K.-K.+Hwang&title=A+comparative+study+of+artificial+membrane+permeability+assay+for+high+throughput+profiling+of+drug+absorption+potential&doi=10.1016%2FS0223-5234%2802%2901360-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">A comparative study of artificial membrane permeability assay for high throughput profiling of drug absorption potential</span></div><div class="casAuthors">Zhu, Chengyue; Jiang, Lan; Chen, Teng-Man; Hwang, Kin-Kai</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">399-407</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Editions Scientifiques et Medicales Elsevier</span>)
        </div><div class="casAbstract">Artificial membrane permeability measurement is a potentially high throughput and low cost alternative for in vitro assessment of drug absorption potential.  It will be an ideal screening/profiling tool in the lead generation program of drug discovery research if it is proven to be generally applicable for classifying drug absorption potential and is advantageous over other in vitro or in silico methods.  This study provides an in-depth evaluation of the method in close comparison to Caco-2, Log D, Log P, polar surface area (PSA), and quant. structure-property relationship (QSPR) predictions using a large and diverse compd. set.  It showed that the accuracy of using artificial membrane permeability in assessing drug absorption is comparable to Caco-2, but significantly better than Log P, Log D, PSA, and QSPR predictions.  This study also explored the artificial membrane compn. by adopting a hydrophilic filter membrane for artificial membrane (lecithin-dodecane) support.  The use of hydrophilic filter membrane increased the rate of permeation significantly and reduced the transport time to 2 h or less as compared with over 10 h when a hydrophobic filter membrane is used.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnV2XGwbLMnLVg90H21EOLACvtfcHk0lgufrnh_EWtbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjtlKksLY%253D&md5=4bfab862f5872f6abf0d0d18f5b5e28f</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2FS0223-5234%2802%2901360-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0223-5234%252802%252901360-0%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DC.%26aulast%3DJiang%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DT.-M.%26aulast%3DHwang%26aufirst%3DK.-K.%26atitle%3DA%2520comparative%2520study%2520of%2520artificial%2520membrane%2520permeability%2520assay%2520for%2520high%2520throughput%2520profiling%2520of%2520drug%2520absorption%2520potential%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2002%26volume%3D37%26spage%3D399%26epage%3D407%26doi%3D10.1016%2FS0223-5234%2802%2901360-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Deacon, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cholerton, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talbot, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nair-Roberts, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanderson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romberg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koros, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bornemann, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rawlins, J. N.</span><span> </span><span class="NLM_article-title">Age-dependent and -independent behavioral deficits in Tg2576 mice</span> <span class="citation_source-journal">Behav. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">189</span><span class="NLM_x">, </span> <span class="NLM_fpage">126</span><span class="NLM_x">–</span> <span class="NLM_lpage">138</span><span class="refDoi"> DOI: 10.1016/j.bbr.2007.12.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=10.1016%2Fj.bbr.2007.12.024" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=189&publication_year=2008&pages=126-138&author=R.+M.+Deaconauthor=L.+L.+Cholertonauthor=K.+Talbotauthor=R.+G.+Nair-Robertsauthor=D.+J.+Sandersonauthor=C.+Rombergauthor=E.+Korosauthor=K.+D.+Bornemannauthor=J.+N.+Rawlins&title=Age-dependent+and+-independent+behavioral+deficits+in+Tg2576+mice&doi=10.1016%2Fj.bbr.2007.12.024"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.bbr.2007.12.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbr.2007.12.024%26sid%3Dliteratum%253Aachs%26aulast%3DDeacon%26aufirst%3DR.%2BM.%26aulast%3DCholerton%26aufirst%3DL.%2BL.%26aulast%3DTalbot%26aufirst%3DK.%26aulast%3DNair-Roberts%26aufirst%3DR.%2BG.%26aulast%3DSanderson%26aufirst%3DD.%2BJ.%26aulast%3DRomberg%26aufirst%3DC.%26aulast%3DKoros%26aufirst%3DE.%26aulast%3DBornemann%26aufirst%3DK.%2BD.%26aulast%3DRawlins%26aufirst%3DJ.%2BN.%26atitle%3DAge-dependent%2520and%2520-independent%2520behavioral%2520deficits%2520in%2520Tg2576%2520mice%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2008%26volume%3D189%26spage%3D126%26epage%3D138%26doi%3D10.1016%2Fj.bbr.2007.12.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Deacon, R. M.</span><span> </span><span class="NLM_article-title">Assessing nest building in mice</span> <span class="citation_source-journal">Nat. Protoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">1117</span><span class="NLM_x">–</span> <span class="NLM_lpage">1119</span><span class="refDoi"> DOI: 10.1038/nprot.2006.170</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=10.1038%2Fnprot.2006.170" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=1117-1119&author=R.+M.+Deacon&title=Assessing+nest+building+in+mice&doi=10.1038%2Fnprot.2006.170"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2006.170&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2006.170%26sid%3Dliteratum%253Aachs%26aulast%3DDeacon%26aufirst%3DR.%2BM.%26atitle%3DAssessing%2520nest%2520building%2520in%2520mice%26jtitle%3DNat.%2520Protoc.%26date%3D2006%26volume%3D1%26spage%3D1117%26epage%3D1119%26doi%3D10.1038%2Fnprot.2006.170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Koch, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchholz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wermann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiser, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schilling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demuth, H. U.</span><span> </span><span class="NLM_article-title">Probing secondary glutaminyl cyclase (QC) inhibitor interactions applying an in silico-modeling/site-directed mutagenesis approach: implications for drug development</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">937</span><span class="NLM_x">–</span> <span class="NLM_lpage">946</span><span class="refDoi"> DOI: 10.1111/cbdd.12046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=10.1111%2Fcbdd.12046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=22967026" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslCmu7fE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2012&pages=937-946&author=B.+Kochauthor=M.+Buchholzauthor=M.+Wermannauthor=U.+Heiserauthor=S.+Schillingauthor=H.+U.+Demuth&title=Probing+secondary+glutaminyl+cyclase+%28QC%29+inhibitor+interactions+applying+an+in+silico-modeling%2Fsite-directed+mutagenesis+approach%3A+implications+for+drug+development&doi=10.1111%2Fcbdd.12046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Probing secondary glutaminyl cyclase (QC) inhibitor interactions applying an in silico-modeling/site-directed mutagenesis approach: implications for drug development</span></div><div class="casAuthors">Koch, Birgit; Buchholz, Mirko; Wermann, Michael; Heiser, Ulrich; Schilling, Stephan; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">937-946</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Glutaminyl cyclases (QCs) catalyze the formation of pyroglutamate-modified amyloid peptides deposited in neurodegenerative disorders such as Alzheimer's disease.  Inhibitors of QC are currently in development as potential therapeutics.  The crystal structures of the potent inhibitor PBD150 bound to human and murine QC (hQC, mQC) have been described recently.  The binding modes of a dimethoxyphenyl moiety of the inhibitor are significantly different between the structures, which contrasts with a similar Ki value.  We show the conformation of PBD150 prone to disturbance by protein-protein interactions within the crystals.  Semi-empirical calcns. of the enzyme-inhibitor interaction within the crystal suggest significant differences in the dissocn. consts. between the binding modes.  To probe for interactions in soln., a site-directed mutagenesis on hQC was performed.  The replacement of F325 and I303 by alanine or asparagine resulted in a 800-fold lower activity of the inhibitor, whereas the exchange of S323 by alanine or valine led to a 20-fold higher activity of PBD150.  The results provide an example of deciphering the interaction mode between a target enzyme and lead substance in soln., if co-crystn. does not mirror such interactions properly.  Thus, the study might provide implications for rapid screening of binding modes also for other drug targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqG1xHVETpdubVg90H21EOLACvtfcHk0ligdcVO3kAbtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslCmu7fE&md5=826cc42ff98381d0a09f6bec93f2a878</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1111%2Fcbdd.12046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcbdd.12046%26sid%3Dliteratum%253Aachs%26aulast%3DKoch%26aufirst%3DB.%26aulast%3DBuchholz%26aufirst%3DM.%26aulast%3DWermann%26aufirst%3DM.%26aulast%3DHeiser%26aufirst%3DU.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DProbing%2520secondary%2520glutaminyl%2520cyclase%2520%2528QC%2529%2520inhibitor%2520interactions%2520applying%2520an%2520in%2520silico-modeling%252Fsite-directed%2520mutagenesis%2520approach%253A%2520implications%2520for%2520drug%2520development%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2012%26volume%3D80%26spage%3D937%26epage%3D946%26doi%3D10.1111%2Fcbdd.12046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Schilling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosche, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manhart, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wasternack, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demuth, H. U.</span><span> </span><span class="NLM_article-title">Heterologous expression and characterization of human glutaminyl cyclase: evidence for a disulfide bond with importance for catalytic activity</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">10849</span><span class="NLM_x">–</span> <span class="NLM_lpage">10857</span><span class="refDoi"> DOI: 10.1021/bi0260381</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi0260381" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=1%3ACAS%3A528%3ADC%252BD38XlvFSmtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2002&pages=10849-10857&author=S.+Schillingauthor=T.+Hoffmannauthor=F.+Roscheauthor=S.+Manhartauthor=C.+Wasternackauthor=H.+U.+Demuth&title=Heterologous+expression+and+characterization+of+human+glutaminyl+cyclase%3A+evidence+for+a+disulfide+bond+with+importance+for+catalytic+activity&doi=10.1021%2Fbi0260381"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Heterologous Expression and Characterization of Human Glutaminyl Cyclase: Evidence for a Disulfide Bond with Importance for Catalytic Activity</span></div><div class="casAuthors">Schilling, Stephan; Hoffmann, Torsten; Rosche, Fred; Manhart, Susanne; Wasternack, Claus; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">10849-10857</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Glutaminyl cyclase (QC, EC 2.3.2.5) catalyzes the formation of pyroglutamate residues from glutamine at the N-terminus of peptides and proteins.  In the current study, human QC was functionally expressed in the secretory pathway of Pichia pastoris, yielding milligram quantities after purifn. from the supernatant of a 5 L fermn.  Initial characterization studies of the recombinant QC using MALDI-TOF mass spectrometry revealed correct proteolytic processing and N-glycosylation at both potential sites with similar 2 kDa extensions.  CD spectral anal. indicated a high α-helical content, which contrasts with plant QC from Carica papaya.  The kinetic parameters for conversion of H-Gln-Tyr-Ala-OH by recombinant human QC were almost identical to those previously reported for purified bovine pituitary QC.  However, the results obtained for conversion of H-Gln-Gln-OH, H-Gln-NH2, and H-Gln-AMC were found to be contradictory to previous studies on human QC expressed intracellularly in E. coli.  Expression of QC in E. coli showed that approx. 50% of the protein did not contain a disulfide bond that is present in the entire QC expressed in P. pastoris.  Further, the enzyme was consistently inactivated by treatment with 15 mM DTT, whereas deglycosylation had no effect on enzymic activity.  Anal. of the fluorescence spectra of the native, reduced, and unfolded human QC point to a conformational change of the protein upon treatment with DTT.  In terms of the different enzymic properties, the consequences of QC expression in different environments are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJohsxahWb8bVg90H21EOLACvtfcHk0ligdcVO3kAbtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlvFSmtro%253D&md5=c7d449a36576aec362a0b17bb7de2d4c</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fbi0260381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi0260381%26sid%3Dliteratum%253Aachs%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DRosche%26aufirst%3DF.%26aulast%3DManhart%26aufirst%3DS.%26aulast%3DWasternack%26aufirst%3DC.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DHeterologous%2520expression%2520and%2520characterization%2520of%2520human%2520glutaminyl%2520cyclase%253A%2520evidence%2520for%2520a%2520disulfide%2520bond%2520with%2520importance%2520for%2520catalytic%2520activity%26jtitle%3DBiochemistry%26date%3D2002%26volume%3D41%26spage%3D10849%26epage%3D10857%26doi%3D10.1021%2Fbi0260381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Ruiz-Carrillo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parthier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wermann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dambe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchholz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludwig, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiser, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahfeld, J. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stubbs, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schilling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demuth, H. U.</span><span> </span><span class="NLM_article-title">Structures of glycosylated mammalian glutaminyl cyclases reveal conformational variability near the active center</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">6280</span><span class="NLM_x">–</span> <span class="NLM_lpage">6288</span><span class="refDoi"> DOI: 10.1021/bi200249h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi200249h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnvF2jsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=6280-6288&author=D.+Ruiz-Carrilloauthor=B.+Kochauthor=C.+Parthierauthor=M.+Wermannauthor=T.+Dambeauthor=M.+Buchholzauthor=H.+H.+Ludwigauthor=U.+Heiserauthor=J.+U.+Rahfeldauthor=M.+T.+Stubbsauthor=S.+Schillingauthor=H.+U.+Demuth&title=Structures+of+glycosylated+mammalian+glutaminyl+cyclases+reveal+conformational+variability+near+the+active+center&doi=10.1021%2Fbi200249h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of Glycosylated Mammalian Glutaminyl Cyclases Reveal Conformational Variability near the Active Center</span></div><div class="casAuthors">Ruiz-Carrillo, David; Koch, Birgit; Parthier, Christoph; Wermann, Michael; Dambe, Tresfore; Buchholz, Mirko; Ludwig, Hans-Henning; Heiser, Ulrich; Rahfeld, Jens-Ulrich; Stubbs, Milton T.; Schilling, Stephan; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">6280-6288</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Formation of N-terminal pyroglutamate (pGlu or pE) from glutaminyl or glutamyl precursors is catalyzed by glutaminyl cyclases (QC).  As the formation of pGlu-amyloid has been linked with Alzheimer's disease, inhibitors of QCs are currently the subject of intense development.  Here, we report three crystal structures of N-glycosylated mammalian QC from humans (hQC) and mice (mQC).  Whereas the overall structures of the enzymes are similar to those reported previously, two surface loops in the neighborhood of the active center exhibit conformational variability.  Furthermore, two conserved cysteine residues form a disulfide bond at the base of the active center that was not present in previous reports of hQC structure.  Site-directed mutagenesis suggests a structure-stabilizing role of the disulfide bond.  At the entrance to the active center, the conserved tryptophan residue, W207, which displayed multiple orientations in previous structure, shows a single conformation in both glycosylated human and murine QCs.  Although mutagenesis of W207 into leucine or glutamine altered substrate conversion significantly, the binding consts. of inhibitors such as the highly potent PQ50 (PBD150) were minimally affected.  The crystal structure of PQ50 bound to the active center of murine QC reveals principal binding determinants provided by the catalytic zinc ion and a hydrophobic funnel.  This study presents a first comparison of two mammalian QCs contg. typical, conserved post-translational modifications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrsCCptP2CFLVg90H21EOLACvtfcHk0ligdcVO3kAbtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnvF2jsbw%253D&md5=2306b3661a368105f6f2dd84f8527efb</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fbi200249h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi200249h%26sid%3Dliteratum%253Aachs%26aulast%3DRuiz-Carrillo%26aufirst%3DD.%26aulast%3DKoch%26aufirst%3DB.%26aulast%3DParthier%26aufirst%3DC.%26aulast%3DWermann%26aufirst%3DM.%26aulast%3DDambe%26aufirst%3DT.%26aulast%3DBuchholz%26aufirst%3DM.%26aulast%3DLudwig%26aufirst%3DH.%2BH.%26aulast%3DHeiser%26aufirst%3DU.%26aulast%3DRahfeld%26aufirst%3DJ.%2BU.%26aulast%3DStubbs%26aufirst%3DM.%2BT.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DStructures%2520of%2520glycosylated%2520mammalian%2520glutaminyl%2520cyclases%2520reveal%2520conformational%2520variability%2520near%2520the%2520active%2520center%26jtitle%3DBiochemistry%26date%3D2011%26volume%3D50%26spage%3D6280%26epage%3D6288%26doi%3D10.1021%2Fbi200249h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Schilling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niestroj, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahfeld, J. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wermann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zunkel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wasternack, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demuth, H. U.</span><span> </span><span class="NLM_article-title">Identification of human glutaminyl cyclase as a metalloenzyme. Potent inhibition by imidazole derivatives and heterocyclic chelators</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">49773</span><span class="NLM_x">–</span> <span class="NLM_lpage">49779</span><span class="refDoi"> DOI: 10.1074/jbc.M309077200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=10.1074%2Fjbc.M309077200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=14522962" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpslSrurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=49773-49779&author=S.+Schillingauthor=A.+J.+Niestrojauthor=J.+U.+Rahfeldauthor=T.+Hoffmannauthor=M.+Wermannauthor=K.+Zunkelauthor=C.+Wasternackauthor=H.+U.+Demuth&title=Identification+of+human+glutaminyl+cyclase+as+a+metalloenzyme.+Potent+inhibition+by+imidazole+derivatives+and+heterocyclic+chelators&doi=10.1074%2Fjbc.M309077200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Human Glutaminyl Cyclase as a Metalloenzyme: Potent inhibition by imidazole derivatives and heterocyclic chelators</span></div><div class="casAuthors">Schilling, Stephan; Niestroj, Andre J.; Rahfeld, Jens-Ulrich; Hoffmann, Torsten; Wermann, Michael; Zunkel, Katrin; Wasternack, Claus; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">49773-49779</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Human glutaminyl cyclase (QC) was identified as a metalloenzyme as suggested by the time-dependent inhibition by the heterocyclic chelators 1,10-phenanthroline and dipicolinic acid.  The effect of EDTA on QC catalysis was negligible.  Inactivated enzyme could be fully restored by the addn. of Zn2+ in the presence of equimolar concns. of EDTA.  Little reactivation was obsd. with Co2+ and Mn2+.  Other metal ions such as K+, Ca2+, and Ni2+ were inactive under the same conditions.  Addnl., imidazole and imidazole derivs. were identified as competitive inhibitors of QC.  An initial structure activity-based inhibitor screening of imidazole-derived compds. revealed potent inhibition of QC by imidazole N-1 derivs.  Subsequent data base screening led to the identification of two highly potent inhibitors, 3-[3-(1H-imidazol-1-yl)propyl]-2-thioxoimidazolidin-4-one and 1,4-bis-(imidazol-1-yl)-methyl-2,5-dimethylbenzene, which exhibited resp. Ki values of 818 and 295 nM.  The binding properties of the imidazole derivs. were further analyzed by the pH dependence of QC inhibition.  The kinetically obtained pKa values of 6.94, 6.93, and 5.60 for imidazole, methylimidazole, and benzimidazole, resp., match the values obtained by titrimetric pKa detn., indicating the requirement for an unprotonated nitrogen for binding to QC.  Similarly, the pH dependence of the kinetic parameter Km for the QC-catalyzed conversion of H-Gln-7-amino-4-methylcoumarin also implies that only N-terminally unprotonated substrate mols. are bound to the active site of the enzyme, whereas turnover is not affected.  The results reveal human QC as a metal-dependent transferase, suggesting that the active site-bound metal is a potential site for interaction with novel, highly potent competitive inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolRoNA9eEuXrVg90H21EOLACvtfcHk0ljYjJ3bW2zDKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpslSrurw%253D&md5=372bdb3cf7603da16c3c2cc888a54cb1</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M309077200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M309077200%26sid%3Dliteratum%253Aachs%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DNiestroj%26aufirst%3DA.%2BJ.%26aulast%3DRahfeld%26aufirst%3DJ.%2BU.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DWermann%26aufirst%3DM.%26aulast%3DZunkel%26aufirst%3DK.%26aulast%3DWasternack%26aufirst%3DC.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DIdentification%2520of%2520human%2520glutaminyl%2520cyclase%2520as%2520a%2520metalloenzyme.%2520Potent%2520inhibition%2520by%2520imidazole%2520derivatives%2520and%2520heterocyclic%2520chelators%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D49773%26epage%3D49779%26doi%3D10.1074%2Fjbc.M309077200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PBB" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PBB','PDB','3PBB'); return false;">PDB: 3PBB</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i70"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00648">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_88207"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b00648">10.1021/acs.jmedchem.7b00648</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Evaluation of the house building capacity of the AD mice by Nesting test and the predicted ADMET_BBB and ADMET_AlogP98 of selected analogues (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00648/suppl_file/jm7b00648_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00648/suppl_file/jm7b00648_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00648/suppl_file/jm7b00648_si_001.pdf">jm7b00648_si_001.pdf (201.77 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00648/suppl_file/jm7b00648_si_002.csv">jm7b00648_si_002.csv (2.87 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-15%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b00648%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b00648" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                8MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67998a6c992f3d5a","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
